2020-06-11T15:05:13Zhttps:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi
oai:pubmedcentral.nih.gov:71488862020-04-13pheelsevierpmc-open
Methods in Microbiology 0580-9517 0580-9517 Elsevier B.V. PMC7148886 PMC7148886 7148886 S0580-9517(04)34010-9 10.1016/S0580-9517(04)34010-9 Article Real-time Fluorescent PCR Techniques to Study Microbial–Host Interactions Mackay Ian M 1 2 Arden Katherine E 1,2 Nitsche Andreas 3 Clinical Virology Research Unit, Sir Albert Sakzewski Virus Research Centre, Royal Children's Hospital, Brisbane, Qld, Australia Clinical Medical Virology Centre, University of Queensland, Brisbane, Qld, Australia Robert Koch Institute, Berlin, Germany 1 12 2004 2004 1 12 2004 34 255 330 Copyright © 2004 Elsevier B.V. All rights reserved. 2004 Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. Publisher Summary

This chapter describes how real-time polymerase chain reaction (PCR) performs and how it may be used to detect microbial pathogens and the relationship they form with their host. Research and diagnostic microbiology laboratories contain a mix of traditional and leading-edge, in-house and commercial assays for the detection of microbes and the effects they impart upon target tissues, organs, and systems. The PCR has undergone significant change over the last decade, to the extent that only a small proportion of scientists have been able or willing to keep abreast of the latest offerings. The chapter reviews these changes. It discusses the second-generation of PCR technology—kinetic or real-time PCR, a tool gaining widespread acceptance in many scientific disciplines but especially in the microbiology laboratory.

Introduction

The development and introduction of new investigative molecular technologies have begun to change the way we think about virulence and pathogenicity. One such technology is the real-time polymerase chain reaction (PCR). In the context of infectious disease, diagnostic microbiology can be divided into two broad sections: routine qualitative screening or detailed qualitative and quantitative investigations of the interplay between the microbe and host. The following review will describe how real-time PCR performs and how it may be used to detect microbial pathogens and elucidate the relationship they form with their host.

Research and diagnostic microbiology laboratories contain a mix of traditional and leading edge, in-house and commercial assays for the detection of microbes and the effects they impart upon target tissues, organs and systems. The wide variety of assays is the result of many factors including the perceived reliability of familiar techniques and technologies, the scope of a test to perform the required task, the existence and cost of commercial tests able to detect microbes of interest, the experience a laboratory has acquired with a particular technique and finally the degree of support offered by the assay manufacturer. Additionally, the cost of a new system may be over-estimated prior to its use in the laboratory, adding to slow uptake of new technologies. In the modern microbiology laboratory, an increasing role is played by molecular techniques and, in particular, the PCR (Freymuth et al., 1995, Mullis and Faloona, 1987). The PCR has undergone significant change over the last decade, to the extent that only a small proportion of scientists have been able or willing to keep abreast of the latest offerings. This chapter will review these changes, bringing the reader up to date with the second-generation of PCR technology: kinetic or real-time PCR, a tool gaining widespread acceptance in many scientific disciplines but especially in the microbiology laboratory (Ginzinger, 2002, Whelan and Persing, 1996).

The ABC of PCR

Microbiology is in the midst of a new era. Technologies that detect nucleic acids have driven the evolution of a plethora of new experimental tools rapidly replacing some traditional methods, which depend on microbial phenotype rather than genotype. For example, it has become common to relegate viral culture to specialised virology laboratories rather than include it in the routine diagnostic laboratory, which can then focus on rapid result turnaround (Carman, 2001). The speed with which a negative result is provided is often as important as the return of a positive result and, when cultures can require weeks to complete, the PCR offers an attractive alternative (Carman, 2001). Of course, speed is the result of a number of factors, and they must all be taken into account when assessing the benefits of any new PCR-based assay. Faster assays must be described using the final optimised and validated test performed on real-world specimens instead of presenting preliminary data using idealised templates and conditions. Unfortunately, incomplete PCR assays are frequently rushed into publication resulting in problems reproducing data in other laboratories.

The PCR is the most commonly used molecular technique to detect and study microbes, appealing more widely than specific commercial template amplification technologies such as Abbott's ligase chain reaction (LCR) (Barany, 1991), Organon Teknika's nucleic acid sequence-based amplification (NASBA) (Compton, 1991, Kievits et al., 1991), Becton Dickinson's strand-displacement amplification (SDA) (Walker et al., 1992) and Gen-Probe's transcription-mediated amplification (TMA). PCR has also been applied more widely than the signal amplification methods such as Bayer's branched DNA (bDNA) and Digene's Hybrid Capture (Fredricks and Relman, 1999, Whelan and Persing, 1996, Persing, 1993). The PCR method utilises a pair of synthetic oligonucleotides called primers, each one hybridising in a 5′ to 3′ orientation to a single strand of a DNA target. The primer pair spans a region that is exponentially duplicated during the subsequent reaction. Each hybridised primer forms a starting point for the production of complementary DNA via the action of a DNA polymerase derived from thermophilic bacteria. The process of primer extension creates a strand that is the complement of the template through the sequential addition of deoxynucleotides. The PCR can be summarised in three steps: (i) double-stranded DNA (dsDNA) separation at temperatures above 90°C, (ii) primer annealing at a specific temperature commonly between 50 and 60°C and, (iii) optimal extension of the primed template at 70–78°C (Figure 10.1). A compact PCR format is recommended with some PCR assays which require only two steps: the denaturation and a combined annealing and extension step.

Time versus temperature plot during a single PCR Cycle. The denaturation (D), primer and probe annealing (A) and primer extension (E) steps are shown. At the indicated optimal temperature ranges, dsDNA denatures (TD) then oligoprobes anneal (TM-PROBE) followed by the primers (TM-PRIMER) as a precursor to their extension. The actual thermal cycler incubation temperature (dashed line) may overshoot the desired temperature to varying degrees, depending on the quality of the thermal cycler employed

The oligonucleotide annealing temperature is usually referred to as the T M (melting temperature) but is in fact 5–10°C below the T M. The term T M describes the temperature at which 50% of the oligonucleotide–target duplexes have formed. The T M is dependent upon the concentration of the DNA, its length, nucleotide sequence and the composition of the solvent in which the DNA is suspended (Ririe et al., 1997).

The rate of temperature change in the reaction vessel, or ramp rate, the length of the incubation at each temperature and the number of times each cycle of temperatures is repeated, are all controlled by a programmable thermal cycler. Current technologies have significantly shortened the ramp rates and therefore total assay times, using electronically controlled heating blocks or fan-forced heated airflows.

Existing combinations of PCR and PCR product (amplicon) detection assays will be called “conventional PCR” throughout this chapter. These detection systems include analytical agarose gel electrophoresis (Kidd et al., 2000), Southern blot and ELISA-like systems such as ELAHA and ELOSA (van der Vliet et al., 1993, Chandelier et al., 2001, Mackay et al., 2001, Hyypiä et al., 1998). Traditional detection of amplified DNA relies upon its electrophoresis in the presence of ethidium bromide followed by visualisation or computer-assisted densitometric analysis of the bands during irradiation by ultraviolet light (Kidd et al., 2000). Whilst Southern blot detection of amplicon by hybridisation with a labelled oligonucleotide probe (oligoprobe) increases the specificity of amplicon detection, it is time consuming, frequently uses radioactive labels and requires multiple PCR product handling steps, increasing the risk of spreading amplicon throughout the laboratory (Holland et al., 1991). Alternatively, PCR–ELISA has been used to capture amplicon onto a solid phase via biotin or digoxigenin-labelled primers, oligoprobes or by direct capture after incorporation of the biotin or digoxigenin into the amplicon (van der Vliet et al., 1993, Keller et al., 1990, Kemp et al., 1990, Kox et al., 1996, Dekonenko et al., 1997, Watzinger et al., 2001). Once captured, amplicon is detected using an enzyme-labelled avidin or anti-digoxigenin reporter molecule in a manner similar to a standard ELISA format. PCR–ELISA has the added benefit of utilising hardware and techniques commonly available to the ELISA-enabled research and diagnostic microbiology laboratory.

The possibility that, in contrast to conventional PCR, real-time PCR could detect amplicon as it accumulated was welcomed by researchers and diagnostic scientists alike. This feat has expanded the view of PCR as a specialist tool to that of a versatile technology providing advanced and powerful systems for the research laboratory as well as permitting the development of contamination-resistant routine diagnostic applications for the clinical microbiology laboratory (Lomeli et al., 1989, Cockerill and Smith, 2002). Along the way, real-time PCR assays have provided insights into the nuts and bolts of the PCR as well as the performance of different nucleic acid extraction methods and the role some compounds play to inhibit amplification (Holland et al., 1991, Rosenstraus et al., 1998, Lee et al., 1993, Livak et al., 1995, Heid et al., 1996, Gibson et al., 1996, Niesters et al., 2000, Read, 2001, Biel et al., 2000, Petrik et al., 1997). Real-time PCR has allowed many more scientists to become familiar with the crucial factors contributing to successful amplification of nucleic acids and in its largest role to date, made the quantitation of gene transcription much simpler and faster. This has proven to be a valuable area of study since many cellular functions are regulated by changes in gene expression (Bustin, 2002, Balnaves et al., 1995). Today in microbiology, real-time PCR detects and quantifies nucleic acids from widely diverse targets including food, viral and non-viral vectors used in gene therapy protocols, genetically modified organisms and to study human and veterinary microbiology, oncology and immunology (Böhm et al., 1999, Kruse et al., 1997, Stordeur et al., 2002, Härtel et al., 1999, Fraaije et al., 2001, Nogva et al., 2000, Barzon et al., 2003, Klein, 2002, Rudi et al., 2002, Mackay et al., 2002, Ahmed, 2002, Mhlanga and Malmberg, 2001).

The monitoring of accumulating amplicon in real time has been made possible by the labelling of primers, oligoprobes or amplicon with molecules exhibiting fluorescent potential. The success of these assays revolves around a rapid and measurable signal change after the interaction of amplicon and fluorescent label (Morrison et al., 1989). The signal is related to the amount of amplicon present during each cycle, increasing as the DNA is replicated. The fluorescent chemistries have clear benefits over earlier radiogenic labels including an absence of radioactive emissions, easy disposal and an extended shelf life (Matthews and Kricka, 1988).

Although some of the oligoprobe systems have been given a specific nomenclature by their developer, we will use the term “fluorophore” to describe the fluorescent moieties, and their inclusion on an oligonucleotide will imply that the resulting oligoprobe has fluorogenic properties.

The Good With the Bad

Traditional diagnostic microbiological assays include microscopy, microbial culture and ELISA, which aim to detect microbial antigens or the host response to microbial presence. The performance of these assays can be limited by poor sensitivity, slowly growing or poorly cytopathic microbes, reduced microbial viability, narrow detection windows, complex result interpretation, host immunosuppression, antimicrobial therapies, high levels of background signal and non-specific cross-reactions (Whelan and Persing, 1996, Carman et al., 2000). Nonetheless, microbial culture and rapid immunofluorescence assays are used to produce valuable epidemiological data, revealing new, uncharacterised or atypical microbes and yielding intact or infectious organisms for further study (Ogilvie, 2001). Although detection of microbial genomic nucleic acids is not identical to the detection of infectious particles, there is good correlation between infectivity and the viral genome as we have found for yellow fever virus (Bae et al., 2003).

Fluorescence microscopy still remains a popular and rapid screening tool for samples containing large microbial loads whilst ELISA and related methods are ideal for identifying detectable levels of immune or cell function modulators (Lipson, 2002). It is, therefore, clear that the role of the traditional assay, be it in screening or research, continues to be an important one (Biel and Madeley, 2001, Pfaller, 1999, Sintchenko et al., 1999, Ellis and Zambon, 2002, Clarke et al., 2002, Johnson, 2000).

The PCR does have some significant limitations. Our ability to design oligonucleotide primers only extends to our knowledge of the sequence of the template (usually the genome of a microorganism or its host) as well as the ability of publicly available sequence databases to suitably represent all variants of that target sequence. It is common for microbial genomes to contain unexpected “mutations”, i.e. nucleotide changes compared to known microbial sequences, which reduce or abrogate the function of a PCR. Additionally, it is often the effects of these variations on colonisation and pathogenesis which warrant further study. Each PCR assay requires careful optimisation of several variables, ensuring that primer and magnesium concentrations are perfected as well as selecting the best polymerase for the assay (Kreuzer et al., 2000, Wolffs et al., 2004). Also, new batches of reagents must be carefully tested against previous batches (Burgos et al., 2002). This testing is especially important for oligonucleotides since all manufacturers have “bad days” that equate to wasted time and added frustration for the assay developer. The use of standardised assay panels and the introduction of international units have begun to improve microbial diagnostics for the limited number of pathogens these encompass (Valentine-Thon, 2002).

False positive results due to amplicon carry-over contamination have always been a major concern for the routine implementation of PCR in the diagnostic laboratory and this has led to strict guidelines for laboratory design and work flow (McCreedy and Callaway, 1993). There are also occasions when the PCR is too sensitive, detecting a microbe that is present below pathogenic levels. Thus, care is required not only for assay design but also for result interpretation.

Real-time PCR assays also carry specific disadvantages compared to conventional PCR, including the inability of certain platforms to detect some fluorogenic chemistries and the relatively restricted multiplex capabilities of current systems. Also, the start-up expense of real-time PCR instruments is prohibitive for many low-throughput laboratories and ongoing costs are higher when compared to agarose gel amplicon detection although lower than many PCR–ELISA formats.

A significant improvement introduced by real-time PCR is the increased speed with which results can be produced. This is largely due to the removal of a separate post-PCR detection step, the use of sensitive fluorescence-detection equipment which permits earlier amplicon detection and the shortened cycle times possible on some instruments (Wittwer et al., 1990, Wittwer et al., 1997b). A reduced amplicon size may also increase assay speed, however, we and others have shown that decreased product size does not strictly correlate with improved PCR efficiency but the distance between the primers and the oligoprobe does play a vital role (Nitsche et al., 2000, Balnaves et al., 1995, Lunge et al., 2002).

Generating a fluorescent signal

Most of the popular real-time PCR chemistries involve hybridisation of one or more fluorescent oligoprobes to a complementary sequence on one of the amplicon strands. Therefore, the inclusion of more of the primer that creates the strand complementary to the oligoprobe – a process called asymmetric PCR – is often beneficial to the generation of an increased fluorescent signal (Gyllensten and Erlich, 1988, Barratt and Mackay, 2002). However, it is critical to determine which strand to target, particularly in the case of single stranded genomes such as those harboured by negative or positive sense viruses.

As mentioned earlier, post-amplification manipulation of the PCR product is not necessary to detect amplicon using real-time PCR because the fluorescent signals are directly measured as they exit the reaction vessel. Therefore, real-time PCR assays are often described as homogeneous or “closed” systems; combining template amplification and amplicon detection into a single reaction. Apart from the time saved by amplifying and detecting template in a single tube, there is minimal potential for amplicon carry-over contamination and the assay's performance can be closely scrutinised without introducing errors due to handling of the PCR product (Higuchi et al., 1993). An often overlooked benefit to the use of real-time PCR is its overall cost effectiveness on a per-run basis, when implemented in a high-throughput laboratory (Martell et al., 1999), particularly when replacing conventional PCR and gel or probe-based amplicon detection systems or microbial culture.

The most commonly used fluorogenic oligoprobes rely upon fluorescence resonance energy transfer (FRET; Figure 10.2) between fluorogenic labels or between one fluorophore and a dark, or black-hole, non-fluorescent quencher (NFQ), which disperses energy as heat rather than fluorescence (Didenko, 2001). FRET is a non-radiative process in which energy is passed between permissive molecules that are spatially separated by 10–100 Å and which have overlapping emission and absorption spectra (Stryer and Haugland, 1967, Heller and Morrison, 1985, Clegg, 1992). Förster primarily developed the theory behind this process (Förster, 1948). The energy transfer reduces the lifetime of the excited state of electrons in the original fluorophore by taking the emitted excess energy and expelling it either as heat or fluorescence. The efficiency of energy transfer is proportional to the inverse sixth power of the distance (R) between the donor and acceptor (1/R 6) fluorophores (Selvin, 1995, Didenko, 2001). FRET permits the determination of nucleic acid hybridisation, without the prior removal of unbound probe required for other hybridisation techniques (Cardullo et al., 1988).

Mechanisms of fluorescence resonance energy transfer (FRET). When the reporter (R) and quencher (Q, unfilled) of a nuclease oligoprobe are in close proximity and illuminated by an instrument's light source (where h is Planck's constant and ν is the frequency of the electromagnetic radiation); (a) the quencher “hijacks” the emissions from excitation of the reporter. The quencher then emits this energy. When the fluorophores are separated, as occurs upon oligoprobe hydrolysis as depicted in (b), the quencher can no longer influence the reporter which now fluoresces at a distinctive wavelength recorded by the instrument. In the reverse process using adjacent oligoprobes (c), the fluorophores begin the cycle as separated entities. Whilst the emission of the donor (D) is monitored, it is the signal from the acceptor (A) produced when in close proximity to the donor that indicates a positive reaction (d). In (e), another form of quenching is shown, caused by the intimate contact of labels attached to hairpin oligoprobes. The fluorophore (F) and an NFQ (Q, filled) interact more by collision than FRET, disrupting each other's electronic structure and directly passing on the excitation energy which is dissipated as heat (jagged, arrows). When the labels are separated, as is the case in (f), the fluorophore is free to fluoresce

Fluorescence data generated by real-time PCR assays are generally collected from PCR cycles that occur early in the reaction where amplification conditions are optimal and the fluorescence accumulates in proportion to the amplicon (Figure 10.3). Because the emissions from fluorescent chemistries are temperature-dependent, data is generally acquired only once per cycle, at the same temperature (Wittwer et al., 1997a). Signal detection occurring at the end point of the reaction is not ideal since amplicon accumulation may have been adversely affected by inhibitors, poorly optimised reaction conditions or saturation effects caused by excess double-stranded amplicon. In fact at the end point there may be no relationship between the initial template and final amplicon concentrations (Figure 10.3).

Kinetic analysis of amplicon accumulation. A chart of the amplification of a template by real-time PCR (solid line) ideally appears as a sigmoidal curve when plotted as cycle number versus fluorescence emission intensity. Early exponential amplification cannot be viewed because the signal is below the sensitivity of the detector. However, when enough amplicon is present, the assay's exponential progress can be monitored as the rate of amplification enters a log-linear phase (LP). Under ideal conditions, the amount of amplicon increases at a rate of one log10 every 3.32 cycles (i.e. it doubles, or increases by one log2 every cycle). As primers and enzymes become limiting and products accumulate that are inhibitory to the PCR or compete for hybridisation with an oligoprobe, the reaction slows, entering a transition phase (TP). Eventually a plateau phase (PP) is reached in which there is little or no increase in fluorescent signal although amplicon may continue to accumulate. Some fluorescent detection chemistries display an overall reduction in fluorescence intensity after the plateau phase (Hook). The point at which fluorescence surpasses a pre-defined background noise (dashed horizontal line) is called the threshold cycle or crossing point (CT or CP; indicated by an arrow). These data are used for the calculation of template quantity when constructing a standard curve. Traditional PCR data collection is performed at the end of the assay (dashed vertical line). Also shown are curves representing a serial titration of template (dashed curves), consisting of decreasing starting template concentrations, which produce increasing numerical CT or CP values

The fractional cycle number at which the real-time fluorescence signal mirrors progression of the amplification reaction above the background noise level is used as an indicator of successful target amplification (Wilhelm et al., 2001a). Most commonly, this is called the threshold cycle (C T) but the same value is described for use with the LightCycler where the fractional cycle is called the crossing point (C P). The C T is defined as the PCR cycle at which the gain in fluorescence generated by the accumulating amplicon exceeds 10 standard deviations of the mean baseline fluorescence, using data taken from cycles 3 to 15 (Jung et al., 2000). The C T and C P are proportional to the number of template copies present in the sample (Gibson et al., 1996). The values are assumed to represent equal amounts of amplicon in each vessel at the time of measurement, since the C T and C P values are acquired from a single fluorescence intensity value (Figure 10.3). In practice C T and C P are calculated after the definition of a noise band which excludes data from early PCR cycles that cannot be distinguished from background fluorescence. Therefore the final C T and C P value is the fractional cycle at which a specimen's plotted PCR curve intersects a single fluorescence value (usually at or close to the noise band; Figure 10.3, Wilhelm et al., 2001a). The accuracy of the C T or C P depends upon the concentration and nature of the fluorescence-generating system, the amount of template initially present, the sensitivity of the fluorescence detector and its ability to discriminate specific fluorescence from background noise.

Real-time instrumentation

Broadly speaking, real-time PCR instruments (Table 10.1 ) can be divided into two classes based on the method used to heat the reaction vessel: the block thermal cyclers and the air thermal cyclers. Block cyclers generally ramp at 1–10°C/s whereas heated air cyclers can ramp as quickly at 20°C/s. The faster rates permit 10–20 min assays (excluding hands-on time); however, these times are infrequently reported for microbial real-time PCR assays, probably due to technical difficulties when applied to clinical specimens under real-life conditions. An off-shoot of the block cyclers are miniaturised thermal cyclers capable of performing real-time PCR but constructed of sturdy solid-state and relatively low-cost materials permitting transport of the PCR laboratory onto the site of testing (Northrup, 1998, Ibrahim et al., 1998).

Popular real-time PCR instrumentation

BrandCompanyLight sourceCapacityHeating methodReal time
LightCyclerRocheLED32Air✓
iCyclerBioRadHalogen96–384Block✓
Mx4000StratageneHalogenBlock✓
RotorGeneCorbettLEDs36–72Air✓
7700 (discontinued)Applied BiosystemsLaser96Block✓
7900HTApplied BiosystemsLaser96Block✓
7000Applied Biosystems96Block✓
ChimaeraHybaidHalogen96Block✓
DNA Engine Opticon 2MJ ResearchLEDs96Block✓
SmartcyclerCepheidLEDs16Block✓

The quality of the instrument has a significant role in the reproducibility of results, which subsequently influences how well a described protocol transports between laboratories around the world. A common discrepancy between systems is the temperature profile of a PCR cycle (Schoder et al., 2003). Since temperature affects enzyme function, fluorescence and oligonucleotide binding, it is an important consideration during the purchase of a real-time PCR system.

The majority of PCR thermal cyclers use capped plastic reaction vessels to house the amplification reaction. However, the LightCycler (Roche Molecular Biochemicals, Germany) differs by using glass capillaries (Wittwer et al., 1997a). The LightCycler's plastic and glass composite capillaries are optically clear and act as cuvettes for fluorescence analysis, as well as facilitating rapid heat transfer. However, they are fragile and require some experience to handle (Schalasta et al., 2000a). For the Roche LightCycler and the Corbett Robotics RotorGene, the temperature is varied by rapidly heating and cooling air using a heating element and fan which produce ramp rates of 2.5 and 20°C/s, respectively. Faster rates prolong polymerase survival and significantly shorten the assay's completion time but existing assays may require some fine tuning (Weis et al., 1992).

In the following sections, we will focus on real-time PCR performance especially the rapidly expanding range of real-time PCR chemistries. Also, we will review the application of real-time PCR to determine the interplay between microbe and host via microbial diagnosis and quantitation. We will also describe the limitations imparted upon real-time PCR by instrument design and the paucity of fluorophores. Although this review focuses on the application of fluorogenic chemistries to real-time PCR applications, they are also valuable as fluorogenic end-point amplicon detection assays. In these instances the ability to collect data as the amplicon accumulates, i.e. kinetic analysis, is lost but the systems retain a homogeneous format.

Detecting amplicon using fluorescence

It is the amplicon detection processes that discriminate real-time PCR from conventional PCR assays. There are a range of chemistries currently in use and these can be broadly categorised as amplicon specific or non-specific (Whitcombe et al., 1999). To further clarify, the amplicon itself is produced from a PCR using sequence-specific primers. However, the specificity we refer to is that of amplicon detection. The difference arises from the use of a fluorophore that interacts with any and all dsDNA such as SYBR® green I, or the use of a sequence-specific, fluorogenic oligoprobe. In general, however, the specific and non-specific fluorogenic chemistries detect amplicon with equal sensitivity (Wittwer et al., 1997b) and have recently been reviewed in detail (Mackay et al., 2002). New fluorogenic systems continue to be described but few applications for the specific detection, quantitation and genotyping of microbes using these recent chemistries have been reported. Undoubtedly some of these new chemistries are the result of pure research projects; however, it is tempting to propose that at least some of these chemistries have been developed in order to circumvent patents rather than to significantly advance the technology.

DNA-associating Fluorophores

The DNA-associating fluorophore is the basis of the non-specific real-time PCR detection methods. Many of these molecules interact with dsDNA by associating with the minor groove of the DNA duplex. As a group, these fluorophores display minimal fluorescence when free in solution, but fluoresce strongly when associated with nucleic acids which occur with high affinity. The simplest real-time PCR reporter systems are included within the DNA-associating fluorophores. Ethidium bromide (Higuchi et al., 1992), YO-PRO-1 (Ishiguro et al., 1995, Tseng et al., 1997), SYBR® green I (Morrison et al., 1998b), SYBR Gold (Tuma et al., 1999), BEBO (Bengtsson et al., 2003) and LCGreen (Vaisse et al., 1996) are all molecules which fluoresce when associated with dsDNA which is exposed to a wavelength of light capable of exciting the fluorophore. This approach to detection is inexpensive and simpler than the design requirements of fluorogenic oligoprobes and is minimally affected by small changes in template sequence which may abrogate hybridisation of an oligoprobe (Komurian-Pradel et al., 2001). However, recent evidence suggests that SYBR green I preferentially binds to amplicon species that melt at higher temperatures, indicating a preference for G+C-rich regions, which would prove detrimental to its use in multiplex assays (Giglio et al., 2003). Possibly, SYBR Green I binds to high-temperature duplexes after melting off lower temperature duplexes, resulting in a hierarchy of melting peak heights expressing no relation to starting template concentration (Vaisse et al., 1996). A recent addition to this chemistry, LCGreen, displays a higher sensitivity for lower temperature duplexes (Vaisse et al., 1996).

Primer–dimer formation is common and is strongly associated with the entry of the PCR into a plateau phase of amplification (Figure 10.3; Chou et al., 1992, Halford, 1999, Halford et al., 1999). Association of a DNA-binding fluorophore with primer–dimer or with another non-specific amplification product can confuse interpretation of the PCR results. The problem of primer–dimer can be addressed using software capable of fluorescent melting curve analysis (FMCA). We will describe the use of FMCA for genotyping in a later section (Figure 10.18); however, in the context of SYBR green I, FMCA is completed in minutes, requires no amplicon manipulation and utilises the temperature at which a dsDNA amplicon denatures or “melts” (T D; Figure 10.1). The shorter primer–dimer can theoretically be discriminated by its reduced T D compared to the full-length amplicon. Practically, this discrimination is heavily reliant upon the G+C content of both the specific amplicon and any primer–dimer, as well as the length of the amplicon. Analysis of the melting character of an amplicon in the presence of SYBR green I has shown that the sensitivity of DNA-binding fluorophores is limited by non-specific amplification at low initial template concentrations (Wittwer et al., 1997a). Unfortunately, limited template is a frequent occurrence when analysing patient specimens. The contribution of non-specific products to the accumulating fluorescence signal can be reduced in many instances by selecting a data collection temperature above the known T D of the unwanted products (Morrison et al., 1998a). However, there is no reliable real-time PCR solution to discriminate non-specific amplicon when it has a similar or higher T D than the target amplicon species.

DNA binding fluorophores increase the T D and broaden the melting transition, requiring substantial sequence change to produce a noticeable shift in the T D compared to using the T M to discriminate nucleotide polymorphisms. Oligoprobes permit the clear discrimination of single point mutation using the T M (Wetmur, 1991). This is especially useful for discriminating related microbes.

Fluorogenic Oligoprobe and Primer Chemistries

The adoption of oligoprobes has added an additional layer of specificity to the PCR by confirming the sequence of the amplicon, in addition to the binding of a specific pair of primers. By using an excess of oligoprobe, the time required for it to hybridise with its target is significantly reduced (Wetmur, 1991). This is especially so when the amount of that target has been increased by PCR or some other molecular amplification process (Morrison et al., 1989).

While the most common oligoprobes are based on conventional nucleic acid chemistry, peptide nucleic acids (PNA) are becoming an increasingly popular choice for oligonucleotide backbones. PNA are a DNA analogue formed from neutral, repeated N-(2-aminoethyl) glycine units instead of the negatively charged sugar phosphates of DNA (Egholm et al., 1993). The PNA oligoprobe retains the same sequence recognition properties of DNA but it cannot be extended or hydrolysed by a DNA polymerase. A more recent family of DNA analogues are the locked nucleic acids (LNA; 2′-O,4′-C-methylene-β-d-ribofuranosyl) (Singh et al., 1998, Koshkin et al., 1998, Obika et al., 1998, Kumar et al., 1998, Petersen and Wengel, 2003). LNA are modified nucleic acids in which the sugar has been conformationally “locked”, imparting unprecedented hybridisation affinity towards DNA and RNA. LNA monomers can be added to a synthetic oligonucleotide as desired using conventional phosphoramidite chemistry and their addition increases the thermal stability of the oligo permitting the construction of shorter oligoprobes for real-time PCR applications (Simeonov and Nikiforov, 2002).

To be optimal, an oligonucleotide label must easily attach to DNA and be detectable at low concentrations. The label or labels should produce an altered signal upon specific hybridisation, remain biologically innocuous and be stable at elevated temperatures. Additionally, the label should not interfere with the activity of the polymerase (Matthews and Kricka, 1988, Holland et al., 1991).

General considerations for the design of a fluorogenic oligoprobe should include a length of 20–40 nt with a G+C content of 40–60%. The oligoprobe should neither contain clusters of a single nucleotide, particularly G, nor should it have repeated sequence patterns nor hybridise with the forward or reverse primers. A fluorescent label should efficiently absorb and emit energy and release its emissions at dissimilar wavelengths so that excitation and emission can occur concurrently. The relationship between a fluorescence signal indicating positive hybridisation and a signal from unwanted fluorescence is often referred to as the signal-to-noise ratio (signal:noise). A high signal:noise is preferred. Generally speaking, this can best be achieved by oligoprobe chemistries that utilise an NFQ and function through a unimolecular signalling configuration, i.e. only one molecule is required to directly indicate the presence of amplicon.

Deoxyguanosine nucleotides (G) naturally quench some fluorophores (e.g. FITC) in a position-dependent manner (Crockett and Wittwer, 2001). Natural quenching varies linearly with a defined concentration range of template. The level of quenching can be increased if more guanines are present or if a single guanine is located in the first non-hybridised position of the oligoprobe:amplicon duplex. In this position, the G will be located one nucleotide beyond the fluorophore-labelled terminus of the probe, where it will remain free once the oligoprobe has hybridised to the target amplicon. A hybridised G does not quench to the same degree as a free G. This knowledge has been applied to some amplicon detection approaches since a single labelled oligonucleotide is easy to design and use and relatively simple to synthesise. In addition, this approach does not require a DNA polymerase with nuclease activity (Crockett and Wittwer, 2001).

Ideally, an oligoprobe should have a T M at least 5°C higher than that of the primers, to ensure the oligoprobe(s) hybridises with its template before extension of the primers begins (Landt, 2001). This caveat also applies to each component of a multi-oligonucleotide fluorogenic chemistry requiring two or more hybridisation events for effective signalling such as the tripartite molecular beacons (TMB), universal template (UT) oligoprobe or duplex scorpion primers.

All the non-incorporating, nucleotide-based, oligoprobe chemistries described in the following sections include a 3′ phosphate or similar moiety, which blocks their extension by the DNA polymerase preventing the oligoprobe acting as a primer, but imparting no effect on the amplicon's yield. These fluorogenic chemistries can be divided into two classes: those which are destroyed to produce fluorescence and those which are not. Oligoprobes depending on a destructive process for signal generation are usually located close to the primer that hybridises to the same strand in order to maximise the chance that polymerase will make contact with the bound oligoprobe. Non-destructive oligoprobes are usually located as far as possible from the primer on the same strand to ensure signal is produced before the polymerase dislodges the duplex. The non-destructive chemistries include linear and hairpin oligoprobes, and incorporating primers. While reviewing these options one should note the number of hybridisation events required to generate a positive signal. Each fluorogenic oligonucleotide must meet and hybridise with its specific amplicon (a bimolecular system). If there is a second oligoprobe required, either to provide a quenching moiety or as a partner for FRET, the likelihood of a chance encounter between all three molecules decreases (a trimolecular system), especially as the amplicon concentration increases. Conversely, the fluorogenic primer systems are incorporated into the nascent amplicon. Therefore, a signal is generated for the remainder of the assay without the need for hybridisation to a new amplicon molecule each cycle (a unimolecluar system).

Destructive oligonucleotide systems

In 1991, Holland et al. described a technique that was to form the foundation for homogeneous PCR using fluorogenic oligoprobes. Radiolabelled amplicon was detected by monitoring the 5′ to 3′ nuclease activity of Taq DNA polymerase on specific oligoprobe and target DNA duplexes. The products were examined using thin layer chromatography and the presence or absence of hydrolysis was used as an indicator of specific duplex formation.

Lee et al. (1993) reported an innovative approach using nick-translation PCR in combination with a dual-fluorophore labelled oligoprobe. In the first truly homogeneous assay of its kind, one fluorophore was added to the 5′ terminus and one to the middle of a sequence-specific oligoprobe. When in such close proximity, the 5′ reporter fluorophore (6-carboxy-fluorescein, FAM) transferred laser-induced excitation energy by FRET to the 3′ quencher fluorophore (6-carboxy-tetramethyl-rhodamine, TAMRA). TAMRA emitted the new energy at a wavelength that was monitored but not specifically utilised in the presentation of data. However, when the oligoprobe is hybridised to its template, the fluorophores were released upon hydrolysis of the oligoprobe component of the probe and target duplex due to the nuclease activity of the DNA polymerase. Once the labels were separated, the reporter's emissions were no longer quenched and the instrument could detect and present the resulting fluorescence data. These oligoprobes have been called 5′ nuclease, hydrolysis or TaqMan® oligoprobes (Figure 10.4).

Function of 5′ nuclease oligoprobes. Following primer hybridisation, the DNA polymerase (pol) progresses along the relevant strand during the extension step of the PCR, displacing and then hydrolysing the oligoprobe. Once the reporter (R) is removed from the extinguishing influence of the quencher (Q), it is able to release excitation energy at a wavelength that is monitored by the instrument and different from the emissions of the quencher. Inset shows the NFQ (Q; filled) and minor groove-binding molecule (grey diamonds) which make up the MGB nuclease oligoprobes. These bimolecular systems acquire data from the reporter's emissions: the opposite of the HybProbe chemistry. Data can be collected during the annealing or extension steps of the PCR

The use of 5′ nuclease probes first required the development of a platform that could excite and detect fluorescence in addition to thermal cycling. A charge-coupled device (CCD) was described in 1992 for the quantification of conventional reverse transcription (RT)-PCR products (Nakayama et al., 1992). In 1993, the CCD was combined with a thermal cycler resulting in the first real-time PCR fluorescence excitation and detection instrument (Higuchi et al., 1993). To date, the commercial version of the platform, the ABI Prism® 7700 sequence detection system (Perkin Elmer Corporation/Applied Biosystems, USA), has been the most frequently reported instrument used with 5′ nuclease oligoprobes.

A recent addition to the destructive chemistry is the UT oligoprobe (Figure 10.5 ; Zhang et al., 2003). This system adds a generic or “universal” sequence to the 5′ end of a PCR primer with which a common 5′ nuclease oligoprobe can hybridise permitting the use of the same oligoprobe for different amplicons. The remainder of the primer provides assay specificity so that multiple primers can be used to amplify numerous targets all detected using the same oligoprobe. During the second PCR cycle, the nascent strand is copied and the polymerase encounters and hydrolyses the bound oligoprobe releasing the reporter and permitting fluorescence to be generated. Because the oligoprobe relies upon hybridisation with a primer, it is possible that this chemistry will also produce fluorescence from the formation of non-specific amplicon.

Function of the UT-oligoprobe. After the UT-primer is extended, the nascent strand acts as the template for the second primer. The polymerase encounters and hydrolyses the UT-oligoprobe whilst extending the second primer in the same fashion as a TaqMan oligoprobe. This trimolecular system can produce fluorescence data from the emissions of the released fluorophore during the annealing or extension steps

Another dual-labelled oligonucleotide sequence has been used as the signal-generating portion of the DzyNA-PCR system (Figure 10.6 ; Todd et al., 2000, Applegate et al., 2002). The reporter and quencher are attached to the termini of an oligonucleotide substrate. Cleavage of the oligosubstrate is performed by a DNAzyme, which is created during the PCR. This creation is the result of the PCR duplicating an antisense DNAzyme sequence included in the 5′ tail of one of the primers. The duplicated sequence is the “functional” form of the DNAzyme. Upon cleavage, the fluorophores are released allowing the production of fluorescence in an identical manner to a hydrolysed 5′ nuclease oligoprobe.

Function of the DzyNA primers. When the strand incorporating the primer is duplicated by a complementary strand (dashed line), a DNAzyme is created. A complementary, dual-labelled oligonucleotide substrate will be specifically cleaved by the DNAzyme releasing the fluorophore (F; circle) from its proximity to the quencher (Q; pentagon), releasing the labels and permitting fluorescence. Data can be collected during the annealing or extension steps of the PCR

Non-destructive oligonucleotide systems Linear chemistries

The majority of fluorogenic oligoprobes fall into the class of linear oligoprobes. In fact, the use of a pair of adjacent, fluorogenic oligoprobes was first described in the mid-1980s, predating the popular 5′ nuclease chemistry but failing to achieve the same degree of early commercial support. The pair of oligonucleotides were used to identify the distance between fluorophores on a complementary nucleic acid template and the system held promise for similar detection within living cells, hinting at further possibilities for diagnostic use (Heller and Morrison, 1985, Cardullo et al., 1988). This trimolecular approach is now known commercially as hybridisation probes (HybProbes), having become the manufacturer's chemistry of choice for the LightCycler™ (Roche Molecular Biochemicals, Germany; Wittwer et al., 1997b). The upstream oligoprobe is labelled with a 3′ donor fluorophore (FITC) and the downstream probe is commonly labelled with either a proprietary LightCycler Red 640 or a Red 705 acceptor fluorophore at the 5′ terminus with a phosphate at the 3′ terminus to prevent extension by the DNA polymerase. When both oligoprobes are hybridised to the amplicon template, the two fluorophores are ideally located within 10 nt of each other (Figure 10.7). The ratio of acceptor to donor emissions can also be used as an internal reference signal rendering the results independent of absolute fluorescence (Huang et al., 2001).

Function of HybProbes. Adjacent hybridisation results in a FRET signal due to interaction between the donor (D) and acceptor (A) spectra detected during the annealing step of the PCR. This trimolecular system (two oligoprobes and a target) acquires its data from the acceptor's emissions: the opposite of the 5′ nuclease oligoprobe chemistry

The double-stranded oligoprobes function by displacement hybridisation (Figure 10.8 ; Li et al., 2002). In this process, a 5′ fluorophore-labelled oligonucleotide is, in its resting state, hybridised with a complementary, but shorter, quenching DNA strand that is 3′ end-labelled with an NFQ. When the full-length complementary sequence in the form of an amplicon is generated, the reporter strand preferentially hybridises to the longer target amplicon strand, disrupting the quenched oligoprobe duplex and permitting the fluorophore to emit its excitation energy directly.

Function of displacement oligoprobes. The shorter NFQ-labelled strand (Q; hexagon) is displaced when the fluorophore-labelled (F; circle) strand preferentially hybridises to the longer specific amplicon strand. Data is collected from this trimolecular system during the annealing step of the PCR

The displacement hybridisation technique can also be used with a fluorophore-labelled primer and, due to added stringency provided by the longer complementary strand, the system performs its own “hot-start” as was shown using an NFQ-labelled PNA strand (Q-PNA; Figure 10.9 ; Stender et al., 2002, Fiandaca et al., 2001). This and the previous chemistry are effectively trimolecular systems since the quenching strand must re-anneal after dissociating with amplicon in order to complete the signalling process. In the Q-PNA approach, a short quenching PNA probe is bound to an unincorporated fluorogenic primer such that the NFQ and fluorophore are adjacent, resulting in a quenched system. However, once the dsDNA amplicon is created by primer extension, the shorter Q-PNA is displaced in favour of the longer target amplicon, after which the fluorophore can fluoresce.

Function of the Q-PNA displacement primer. In the absence of the longer specific amplicon, quenching of the chemistry is achieved by a short NFQ-labelled PNA backbone (grey hexagons) designed to hybridise with the fluorophore-labelled primer (F; circle). Fluorescence data can be collected from this trimolecular system during the annealing and extension steps of the PCR

The first generation Light-up probe (Light-Up Technologies) is also a linear PNA, and is labelled with an asymmetric cyanine fluorophore, thiazole orange (Figure 10.10 ; Svanvik et al., 2001). When hybridised with a nucleic acid target, either as a duplex or triplex, the fluorophore emits fluorescence due to association with amplicon. These probes do not interfere with the PCR, do not require conformational change and they are sensitive to single nucleotide mismatches, permitting further amplicon characterisation. The system is bimolecular and because a single reporter is used, a direct measurement of fluorescence can be made instead of the measurement of a change in fluorescence between two fluorophores (Svanvik et al., 2001, Isacsson et al., 2000). However, non-specific fluorescence has been reported during extended cycling (Svanvik et al., 2000).

Function of the Light-Up Probe. These PNA (grey hexagons) oligoprobes fluoresce when their asymmetric thiazole orange fluorophore (T; open triangle) hybridises to the specific DNA strand. Data is collected from this bimolecular system during the annealing step of the PCR

The HyBeacon™ is a single linear oligonucleotide internally labelled with a fluorophore that emits an increased signal upon formation of a duplex between the target DNA strand and the HyBeacon (Figure 10.11 ; French et al., 2001, French et al., 2002). The HyBeacon and Light-up probe are relatively inexpensive and simple bimolecular systems to design and use.

Function of the HyBeacon Oligoprobe. The fluorophore (F; circle) emits fluorescence when in close proximity to DNA as occurs upon hybridisation with the specific amplicon strand. Data is collected from this bimolecular system during the annealing step of the PCR

The dual-labelled PNA was produced briefly as the Lightspeed probe or linear PNA beacon by Boston Probes Inc., USA (Stender et al., 2002). The oligoprobe is analogous to the TaqMan chemistry terminally labelled with a fluorophore and quencher, but it differs in its backbone, which is PNA (Figure 10.12). In an aqueous solution the PNA backbone brings the fluorophore and quencher into close proximity, quenching the system. When the probe hybridises to its specific target, it opens and fluorescence is possible.

Function of the Lightspeed probe. In aqueous solution the PNA (grey hexagons) probe forms a random coil conformation that is quenched due to the proximity of the fluorophore (F; circle) and quencher (Q; hexagon). Upon hybridisation this bimolecular system is stretched open and the fluorophore can emit fluorescence which is acquired during the annealing step of the PCR

A modification to the 5′ nuclease chemistry resulted in the minor groove binding (MGB) oligoprobes (Figure 10.4, inset; Afonina et al., 2002a). This chemistry has a fluorescent reporter dye at the 5′ end and a NFQ at the 3′ end. In addition, the oligoprobe has an MGB molecule at the 3′ end that hyper-stabilises each oligoprobe–target duplex by folding into the minor groove of the dsDNA (Kutyavin et al., 2000, Afonina et al., 2002b). In the unbound state the oligoprobe assumes a random coil configuration that is quenched. When hybridised, the stretched oligoprobe is able to fluoresce. However, as with many dual-labelled oligoprobe systems, this relaxed state can “leak” fluorescence at higher temperatures when the oligoprobe is prone to partial unfolding. When using 5′ nuclease oligoprobes we found that this leakage can even produce a melting peak under controlled conditions (Mackay et al., 2003b).

The MGB chemistry permits the use of very short (12–17 nt) oligoprobes because of a 15–30°C rise in their T M resulting from the interaction of the MGB and the DNA helix, in particular its stabilisation of A:T bonds. These short oligoprobes are theoretically ideal for detecting single nucleotide polymorphisms, since a short oligoprobe is more significantly destabilised by changes within the hybridisation site than a longer oligoprobe. However, in practice the degree of discrimination depends on the base to be determined, since some nucleotides can significantly influence fluorescence intensity. Originally this approach was designed for the allelic discrimination of genomic DNA where the ratio of heterozygotes to wild-type sequence was 1:1. In situations where this ratio is significantly skewed, the discriminatory power of polymorphism detection by oligoprobe may be reduced. A similar chemistry is the commercial MGB-Eclipse™ oligoprobe, which replaces the standard TAMRA or DABCYL quencher with a proprietary NFQ at the 5′ and a fluorophore at the 3′ end. The MGB molecule protects the oligoprobe from degradation by the polymerase and instead the signal is generated by stretching and relaxing of the oligoprobe during annealing and melting.

The result of combining a single sequence specific, Cy5-labelled linear oligoprobe with SYBR green I created the Bi-probe system. This functions via a variation of FRET recently termed Induced FRET (iFRET; Cardullo et al., 1988, Howell et al., 2002). Bi-probes are more specific than using SYBR green I alone and have an enhanced signal:noise (Brechtbuehl et al., 2001, Walker et al., 2001). Interestingly this approach functions using the Idaho Technologies LightCycler but not the closely related Roche LightCycler version 1.0. The disparity is due to the narrow bandpass filter sets employed by the latter instrument, which prohibited FRET between these two particular fluorophores. A similar technical problem rendered some proprietary LightCycler fluorophores unusable on the ABI PRISM 7700 (Nitsche et al., 1999). The commercial form of the Bi-probe chemistry, called the ResonSense® probe (Defence Science and Technology Laboratory, United Kingdom; Lee et al., 2002b), has overcome the platform-specific incompatibility possibly due to the substitution of SYBR Gold for SYBR Green I and the use of Cy5.5.

Single-fluorophore systems utilising a labelled oligoprobe or primer and FMCA to discriminate homozygous from heterozygous DNA without the need for FRET have also been described (Kurata et al., 2001, Gundry et al., 2003). The fluorophore is carefully chosen and positioned so that its emissions are quenched by proximity to a complementary guanine (Crockett and Wittwer, 2001). A commercial form, called the SimpleProbe, is used on the LightCycler and the LightTyper (Roche Diagnostics). This approach targets a single fluorescein-labelled hybridisation oligoprobe to polymorphism and produces an increased fluorescence when hybridised. Genotyping is performed by FMCA. The LightTyper is not a thermal cycler and as such this is not a real-time PCR system. The LightTyper is designed to rapidly characterise amplicon generated by PCR in a conventional thermal cycler. These systems suffer if used for the detection of nucleotide polymorphisms in a guanine-rich sequence.

Hairpin oligoprobes

Molecular beacons were the first fluorogenic hairpin oligoprobes described for real-time PCR applications. The hairpin oligoprobe's fluorogenic labels are called the fluorophore and quencher and are positioned at the termini of the oligoprobe (Figure 10.13). The most commonly used quencher, DABCYL (4-[4′-dimethylamino-phenylazo]-benzene), is an NFQ. The labels are held in close proximity by distal regions of homologous base pairing deliberately designed to create a hairpin structure. The intimate proximity of the label molecules results in quenching either by FRET or direct energy transfer via a collisional mechanism (Tyagi et al., 1998). In the presence of a sequence complementary to the molecular beacon's loop, the oligoprobe is shifted into an open configuration. The reporter is then removed from the quencher's influence and fluorescence can be detected (Tyagi and Kramer, 1996).

Function of the molecular beacon. Hybridisation of the loop section of the beacon to the target separates the fluorophore (F; open circle) and NFQ (Q; filled hexagon) allowing fluorescence. Data from this bimolecular system is collected during the annealing step of the PCR. Inset shows a wavelength-shifting hairpin oligoprobe incorporating a harvester molecule (H; filled circle)

Wavelength-shifting hairpin oligoprobes are a recent improvement to the hairpin oligoprobe chemistry, making use of a second, “harvesting” fluorophore (Figure 10.13, inset). The harvester passes on excitation energy acquired from a blue light source as fluorescent energy in the far-red spectrum. A receptive “emitter” fluorophore can then be selected which uses the energy to produce light at characteristic wavelengths. This approach offers the potential for improved multiplex real-time PCR and nucleotide polymorphism analysis by increasing the number of emitters that can be excited using a single energising wavelength (Tyagi et al., 2000). This is a useful workaround for instruments with a limited energising light source.

Recently, TMB have been added to the hairpin oligoprobe class of fluorogenic chemistry (Figure 10.14 ; Nutiu and Li, 2002). These highly complex oligoprobes combine a molecular beacon's hairpin with longer, unlabelled, single-stranded arms. Each arm is designed to hybridise to an oligonucleotide labelled with either a fluorophore or an NFQ. The system is quenched in the hairpin state due to the close proximity of the labels but fluorescent when hybridised to the specific amplicon strand. However, for quenching to occur the arms must re-hybridise after the denaturation step. This is the only tetramolecular real-time PCR chemistry, so-called because it relies upon four intermolecular collisions to function correctly. The TMB chemistry may be subject to high background fluorescence in practical applications where genomic nucleic acids interfere with re-annealing.

Function of the tripartite molecular beacon. The fluorophore (F; circle) is removed from the influence of the NFQ (Q; hexagon) upon binding to specific amplicon, which opens the hairpin and permits fluorescent emissions. Data are collected from this tetramolecular system during the annealing step of the PCR

Because the function of all the hairpin oligoprobes depends upon correct hybridisation of the stem, accurate design is crucial to their function and is considerably more challenging than for other oligoprobe chemistries.

Self-priming fluorogenic amplicon

The self-priming amplicon is similar in concept to the hairpin oligoprobe, except that the label(s) becomes irreversibly incorporated into the nascent amplicon. While these systems have only been described with a single primer, it is conceivable that both primers could be labelled in a similar way to provide a stronger, if more costly, fluorescent signal. The first contact between primer and template is a bimolecular event, but from then on the signalling is unimolecular. Intramolecular hybridisation is extremely fast and kinetically favourable since it does not rely upon the chance meeting of oligoprobe and amplicon in each cycle (Bustin, 2002). Fast cycling conditions appear to better suit the chemistries in this group (Thelwell et al., 2000). Three approaches have been described: sunrise primers (commercially called Amplifluor™ hairpin primers), scorpion primers (Nazarenko et al., 1997) and the recently described Light Upon eXtension primers (LUX; Whitcombe et al., 1999).

Sunrise primers consist of a 5′ fluorophore and a 3′ DABCYL NFQ (Figure 10.15). The labels are brought together by complementary sequences that create a stem when the sunrise primer is closed. A target-specific primer sequence is located at the 3′ terminus downstream of the NFQ. The sunrise primer's sequence is intended to be duplicated by the nascent complementary strand and during subsequent annealing and extension steps, the stem is destabilised, the two fluorophores are forced approximately 20 nt (70 Å) apart and the fluorophore can emit excitation energy (Nazarenko et al., 1997). It is possible, however, that this sequence duplication could also occur during the formation of non-specific amplicon.

Function of the sunrise primer. The fluorophore (F; circle) is separated from the NFQ (Q; hexagon) during disruption of the sunrise primer's hairpin structure and free to fluoresce. This disruption occurs during extension of a nascent complementary DNA strand and whenever dsDNA duplexes form during re-annealing. Data from this unimolecular system can be collected during the annealing step of the PCR

The scorpion primer is almost identical in design to the sunrise primer except for a hexethylene glycol molecule that blocks duplication of the signalling portion of the scorpion (Figure 10.16). In addition to the difference in structure, the function of the scorpion primer differs in that the 5′ region of the oligonucleotide is designed to hybridise to a complementary region within the nascent amplicon strand creating an intramolecular signalling system. This approach to signal generation separates the labels disrupting the hairpin and permitting fluorescence in the same way that hairpin oligoprobes function (Whitcombe et al., 1999). The duplex scorpion primer is initially a trimolecular system requiring the primer, quencher and target amplicon to interact. However, once the primer is incorporated into the nascent strand the system reverts to a bimolecular system which is simpler to synthesise and purify than the unimolecluar form. The stem-loop is exchanged for a separate, complementary oligonucleotide labelled with a quencher at the 5′ terminus. The additional oligonucleotide interacts with the primer element which is terminally labelled with the fluorophore (Figure 10.16, inset; Solinas et al., 2001). When it exists as a duplex, the chemistry is quenched but becomes fluorescent after hybridisation to the longer specific amplicon strand. Interestingly, because the quencher is not part of the same molecule, brighter fluorescence can be achieved than for the unimolecular version where the labels are neither absolutely quenched, nor freely fluorescent. Scorpion primers can be used for nucleotide polymorphism detection by designing the placement of either the primer component or the probe component to cover the polymorphism (Whitcombe et al., 1999, Thelwell et al., 2000).

Function of the scorpion primer. The scorpion primer is blocked from being extended by a hexethylene glycol molecule (B; diamond) so that the hairpin can only be disrupted by specific hybridisation and not by the extension of a complementary amplicon strand as occurs for sunrise primers. The 5′ fluorophore (F; circle) is separated from a 3′ methyl red quencher (Q; hexagon) during self-hybridisation of the loop portion of the scorpion with a complementary region on the nascent amplicon strand. Inset shows a duplex scorpion. Data is collected from this unimolecular system during the annealing step of the PCR

A recently described variation of the hairpin chemistry is the self-quenching hairpin oligonucleotide primer which has been commercially labelled as the LUX fluorogenic primer (Figure 10.17 ; Nazarenko et al., 2002). This chemistry is non-fluorescent in the absence of specific amplicon through the natural quenching ability of a carefully placed guanosine nucleotide. The natural quencher is brought into close proximity with the FAM or JOE fluorophore via a stretch of 5′ and 3′ complementary sequences. In the presence of the complementary target strand, a nascent strand is extended, which incorporates the LUX primer. The dsDNA opens the hairpin, permitting fluorescence from the fluorophore. This non-destructive chemistry is simple to design and use, relatively inexpensive and it does not require the inclusion of an additional oligoprobe. However, the presence of primer–dimer and non-specific amplicon will, as for SYBR Green I and the sunrise primers, be displayed as a fluorogenic signal. The products can be discriminated using their differing T D, however, there is no reliable way to account for their signal in quantitative real-time PCR.

Function of the LUX primer. The LUX primer is labelled with a single fluorophore (F; circle) positioned next to a guanine nucleotide when the hairpin portion of the primer is intact. The G naturally quenches the fluorophore. In the presence of the specific target strand the primer hybridises, disrupts the hairpin and is extended. The fluorophore is now free to fluorescence and data can be collected from this unimolecular signalling system during the annealing or extension step of the PCR

A variant of these chemistries are the Angler® oligoprobes which closely resemble a Scorpion primer, except for the absence of a quenching moiety (Lee et al., 2002b). Angler oligoprobes consist of a 3′ specific primer sequence linked via a hexethylene glycol molecule to a 5′, Cy5-labelled tail. The tail portion of the Angler is designed to self-hybridise to downstream sequences in the nascent strand producing a unimolecular signalling system. In contrast to the dual-labelled Scorpion, the Angler uses FRET between the terminal Cy5 and SYBR gold incorporated into the self-annealed duplex to produce a fluorescent signal.

Comparison of fluorogenic chemistries

When comparing the mechanism of signal generation by the different fluorescence systems, the most popular chemistries display unique quirks. The cyclical destruction of nuclease oligoprobes continues despite a plateau in amplicon accumulation whereas SYBR green I fluorescence generally increases non-specifically during later cycles even without template due to primer–dimer formation. HybProbe fluorescence begins to decrease as the rate of collision between the growing numbers of complementary amplicon strands increases resulting in a phenomenon called the “hook effect” (Figure 10.3). At this stage, the formation of dsDNA is favoured over the hybridisation of oligoprobe to its target DNA strand, adversely affecting total fluorescence. The possibility exists that some linear oligoprobes are consumed by sequence-related nuclease activity and it may also contribute to the hook effect as has been reported for HybProbes (Wilhelm et al., 2001b, Wittwer et al., 1997a, Lyamichev et al., 1993).

Microbial genotyping

Although nucleotide sequencing is the gold standard for in-depth characterisation of nucleic acids, it is a relatively lengthy process. The development of real-time PCR has partially addressed this by providing a tool capable of rapid detection of characterised nucleotide polymorphisms.

The non-destructive fluorescent chemistries are mostly intact at the end of the PCR and can be used to indirectly genotype a microbial template by characterising its amplicon (Bustin, 2000). Careful control of ionic strength, amplicon size and cooling and melting rates can improve the resolution of experimental data collected from FMCA. FMCA can also be used with a single labelled oligonucleotide (Gundry et al., 2003). The SYBR green I and HybProbe chemistries are most commonly used to perform these analyses; however, the double-stranded and Light-up oligoprobes as well as the HyBeacons should be capable of functioning in this role. Other chemistries, such as the TaqMan and Eclipse oligoprobes and hairpin oligonucleotides and primers, require two sets of oligoprobes to differentiate a wild-type from an altered sequence. While this is a perfectly legitimate and functional approach for genotyping by real-time PCR, the extra fluorogenic oligonucleotides increase the overall cost and complexity of the assay. However, this approach does permit the creation of a dedicated mutation detection assay which will often perform more reliably than a single assay intended to detect both the wild-type and mutated sequences. Unfortunately, the use of two sets of fluorophores reduces the number of related but different microbes that can be discriminated in a single vessel, since two fluorophores must be assigned to analyse each nucleotide variant. The technique of FMCA has proven popular for the rapid diagnosis of human genetic disorders and has advanced the detection of multiple targets by real-time PCR. It should again be noted that genotyping two sequences by FMCA requires that the amount of one amplified sequence is less than 10-fold above the amount of the other sequence; otherwise the more common sequence will overpower detection of the more rare sequence.

The occurrence of a mismatch between a hairpin oligonucleotide and its target has a greater destabilising effect on the duplex than the introduction of an equivalent mismatch between the target and a linear oligoprobe. This is because the hairpin structure provides a highly stable alternate configuration. Therefore, hairpin oligonucleotides are more specific than the commonly used linear oligoprobes making hairpin oligonucleotides good candidates for detecting nucleotide changes, albeit more technically demanding to design (Tyagi et al., 1998). Despite the fact that hybridisation does not reach equilibrium using rapid ramp rates, the apparent T M values deduced from FMCA are both reproducible and characteristic of a given probe and target duplex (Gundry et al., 1999). Importantly, different nucleotide changes destabilise hybridisation to differing degrees and this can be incorporated into the design of oligoprobes for genotyping assays to control the extent of discrimination between the melt peak temperatures. The least destabilising mismatches involve a change to a G on one of the strands (G:T, G:A, and G:G), whereas the most destabilising include a change to a C (C:C, C:A and C:T) (Bernard et al., 1998).

Because real-time PCR genotyping data is obtained at the completion of the PCR amplification phase, it is an end-point analysis, although the reaction vessel remains unopened throughout the process. The amplicon is denatured and rapidly cooled to encourage the formation of fluorophore and target strand complexes. The temperature is then gradually raised and the fluorescence from each vessel is continuously recorded. The detection of sequence variation using fluorescent chemistries relies upon duplex destabilisation incurred as a result of nucleotide changes. As mentioned earlier, the non-specific chemistries reflect these changes in the context of the entire dsDNA amplicon. The sequence changes have a different impact upon the specific fluorogenic chemistries, altering the expected T M in a manner that reflects the particular nucleotide difference. The resulting rapid decrease in fluorescence using either approach can be presented as a “melt peak” using software capable of calculating the negative derivative of the fluorescence change with temperature and plotting that data against temperature (Figure 10.18 ).

Fluorescence melting curve analysis (FMCA). At the completion of a real-time PCR using a fluorogenic chemistry, the reaction is rapidly heated and then cooled to a temperature below the expected TD of the dsDNA or TM of the oligoprobe(s). It is then heated to 85°C or more at a fraction of a degree per second (A). During heating, the raw data representing the emissions of a relevant fluorophore are constantly acquired (B). Software calculates the negative derivative of the fluorescence with temperature which is plotted against temperature to produce a melt peak indicative of the TD of the dsDNA, or the TM of the oligoprobe-target melting transition (dashed line and black peak; C). When sequence differences exist, the TD or TM is reduced (grey peak) due to the lower stability of heteroduplexes and the extent of the resulting temperature shift is used diagnostically to characterise an amplified template. Generally speaking, a ramp rate of 0.2°C/s permits clear discrimination between different genotypes. However, variation of the ramp rate can be helpful if unsatisfactory results are generated. Hybridisation can be enhanced by slowing the ramp rate whereas an accelerated ramp rate can help remove stable secondary structures at the oligoprobe hybridisation region resulting in sharper melt peaks

Nucleic acid quantitation

Although the terminology is often confused, real-time PCR does not inherently imply quantitative PCR. To determine the amount of template present in a sample, care must be taken to include the correct control system. External controls or “standards” are used for calculating the amount of template present in a patient sample and are amplified in a separate vessel to the unknown target (Figure 10.19). Internal controls are amplified in the same vessel as the unknown target, frequently indicating the occurrence of false negative reactions and examining the ability to amplify from a preparation of nucleic acids (Niesters, 2002). Certainly, the reliability of quantitative PCR methods is intimately associated with the choice and quality of the assay controls (Celi et al., 2000, Alexandre et al., 1998).

External standard curve for quantitation. Threshold cycle or crossing point data collected from an amplified titration of standard plotted against the concentration of each template. Through interpolation, CT/CP values for unknowns (Unk) permit the calculation of the starting template concentrations (dashed line). This is performed by rearranging the equation for the linear regression line (i), to solve for the x-axis value of interest, (ii). When the relevant values are substituted (iii), the concentration of template in each unknown can be calculated

No matter what controls are used to generate quantitative data or monitor successful amplification, it is imperative to accurately determine their concentration and to ensure that internal controls are added at suitable levels in order to prevent extreme competition for reagents with the wild-type template (Zimmermann and Manhalter, 1996, Brightwell et al., 1998). A spectrometer alone is inadequate for quantifying a control molecule; however, in combination with experimental and statistical analysis, the reliability of the data is greatly enhanced (Glasel, 1995, Bagnarelli et al., 1995, Wang and Spadoro, 1998, Rodrigo et al., 1997, Taswell, 1981, Sykes et al., 1998). Finally, one must remember that the results of quantitation using a control need to be expressed relative to a suitable biological marker, e.g. in terms of the volume of plasma, the number of cells or the mass of tissue or genomic nucleic acid. Standardisation such as this will ensure comparability between assay results and testing locations (Niesters, 2001).

The ability to quantify nucleic acids is predominantly used in the field of gene expression or transcriptome analysis (PhorTech, 2003). For this application, primers are often carefully designed to span exon–intron boundaries or cross overly large expanses of intron to avoid co-amplification of genomic DNA (Yin et al., 2001). In our hands the enhanced specificity of an oligoprobe format is preferred to the use of non-specific chemistries for quantitation.

Another area suited to sensitive, specific quantitation with the ability to genotype a target is the detection of minimal residual disease in malignancy. The role of real-time PCR for the investigation of lymphoma and leukaemia patients is expanding. This role examines and quantifies the number and genetic profile of malignant cells remaining in a clinically well patient as an indicator of response to therapy or to identify those patients at high risk of disease relapse (Sharp and Chan, 1999, Liu Yin, 2002).

External Control Templates

Standards used to monitor or enhance the power of PCR are most commonly created by cloning an amplicon, a portion of the target organism's genome or simply using the purified amplicon itself as the template (Borson et al., 1998). Because these molecules are amplified separately and because they are not inherently present within the sample matrix, they are called exogenous or external controls. These form the basis of external standard curves, which are created from the data produced by the individual amplification of a dilution series of control template (Figure 10.3). The concentration of an unknown, which is amplified in the same assay but in a separate vessel, can then be interpolated from the standard curve (Figure 10.19). While the external standard curve is the more commonly described approach for quantitative PCR, it frequently suffers from uncontrolled and unmonitored inter-vessel variations. Some real-time PCR systems have partially overcome this problem by including the ability to detect and correct for variation in the emissions of a non-participating, or “passive”, internal reference fluorophore (6-carboxy-N,N,N′,N′-tetramethylrhodamine, ROX). This reference is present in the reaction buffer and is used to indicate volume variations and non-specific fluorescence quenching. The corrected values, obtained from a ratio of the emission intensity of the fluorophore and ROX, are called RQ+. To further control amplification fluctuations, the fluorescence from a “no-template” control reaction (RQ−) is subtracted from RQ+ for each sample, resulting in the ΔRQ value that indicates the magnitude of the reference signal generated for the given PCR (Gelmini et al., 1997).

The simplest mathematical representation of PCR amplification is described by the Equation:N=N0(E+1)Cwhere N is the number of amplified molecules, N 0 the initial number of template molecules, E the amplification efficiency and C the number of amplification cycles.

This equation is essential to obtaining accurate data from real-time PCR and is usually considered to apply to each reaction in an experimental run. However, the efficiency of the PCR is commonly calculated from the amplification of a standard curve, assuming that each unknown reaction will amplify with equivalent efficiency. Furthermore, the amount of amplicon in each reaction at the C T is assumed to be equal because the fluorescence is the same (Figure 10.3). Nonetheless, by adopting these assumptions and deducing the linear regression line of best fit through the C T values from a standard curve we can determine the reaction efficiency from the slope given by the following Equation:E=10−Slope−1

Internal Control Templates

The use of an internal control molecule has been described in the earliest of PCR experiments and is considered essential to increase assay quality (Reiss and Rutz, 1999) and as a competitive template for conventional quantitative PCR (Chehab et al., 1987, Rosenstraus et al., 1998). When such a control is added prior to template purification (extraction control) or amplification (amplification control), it is called an exogenous internal control since it does not occur naturally within the sample matrix, but it is co-amplified within the same reaction. Ideally the exogenous internal control template should hybridise to the same primers and have an identical amplification efficiency to the template under investigation (Zimmermann and Manhalter, 1996). The control should also contain a discriminating feature such as a change in its length (Orlando et al., 1998, Möller and Jansson, 1997, Hall et al., 1998; Brightwell et al., 1998, Celi et al., 2000) or more commonly in today's oligoprobe-based methods, a change in the sequence of the target (Alexandre et al., 1998, Tarnuzzer et al., 1996, Celi et al., 2000, Natarajan et al., 1994, Aberham et al., 2001, Rosenstraus et al., 1998, Kearns et al., 2001b, Stöcher et al., 2002, Gruber et al., 2001). However, the internal control should not significantly interfere with the detection of small quantities of the template under investigation; therefore, its use must be carefully evaluated. Internal control templates that bind different primers or have different amplification efficiencies are still useful as standards for semi-quantitative PCR or relative quantitation.

An endogenous internal control occurs naturally within the specimen matrix and is therefore co-amplified with the specific target. Housekeeping genes are a common example that has been successfully used to quantify gene expression by RT-PCR and monitor template integrity after its purification (Chehab et al., 1987). When housekeeping genes are used for the quantitation of RNA it is essential that they are minimally regulated and exhibit a constant and cell cycle-independent basal level of transcription (Selvey et al., 2001). Studies have shown that an 18S rRNA target successfully meets the desired criteria for some applications (Selvey et al., 2001, Thellin et al., 1999). This is not the case for some commonly used genes including β-actin; unfortunately their use is widespread, especially for transcript analyses (Härtel et al., 1999). To ensure the suitability of the housekeeping gene, a panel of candidate targets should be examined under the desired experimental conditions and the extent of change in the C T used to indicate the stability of target expression (Löseke et al., 2003).

We have found several promising candidate targets during a systematic quantitative study of the expression levels of 13 genes in 16 different tissues (Radonic et al., 2004). As expected, no single gene was consistently expressed among all the tissues investigated. However, the RNA polymerase gene displayed the lowest variation over all tissues, even during mitogenic stimulation of a T-cell line. RNA polymerase mRNA encodes the principle enzyme used in mRNA transcription and is therefore part of a self-regulating cycle. It can be assumed that this gene is expressed steadily and independent of the cell state.

Real-time PCR assays that lack the capacity to correct for vessel-to-vessel variations such as those caused by variation in reverse transcription efficiency, cell number, nucleic acid isolation technique and PCR efficiency are more appropriately described as being semi-quantitative. To this day it is rare to find well-controlled real-time PCR assays among those in the literature. That will hopefully change as pressure to publish comprehensively optimised and validated assays is brought to bear by the editorial staff and peer reviewers of scientific journals (Hoorfar et al., 2003).

Relative versus Absolute Quantitation

The amount of template in a sample can be described either relatively or absolutely. Relative quantitation is the simpler approach, which, as the name suggests, describes differences in the amount of a target sequence compared to its level in a related matrix, or within the same matrix by comparison to the signal from an endogenous or other reference control. This approach has proven particularly popular for gene expression studies and can be conveniently employed using the 2−ΔΔCT method (Livak and Schmittgen, 2001). Absolute quantitation is more demanding to perform but states the exact number of nucleic acid targets present in the specimen in relation to a specific unit and it is therefore easier to compare data between different assays and laboratories (Freeman et al., 1999, Pfaffl et al., 2002). Absolute quantitation may be necessary when there are no sequential specimens to demonstrate a relative change in template load, or when no accurately standardised reference reagent or suitable endogenous control is available.

A highly accurate approach used for absolute quantitation by conventional PCR utilises competitive co-amplification of one or more dilutions of an internal control template of known concentration with a wild-type target nucleic acid of unknown concentration (Becker-Andre and Hahlbrock, 1989, Clementi et al., 1995, Gilliland et al., 1990, Siebert and Larrick, 1992). However, conventional competitive quantitation is technically demanding and time consuming, requiring significant development and optimisation compared to quantitation by real-time PCR. Thus, it is not suited to the quick decision making required within research and clinical environments (Locatelli et al., 2000, Wall and Edwards, 2002, Tanaka et al., 2000b). The existence of software with the ability to calculate the concentration of an unknown by comparing real-time PCR signals generated from a co-amplified target and internal control is rare but improving (Pfaffl et al., 2002). In addition, new or improved mathematical interpretations are appearing which aim to make quantitation more reliable and simpler (Liu and Saint, 2002, Rutledge and Côte, 2003).

Improved Quantitation Using Real-time PCR

Common microbiological methods to quantify an organism have traditionally required culture-based methods. While these methods are often considered the gold standard and are the only way to obtain data on microbial viability and infectivity, they are not without significant problems of their own. These problems are caused by variation in the method of inoculation, the choice of target cell, the type of culture medium, the sensitivity of the microbe to transport and storage conditions and the conditions of culture (Luria and Darnell, 1967). One must remember that titres obtained from culture only hold true under the specific conditions of that assay, making the results less portable than those obtained from nucleic acid quantitation by well-developed real-time PCR assays.

We have used conventional competitive PCR to obtain quantitative data with promising results (Mackay et al., 2001, Mackay et al., 2003a). However, these approaches are laborious to develop and perform. The wide dynamic range of real-time PCR encompassing at least eight log10 copies of nucleic acid template is a significant benefit for microbial load determination (Ishiguro et al., 1995, Kimura et al., 1999, Najioullah et al., 2001, Ryncarz et al., 1999, Monopoeho et al., 2000, Alexandersen et al., 2001, Abe et al., 1999, Locatelli et al., 2000, Gruber et al., 2001, Brechtbuehl et al., 2001, Moody et al., 2000). This broad dynamic range obviates the need to dilute an amplicon before detecting it or the repetition of an assay using a diluted template because a preliminary result falls above the upper limits of the detection assay. Both these problems occur when using conventional end-point PCR assays for quantitation because their detection systems cannot encompass the products of high template loads whilst maintaining adequate sensitivity (Weinberger et al., 2000, Schaade et al., 2000, Brechtbuehl et al., 2001, Kawai et al., 1999). The flexibility of real-time PCR is further demonstrated by its ability to detect one target in the presence of a vast excess of another target during duplexed assays or, with careful manipulation, to quantify expression from a single cell (Ryncarz et al., 1999, Liss, 2002).

Real-time PCR is also a particularly attractive alternative to conventional PCR for the study of microbial load. We and others have found the consistently low inter-assay and intra-assay variability especially useful compared to other assays (Schutten et al., 2000, Nitsche et al., 2000, Locatelli et al., 2000). Real-time PCR also has equivalent or improved sensitivity compared to microbial culture, or conventional single-round and nested PCR (Kearns et al., 2001c, Clarke et al., 2002, Kupferschmidt et al., 2001, Kennedy et al., 1997b, Locatelli et al., 2000, Capone et al., 2001, Leutenegger et al., 1999, Smith et al., 2001, Monopoeho et al., 2000, van Elden et al., 2001, Lanciotti et al., 2000). It has been reported to be at least as sensitive as Southern blot, still considered by some as the gold standard for probe-based hybridisation assays (Capone et al., 2001).

Multiplex real-time PCR

Conventional multiplex PCR applies a number of primer sets to potentially amplify multiple templates within a single reaction vessel (Chamberlain et al., 1988, Burgart et al., 1992). However, its adaptation to real-time PCR has clouded the traditional terminology. Multiplex real-time PCR more commonly describes the use of multiple fluorogenic oligoprobes for the discrimination of amplicons which have been produced by one or more primer pairs in a single vessel. The transfer of this technique from conventional PCR protocols has proven problematic because of the limited number of fluorophores available and the closed nature of real-time PCR which prohibits the monitoring of specificity made possible by size determination using agarose gel electrophoresis (Lee et al., 1993). The commonly used monochromatic energising light source and the application of narrow bandpass filters on some real-time PCR instruments have limited their ability to perform multiplex PCR. Although excitation by a single wavelength produces bright emissions from an appropriate fluorophore, it restricts the number of fluorophores that can be successfully combined and discriminated in a single vessel (Tyagi et al., 2000). The discovery and application of non-fluorescent quenching labels has made available some regions of the spectrum that were previously occupied by the emissions of early quenchers. This development has permitted a slight increase in the number of spectrally discernable oligoprobes per reaction.

Recent improvements to the design of hairpin primers and hairpin and nuclease oligoprobes, as well as novel combinations of fluorophores such as the Bi-probe and Light-up probes, have promised alternatives that should permit the discrimination of a greater variety of amplicons per reaction vessel.

Currently, the number of fluorophores that can be combined and clearly distinguished is extremely limited when compared to the capability of conventional multiplex PCR to discriminate amplicon. Some real-time PCR platforms have incorporated multiple light-emitting diodes to span the entire visible spectrum, or a tungsten light source, which emits light over a broad range of wavelengths permitting the excitation of a wide range of fluorophores. The inclusion of high-quality optical filters to clarify both the excitation and emission energies makes possible the use of a wider range of real-time PCR detection chemistries on one machine. Nonetheless, these improvements have to date permitted the multiplexing of only four different colours, of which one colour is ideally set aside for an internal control to monitor inhibition and one may be required for a passive reference. Some real-time PCR designs have astutely made use of single or multiple nucleotide changes between similar templates to discriminate the amplicon by T M using FMCA and thus avoid the need for multiple fluorophores (Espy et al., 2000b, Boivin et al., 2004, Espy et al., 2000a, Schalasta et al., 2000a, Kearns et al., 2001c, Loparev et al., 2000, Read et al., 2001, Whiley et al., 2001). This approach has been common for the detection of human genetic diseases where as many as 27 possible nucleotide substitutions have been detected using only one or two fluorophores (Schütz et al., 2000, Lay and Wittwer, 1997, Herrmann et al., 2000, Lee et al., 1999a, Gundry et al., 1999, Bernard and Wittwer, 2000, Elenitoba et al., 2001).

To date, only a handful of assays have been described in the literature that truly multiplex more than two fluorophores. Few of these duplexed assays have been applied to the diagnosis of infectious disease and those that have are frequently used to detect subtle changes within a single species rather than a number of different species. It is important to remember that the ultimate benefits to be gained from multiplex PCR derive from its use of minimal specimen to detect the maximum number of targets. Some approaches cannot technically be considered real-time homogeneous assays, because they require interruption of the procedure to transfer template, detect fluorescence using a separate end-point analysis or perform the assays in separate reaction vessels but within the same run (Stocher et al., 2003). The best microbial multiplex real-time PCR can discriminate between four retroviral target sequences (Vet et al., 1999); however, we and others have found conventional multiplex PCR using end-point detection capable of easily discriminating five or more different amplicons (Mackay et al., 2003a, Quereda et al., 2000). This discrepancy continues to highlight the greater flexibility of conventional PCR for true multiplex PCR assays (Kehl et al., 2001, Echevarria et al., 1998, Henegariu et al., 1997, Weigl et al., 2000, Stockton et al., 1998).

Assays capable of detecting several viral genomes include those using the non-specific label, SYBR green I, to detect herpes simplex viruses (HSV), varicella zoster virus (VZV) or cytomegalovirus (CMV) in separate tubes (Nicoll et al., 2001), or by adaptation of a conventional multiplex PCR, to identify HSV-1 and HSV-2, VZV and enteroviruses within a single capillary by applying FMCA (Read et al., 2001).

Future development of novel chemistries and improved real-time PCR instrumentation and software will hopefully enhance our ability to perform truly multiplexed real-time PCR assays. Meanwhile, the promise of multiplex real-time PCR applications remains tantalisingly out of reach.

Application of real-time PCR to microbiology

Microbiology has been a significant driving force for the development of real-time PCR technology. The resulting benefits to microbial studies have already been discussed in a number of elegant reviews (Niesters, 2001, Mackay et al., 2002, Cockerill and Smith, 2002, Versalovic and Lupski, 2002, Niesters, 2002, Bretagne, 2003). The final sections of this chapter will update the reader on the use of real-time PCR for the study of viruses, bacteria, fungi, parasites and protozoans as well as some specialist areas that have been significantly enhanced by the technology.

Viruses

In microbiology, the application of real-time PCR has had the most dramatic impact upon virology where it has provided an alternative to assays which either use morbidity and mortality as an indicator of disease progression, or qualitatively investigate the role of viruses in a range of human diseases (Kato et al., 2000). Also, epidemiological studies of co-infections have been improved by the use of duplex real-time PCR (Zerr et al., 2000, Furuta et al., 2001, Kearns et al., 2001c).

Real-time PCR has been used as a tool to complement conventional research techniques when investigating direct and indirect links between viral infection and chronic conditions such as sarcoma (Kennedy et al., 1997a, Kennedy et al., 1997b, Kennedy et al., 1998a, O'Leary et al., 2000b, O'Leary et al., 2000a), carcinoma (Lo et al., 1999, Capone et al., 2001), cervical intraepithelial neoplasia (Josefsson et al., 1999, Lefevre et al., 2003, Swan et al., 1997, Lanham et al., 2001) and lymphoproliferative disorders (MacKenzie et al., 2001, Jabs et al., 2001).

More commonly, real-time PCR studies simply describe the presence of viruses in their host with a long-term view of improving clinical management of the affected patients. Viruses studied to date include the bunyaviruses (Stram et al., 2004), caliciviruses (Song et al., 1997), flaviviruses (Laue et al., 1999, Kilpatrick et al., 1996, White et al., 2002, Callahan et al., 2001, Ratge et al., 2002, Ishiguro et al., 1995, Komurian-Pradel et al., 2001, Lanciotti et al., 2000, Beames et al., 2000), hepadnaviruses (Weinberger et al., 2000, Chen et al., 2001, Cane et al., 1999, Brechtbuehl et al., 2001), herpesviruses (Nitsche et al., 2000, Takaya et al., 1996, Song et al., 2002, Whiley et al., 2003b, Fan and Gulley, 2001, Schalasta et al., 2000b, Kearns et al., 2001a, Stevens et al., 2002, Loparev et al., 2000, Gallagher et al., 1999, Kennedy et al., 1997b, Fernandez et al., 2002, Biggar et al., 2000, Tanaka et al., 2000b, Locatelli et al., 2000, Ohyashiki et al., 2000, Kearns et al., 2001c, Lallemand et al., 2000, White and Campbell, 2000, Najioullah et al., 2001, Schaade et al., 2000, Capone et al., 2001, Lo et al., 1999, Niesters et al., 2000, Kimura et al., 1999, Ryncarz et al., 1999, Peter and Sevall, 2001, Hawrami and Breur, 1999, Furuta et al., 2001), orthomyxoviruses (van Elden et al., 2001, Ellis and Zambon, 2002), papovaviruses (Jordens et al., 2000, Lefevre et al., 2003, Biel et al., 2000, Whiley et al., 2001), paramyxoviruses (Smith et al., 2001, Daniels et al., 2001, Côte et al., 2003, Mackay et al., 2003b, Whiley et al., 2002b, Aldous et al., 2001), parvoviruses (Gruber et al., 2001), pestiviruses (Vilcek and Paton, 2000), picornaviruses (Alexandersen et al., 2001, Kares et al., 2004, Lai et al., 2003, Hu et al., 2003, Reid et al., 2004, Monpoeho et al., 2002, Nijhuis et al., 2002, Corless et al., 2002, Watkins-Reidel et al., 2002, Verstrepen et al., 2001, Verstrepen et al., 2002, Monopoeho et al., 2000), polydnaviruses (Chen et al., 2003), poxviruses (Espy et al., 2002, Ibrahim et al., 1997, Ibrahim et al., 1998, Shaw et al., 1995), reoviruses (Pang, 2004), retroviruses (Lewin et al., 1999, Lew et al., 2004a, Argaw et al., 2002, Schutten et al., 2000, Choo et al., 2000, Klein et al., 1999, Leutenegger et al., 1999), rhabdoviruses (Smith et al., 2002, Hughes et al., 2004) and TT virus (Iriyama et al., 1999).

Less commonly, studies of the pathogenic effects of viruses on the biology of specific cellular populations has provided a snapshot of the mechanism of disease progression as occurs during hepatitis C virus induced chronic liver disease (Shaw et al., 1995).

Over the last decade, conventional quantitative PCR has repeatedly demonstrated that the determination of viral load is a useful marker of disease progression and a valuable way to monitor the efficacy of antiviral compounds (Holodniy et al., 1991, Held et al., 2000, Roberts et al., 1998, Rollag et al., 1998, Kaneko et al., 1992, Clementi et al., 1995, Clementi, 2000, Menzo et al., 1992). Quantitative real-time PCR has similarly examined the interaction between virus and host and monitored changes in viral load resulting from antiviral therapy ultimately impacting on the treatment regimen selected (Nitsche et al., 1999, Clementi, 2000, Limaye et al., 2000). Because disease severity and viral load are linked, microbial quantitation by real-time PCR has proven beneficial when studying the impact of viral reactivation, persistence or isolated gene expression on the progression of disease (Ohyashiki et al., 2000, Chen et al., 2003, Kearns et al., 2001c, Furuta et al., 2001, Limaye et al., 2001, Tanaka et al., 2000b, Lallemand et al., 2000, Laue et al., 1999, Kimura et al., 1999, Chang et al., 1999, Lo et al., 1999, Hawrami and Breur, 1999, Hoshino et al., 2000, Nitsche et al., 2000, Machida et al., 2000, Limaye et al., 2001, Najioullah et al., 2001, Gault et al., 2001, Tanaka et al., 2000a). Altered microbial tropism or replication and the effect of these changes on the host cell can also be followed using real-time PCR (Kennedy et al., 1998b, Kennedy et al., 1999a, Kennedy et al., 1999b). Molecular assays are increasingly being used to augment or replace traditional assays. Two examples are the use of real-time PCR to calculate bacteriophage titer more accurately and over a broader dynamic range than plaque assays and the indirect determination of neutralising antibody titer to chicken anemia virus in chickens by quantifying viral load (Edelman and Barletta, 2003, van Santen et al., 2004).

The speed and flexibility of real-time PCR has proven useful to commercial interests that require exquisite sensitivity to screen for microbial contamination within large-scale reagent preparations produced from eukaryotic expression systems or among livestock used for the production of food (Brorson et al., 2001, Pinzani et al., 2004, Stram et al., 2004, Reid et al., 2004, Lew et al., 2004b, van Santen et al., 2004, Rudi et al., 2002, de Wit et al., 2000). Additionally, highly sensitive assays are proving invaluable for the thorough assessment of viral gene therapy vectors prior to their use in clinical trials. Nuclease oligoprobes have been most commonly used for these studies, which assess the biodistribution, function and purity of the novel “drug” preparations (Gerard et al., 1996, Suzuki et al., 2003, Barzon et al., 2003, Rohr et al., 2002, Josefsson et al., 2000, Hackett et al., 2000, Sanburn and Cornetta, 1999, Choo et al., 2000, Scherr et al., 2001).

Likewise, the study of new and emerging viruses has embraced the use of homogeneous real-time PCR assays as tools to demonstrate and strengthen epidemiological links between unique viral sequences and the clinical signs and symptoms experienced by patients (Lanciotti and Kerst, 2001, Mackay et al., 2003b, Smith et al., 2002, Lanciotti et al., 2000, Halpin et al., 2000, Smith et al., 2001, Gibb et al., 2001a, Gibb et al., 2001b).

The severe acute respiratory syndrome (SARS) arose in early 2003 in China and the causative agent was rapidly identified (Peiris et al., 2003, Poutanen et al., 2003, Tsang et al., 2003, WHO, 2003). As soon as the first stretches of sequence were known, real-time PCR assays provided the potential for fast and reliable diagnoses and epidemiological studies (Drosten et al., 2003, Emery et al., 2004, Zhai et al., 2004, Ruan et al., 2003, Ng et al., 2004). These assays are performed either as one-step or two-step RT-PCR assays. At the time of writing 48 complete SARS coronavirus (SARS-CoV) genomic sequences existed on GenBank. All these sequences are closely related. However, as with all RNA virus genomes, the coronaviruses display a tendency to vary with time and location (Wood, 2003). We recently described an approach to maintain the reliability of SARS coronavirus molecular assays. In this approach, three independent real-time PCR assays, based on the 5′ nuclease format, were established to be performed under identical reaction conditions. All three assays are located in different, yet highly conserved regions of the known SARS-CoV genomes separated by approximately 9000 nucleotides. Because of this distance, under the chosen reaction conditions the primers used in one assay cannot react with primers of another assay performed in the same tube. The fluorescence signals produced by all three individual assays are indistinguishable; however, for diagnostic purposes it is not necessary to assign the signals to a certain amplicon. We were able to demonstrate that the sensitivity was maintained by the simultaneous amplification of three amplicons. The strength of this approach is that all three assays would need to be adversely affected by nucleotide change for the diagnostic system to fail, a virtually impossible occurrence. We believe that the amplification of more than one sequence stretch of the pathogen of interest is a useful technique to increase the reliability of diagnosis, especially for new and emerging microbes.

Nonetheless, the absolute reliance of PCR upon fully representative characterised genome sequences is highlighted in this area of microbial study. The early assay developer may suffer setbacks due to a paucity of sequence data representing all viral variants. We found this to be a problem when developing a 5′ nuclease assay for human metapneumovirus (Mackay et al., 2003b). At the time of development the majority of viral sequences present on GenBank represented what was later to become known as the Type A virus – a bias which was reflected by the new assay.

Bacteria

Rapid real-time PCR assays provide significant benefit to the diagnosis of a bacterially infected host. The results can quickly inform the clinician, allowing a more specific and timely application of antibiotics, which are far more than antiviral therapies. This speed can limit the potential for toxicity caused by shotgun treatment regimens, reduce the duration of a hospital stay and prevent the improper use of antibiotics, minimising the potential for resistant bacterial strains to emerge.

Once again, elegant applications of real-time PCR can augment or even replace traditional culture and histochemical assays as was seen with the creation of a molecular assay capable of classifying bacteria in the same way as a Gram stain (Klaschik et al., 2002). However, particular bacterial species are the more frequent focus of real-time PCR assays especially when slow culture times can be replaced by rapid and specific gene detection. Leptospira genospecies, Mycobacterium and Propionibacterium species, Chlamydia species, Legionella pneumophila and Listeria monocytogenes have all been successfully detected and in some cases quantified using real-time PCR assays (Woo et al., 1997, DeGraves et al., 2003, Huang et al., 2001, Rudi et al., 2002, Nogva et al., 2000, Desjardin et al., 1998, Bassler et al., 1995, Miller et al., 2002, O'Mahony and Hill, 2002, Torres et al., 2000, Eishi et al., 2002, Kraus et al., 2001, de Viedma et al., 2002, Li et al., 2000, Creelan and McCullough, 2000, Hayden et al., 2001, Ballard et al., 2000, Wellinghausen et al., 2001, Reischl et al., 2002, Lunge et al., 2002). Real-time RT-PCR has proven useful for quantitation of bacterial transcripts in response to infection or the application of specific metabolic intermediates; however, these assays do not always agree with conventional methods of microbial detection, indicating the difference between detecting a live organism by culture and a dead organism by fluorescence or DNA detection (Goerke et al., 2001, Corbella and Puyet, 2003, Desjardin et al., 1998).

The detection of Neisseria gonorrhoeae has benefited from real-time PCR, particularly when used as a confirmatory test for commercial assays (Whiley et al., 2002a). This example again demonstrates the need for care when choosing a PCR target, especially when that target exists on a plasmid which is exchanged among other bacteria, potentially providing confusing diagnostic results. Neisseria meningitidis, Haemophilus influenzae and Streptococcus pneumoniae are the major pathogens causing bacterial meningitis and the introduction of diagnostic real-time PCR has proven to be a powerful tool that we and others have quickly developed and deployed for the rapid discrimination of circulating pathogens (Corless et al., 2001, Whiley et al., 2003a, Probert et al., 2002, Mothershed et al., 2004).

The detection and monitoring of antibiotic resistance among clinical isolates of Staphylococcus aureus, Staphylococcus epidermidis, Helicobacter pylori, Enterococcus faecalis and Enterococcus faecium has benefited from the speed and reliability of real-time applications (Randegger and Hachler, 2001, Woodford et al., 2002, Tan et al., 2001, Hein et al., 2001a, Shrestha et al., 2002, Lindler et al., 2001, Reischl et al., 2000, Martineau et al., 2000, Matsumura et al., 2001, Gibson et al., 1999, Chisholm et al., 2001). These technologies have proven useful for determining the efficacy of antibiotic therapies when treating uncultivable organisms such as Mycoplasma haemofelis which infects cats (Tasker et al., 2004, Tasker et al., 2003). Meanwhile, the understanding and treatment of fulminant diseases such as meningitis, sepsis, inflammatory bowel disease and the sourcing of food poisoning outbreaks caused by characterised bacteria such as the group B Streptococci, Mycobacterium sp., Escherichia coli, Bacteroides vulgatus and Salmonella species have been enhanced by the speedy return of results from real-time and end-point fluorogenic assays (Taylor et al., 2001, Bergeron et al., 2000, Fujita et al., 2002, Fortin et al., 2001, Ibekwe et al., 2002, Bellin et al., 2001, Ke et al., 2000, Chen et al., 1997).

Real-time PCR has made possible the rapid quantitation and differentiation of some of the more exotic pathogenic bacteria such as the tick-borne spirochete Borrelia burgdorferi (Rauter et al., 2002, Pietilä et al., 2000, Pahl et al., 1999), the methanotropic bio-remediating Methylocystis species (Kikuchi et al., 2002) and bacteria capable of degrading agricultural herbicides such as the Pseudomonas sp. ADP and Chelotobacter heintzii (Devers et al., 2004). The involvement of treponemes in the formation of periodontal disease has been studied using TaqMan chemistry, revealing a microbial role at every stage of disease (Asai et al., 2002). In addition, measurement of the bacterial load of Tropheryma whipplei has permitted the discrimination of environmental contamination and low-level colonisation from active infection (Fenollar et al., 2002).

Fungi, Parasites and Protozoans

A smaller but rapidly increasingly number of published applications have examined fungal, parasitic and protozoan pathogens of humans and plants. Real-time PCR assays have significantly contributed to the general diagnosis of invasive diseases, which are continually increasing with a rise in the population of immunocompromised patients. These pathogens include Aspergillus fumigatus, Aspergillus flavus, Candida albicans, Candida parapsilosis, Candida tropicalis, Candida krusei, Candida kefyr and Candida glabrata (Brandt et al., 1998, O'Sullivan et al., 2003, Guiver and Oppenheim, 2001, Costa et al., 2002). Monitoring the transcriptional activity of certain Aspergillus nidulans transporter genes has provided important information about their role in multidrug resistance (Semighini et al., 2002). The homogeneous nature of real-time PCR has proven useful when assays have been employed to investigate buildings for the presence of potentially harmful levels of toxigenic fungal spores, or conidia, such as those produced by Stachybotrys chartarum (Roe et al., 2001, Haugland et al., 1999, Cruz-Perez et al., 2001). Quantifying Septoria tritici, Stagonospora nodorum, Puccinia striifomis and Puccinia recondita, which cause blotch and rust in wheat crops, permitted crops at risk of full-blown disease to be identified so that specific fungicide treatments could be quickly employed (Fraaije et al., 2001). Similar benefits have resulted from the detection of Glomus mosseae, Phytophthora infestans and Phytophthora citricola which infect and damage a wide range of plants including those used as food crops (Böhm et al., 1999). Rapid molecular assays are playing an increased role in the detection and monitoring of fungicide resistance, the presence of compatible mating types, pathogenic variation within fungal populations and for airborne monitoring of dispersed pathogens (Zhang et al., 1996, McCartney et al., 2003).

Cryptosporidium parvum oocysts and the spores from Encephalitozoon species have been successfully genotyped or speciated using real-time PCR significantly improving upon laboratory diagnosis using microscopy and histochemical staining, especially for low concentrations of excreted material (Tanriverdi et al., 2002, Wolk et al., 2002).

Rapid serological detection of Toxoplasma gondii is often hampered by the presence of the parasite in patients who are immunocompromised. Additionally, the length of time required for traditional culture or mouse inoculation is excessive. Therefore, rapid molecular methods have vastly improved detection of this microbe (Kupferschmidt et al., 2001, Costa et al. 2001). This technology is also useful to study how Toxoplasma gondii responds to antimicrobial therapies (Costa et al., 2000).

Detection of malarial parasites using a mouse model in combination with real-time PCR has improved result turnaround and meant that parasite load data can be obtained (Bruña-Romero et al., 2001, Witney et al., 2001). Direct in vivo detection and quantitation of malarial parasites with a high level of sensitivity is also possible (Hermsen et al., 2001, Lee et al., 2002a) in addition to the indirect monitoring of stage-specific Plasmodium falciparum maturation by tracking the transcription of specific genes (Blair et al., 2002).

Trichomonas vaginalis is the most common non-viral sexually transmitted organism in the world and the cost and time savings of real-time PCR assay have meant improvements to large-scale screening of patients at risk (Hardick et al., 2003).

Detecting agents of biowarfare

Perhaps no area of microbiology has impacted upon the community's psyche as much as the potential for microbes to be used as weapons of terror. While reported incidents of bioterrorism have to date been rare, further occurrences are considered by some to be inevitable and the potential for widespread disruption to communities is undoubtedly a serious threat to the population at large (Broussard, 2001). These disruptions need not take the form of widespread mortality, as small foci of morbidity would be sufficient to cause panic and disruption to essential services and financial markets. Hence, timely detection systems are an essential defence to minimise the effects of any such attack. Recently, there has been an explosion of literature indicating that real-time PCR is the tool of choice for rapidly detecting microbes used as agents of biological warfare. Many of these agents were, until recently, rarely encountered in the clinical laboratory and when they were, their detection relied upon relatively laborious and slow diagnostic techniques (Nulens and Voss, 2002). Nonetheless, this most recent area of application for real-time PCR technology enforces the role of real-time PCR as a new tool to complement the diagnostic arsenal rather than a complete replacement for traditional microbiological techniques.

There are three forms of human anthrax caused by Bacillus anthracis. These are the cutaneous, gastrointestinal and pulmonary forms. In contrast to self-limiting cutaneous anthrax, the ingestion or inhalation of endospores is generally fatal unless rapidly treated with antibiotics. The need for fast and reliable diagnostic tools became evident following the anthrax postal attacks late in 2001 in the United States. Real-time PCR assays permitted the rapid discrimination of weaponised pathogens from harmless laboratory-adapted or vaccine-related strains detecting B. anthracis spores and important plasmid or chromosomal markers (Makino et al., 2001, Drago et al., 2002, Uhl et al., 2002, Drago et al., 2002, Oggioni et al., 2002, Lee et al., 1999b, Qi et al., 2001). These assays could also discriminate pathogenic from mildly or apathogenic Bacillus spp. taken from colonies or enrichment broths (Ellerbrok et al., 2002, Hurtle et al., 2004). The addition of hand-held miniaturised real-time instruments and mobile laboratory systems has further enhanced the detection of bioweapons by providing the potential for on-site results in under 30 min during emergency situations (Higgins et al., 2003b, Higgins et al., 2003a). Additionally Francisella tularensis, the cause of tularemia and Yersinia pestis the causative agent of plague have been detected using nuclease or HybProbe assays (Lindler et al., 2001, Lindler and Fan, 2003). In some instances these assays can be modified for use in the field, permitting rapid and highly specific detection at the point of concern (Higgins et al., 2000, Higgins et al., 1998).

Smallpox is caused by infection with variola virus (VARV), a member of the family Poxviridae, genus Orthopoxvirus. VARV evokes the most serious concerns as a biowarfare agent because of low immunity among the population and the application of real-time PCR is attempting to address the diagnostic issues (Ibrahim et al., 2003). The disease was declared eradicated in 1979 by a global vaccination program with the last naturally occurring VARV infection occurring in 1977 in Somalia (WHO, 1980, Behbehani, 1983). While humans are the only natural host for VARV, both vaccinia virus and cowpox virus have a much broader host spectrum. Although zoonotic infections of humans by monkeypox and other members of the genus Orthopoxvirus occur, potential VARV infections bear by far the most lethal risk for man (Centers for Disease Control and Prevention, 2003, Czerny et al., 1991, Lewis-Jones, 2002, Stephenson, 2003). Due to this infectious potential, VARV has recently been flagged as a biological weapons threat (Henderson et al., 1999, Whitley, 2003). The highest degree of sequence homology among characterised members of the genus Orthopoxvirus is found towards the centre of the genome while the terminal regions can exhibit considerable variability. Clearly, rapid and sensitive identification of variola virus and its discrimination from other members of the genus is fundamental to reliable diagnosis and risk evaluation of environmental samples. However, the consequences of a false positive or a false negative PCR result in smallpox diagnosis caused by unexpected sequence variation is considerable; therefore, identification of variola virus should also benefit from amplification of several independent targets by PCR.

Conventional VARV typing and sequencing assays may take more than 48 h to complete and, for obvious reasons, this is an unacceptable lag period. Even the use of end-point fluorescence detection decreases assay times drastically (Ibrahim et al., 1997). Variola virus has also been used as a target to test new field-portable real-time PCR instruments in combination with rapid nucleic acid extraction techniques demonstrating their potential for detecting potential bioweapons on site (Ibrahim et al., 1998). However, these applications have once again highlighted the importance of careful assay design when discriminating highly pathogenic microbes from innocuous, but closely related species (Espy et al., 2002; Nitsche et al., 2004, in press). This is an issue that clearly highlights technical difficulties, which remain in the area of diagnostic PCR design. In many cases gene sequencing is still the final stage for confirming a provisional identification of microbial material from a site or patient suspected of infection with a bioweapon.

Host immunity: measuring the response to a microbe

The application of real-time PCR is beginning to provide evidence to support paradigm shifts in the way we conceptualise the interplay between microbe and host and in the way we describe these interactions (Casadevall and Pirofski, 2003). Pathogen-centric views have dogmatically defined virulence as the result of microbial factors, when in fact the role of the host can be clearly shown to exert a significant influence (Casadevall and Pirofski, 2001, Mitchell, 1998). Increasingly, the old view is being challenged by our growing understanding that changing host immunity is as integral to the course of an infectious disease as the microbe causing the infection. This poses the question “what is a pathogen”? (Casadevall and Pirofski, 2002). Real-time PCR is helping formulate answers to this and other questions by defining the fitness of the host though quantitation of the immune response to infection and antimicrobial therapies and also as a tool to quantify the damage caused. While micro-array technologies provide a comprehensive snap-shot of the state of the host or invading microbe's transcriptome, arrays do not permit reliable quantitation of the target change over a broad dynamic range (Lockhart and Winzeler, 2000, Clewley, 2004, Lucchini et al., 2001). Real-time PCR has increasingly become the method of choice for validating and further characterising experimental data generated by micro-arrays and is the favoured tool for determining gene transcript abundance in basic research, molecular medicine and biotechnology. These determinations are essential markers of microbial–host interaction. While Northern blotting and RNase protection can determine both the size and amount of a transcript, the former is relatively insensitive, and both require large amounts of starting template (Wang and Brown, 1999). Considerably more has been published on the role of real-time PCR in the basic detection of cytokine transcripts from stored or in vitro stimulated blood cells than as an indicator of microbial activation (Kruse et al., 1997, Härtel et al., 1999, Blaschke et al., 2000, Stordeur et al., 2002). This is set to be a growth area for future real-time PCR applications.

Cytokines constitute the majority of mediators involved in the innate mammalian immune response recognising microbes, communicating with and recruiting leukocytes and removing invading microorganisms. However, it is the host's molecular pattern recognition systems operating via specialised receptors which trigger many of the events leading to cytokine induction post-infection (Strieter et al., 2003). Real-time PCR has identified critical mRNA from these receptors and from cytokine genes as a de facto indicator of protein production (Overbergh et al., 1999, Overbergh et al., 2003, Giulietti et al., 2001, Hein et al., 2001b). While this is not a perfect relationship insofar as protein levels are modified by more than simple transcript availability, studies have shown a good correlation between the transcriptome and the proteome for many genes (Balnaves et al., 1995). Additionally, it is often impossible to detect the expressed product in tissue samples due to the low expression levels and short half-lives of cytokine proteins (Broberg et al., 2003, Stordeur et al., 2002). Nonetheless, transcriptional studies using real-time PCR are enhanced by protein expression data.

Well-controlled quantitative real-time PCR experiments have permitted the differentiation and quantitation of IFN-α subclasses as a measure of the innate immune response to infectious or inactivated virus in humans (Löseke et al., 2003). The expression of other cytokines has also been monitored in murine models of microbial immunopathogenesis (Deng et al., 2003, Broberg et al., 2003). Microbial load studies in concert with cytokine protein detection have demonstrated relationships that may play a role in predicting the course and severity of post-transplant lymphoproliferative disease in EBV-positive patients (Muti et al., 2003). The direct impact of cytokines on viral gene expression and the effect of viral cytokine homologues on co-infecting viruses have potentially established new therapeutic strategies for diseases (Song et al., 2002).

Rapid advances in the performance and variety of fluorogenic chemistries and real-time PCR platforms together with the exponential increase in our understanding of the process have ensured real-time PCR is as important a technology for the diagnostic and research microbiology laboratory of tomorrow as agarose gel electrophoresis was to the laboratory of yesterday. Real-time PCR is no more or less than a diagnostic tool and therefore the data it generates are only as reliable as the design and implementation of each assay. Judicious application of the technology will both simplify and hasten the search for answers to many complex experimental and diagnostic questions. In order to more accurately understand the process of virulence, such reliable and robust tools will be essential for defining the interplay between the host and the invading microbe, and when necessary, to do so in a clinically relevant period of time.

References Abe A. Inoue K. Tanaka T. Kato J. Kajiyama N. Kawaguchi R. Tanaka S. Yoshiba M. Kohara M. Quantitation of hepatitis B virus genomic DNA by real-time detection PCR J. Clin. Microbiol 37 1999 2899 2903 10449472 Aberham C. Pendl C. Gross P. Zerlauth G. Gessner M. A quantitative, internally controlled real-time PCR assay for the detection of parvovirus B19 DNA J. Virol. Meth 92 2001 183 191 Afonina I.A. Reed M.W. Lusby E. Shishkina I.G. Belousov Y.S. Minor groove binder-conjugated DNA probes for quantitative DNA detection by hybridization-triggered fluorescence Biotechniques 32 2002 940 949 11962616 Afonina I.A. Sanders S. Walburger D. Belousov Y.S. Accurate SNP typing by real-time PCR Pharmagenomics Jan/Feb 2002 48 54 Ahmed F.E. Detection of genetically modified organisms in foods Trends Biotechnol 20 2002 215 223 11943377 Aldous E.W. Collins M.S. McGoldrick A. Alexander D.J. Rapid pathotyping of Newcastle disease virus (NDV) using fluorogenic probes in a PCR assay Vet. Microbiol 80 2001 201 212 11337136 Alexandersen S. Oleksiewicz M.B. Donaldson A.I. The early pathogenesis of foot-and-mouth disease in pigs infected by contact: a quantitative time-course study using TaqMan RT-PCR J. Gen. Virol 82 2001 747 755 11257178 Alexandre I. Zammatteo N. Ernest I. Ladriere J.-M. Hamels L.S. Chandelier N. Vipond B. Remacle J. Quantitative determination of CMV DNA using a combination of competitive PCR amplification and sandwich hybridization Biotechniques 25 1998 676 683 9793652 Applegate T.L. Iland H.J. Mokany E. Todd A.V. Diagnosis and molecular monitoring of acute promyelocytic leukemia using DzyNA reverse transcription-PCR to quantify PML/RARα fusion transcripts Clin. Chem 48 2002 1338 1343 12142392 Argaw T. Ritzhaupt A. Wilson C.A. Development of a real time quantitative PCR assay for detection of porcine endogenous retrovirus J. Virol. Meth 106 2002 97 106 Asai Y. Jinno T. Igarashi H. Ohyama Y. Ogawa T. Detection and quantification of oral treponemes in subgingival plaque by real-time PCR J. Clin. Microbiol 40 2002 3334 3340 12202575 Bae H.G. Nitsche A. Teichmann A. Biel S.S. Niedrig M. Detection of yellow fever virus: a comparison of quantitative real-time PCR and plaque assay J. Virol. Meth 110 2003 185 191 Bagnarelli P. Menzo S. Valenza A. Paolucci S. Petroni S. Scalise G. Sampaolesi R. Manzin A. Clementi M. Quantitative molecular monitoring of human immunodeficiency virus type 1 activity during therapy with specific antiretroviral compounds J. Clin. Microbiol 33 1995 16 23 7699034 Ballard A.L. Fry N.K. Chan L. Surman S.B. Lee J.V. Harrison T.G. Towner K.J. Detection of Legionella pneumophila using real-time PCR hybridisation assay J. Clin. Microbiol 38 2000 4215 4218 11060093 Balnaves M.E. Bonacquisto L. Francis I. Glazner J. Forrest S. The impact of newborn screening on cystic fibrosis testing in Victoria Austr. J. Med. Genet 32 1995 537 542 Barany F. The ligase chain reaction in a PCR world PCR Meth. Appl 1 1991 5 16 Barratt K. Mackay J.F. Improving real-time PCR genotyping assays by asymmetric amplification J. Clin. Microbiol 40 2002 1571 1572 11923402 Barzon L. Bonaguro R. Castagliuolo I. Chilosi M. Franchin E. Del Vecchio C. Giaretta I. Boscaro M. Palù G. Gene therapy of thyroid cancer via retrovirally-driven combined expression of human interleukin-2 and herpes simplex virus thymidine kinase Eur. J. Endocrinol 148 2003 73 80 12534360 Bassler H.A. Flood S.J.A. Livak K.J. Marmaro J. Knorr R. Batt C.A. Use of a fluorogenic probe in a PCR-based assay for the detection of Listeria monocytogenes Appl. Environ. Microbiol 61 1995 3724 3728 7487008 Beames B. Chavez D. Guerra B. Notvall L. Brasky K.M. Lanford R.E. Development of a primary tamarin hepatocyte culture system for GB virus-B: a surrogate model for hepatitis C virus J. Virol 74 2000 11764 11772 11090176 Becker-Andre M. Hahlbrock K. Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY) Nucleic Acids Res 17 1989 9437 9447 2479917 Behbehani A.M. The smallpox story: life and death of an old disease Microbiol. Rev 47 1983 455 509 6319980 Bellin T. Pulz M. Matussek A. Hempen H.-G. Gunzer F. Rapid detection of enterohemorrhagic Escherichia coli by real-time PCR with fluorescent hybridization probes J. Clin. Microbiol 39 2001 370 374 11136804 Bengtsson M. Karlsson H.J. Westman G. Kubista M. A new minor groove binding asymmetric cyanine reporter dye for real-time PCR Nucleic Acids Res 31 2003 e45 12682380 Bergeron M.G. Ke D. Ménard C. Picard F.J. Gagnon M. Bernier M. Ouellette M. Roy P.H. Marcoux S. Fraser W.D. Rapid detection of group B streptococci in pregnant women at delivery N. Engl. J. Med 343 2000 175 179 10900276 Bernard P.S. Wittwer C.T. Homogeneous amplification and variant detection by fluorescent hybridization probes Clin. Chem 46 2000 147 148 10657368 Bernard P.S. Lay M.J. Wittwer C.T. Integrated amplification and detection of the C677T point mutation in the methyltetrahydrofolate reductase gene by fluorescence resonance energy transfer and probe melting curves Anal. Biochem 255 1998 101 107 9448847 Biel S.S. Madeley D. Diagnostic virology – the need for electron microscopy: a discussion paper J. Clin. Virol 22 2001 1 9 11418348 Biel S.S. Held T.K. Landt O. Niedrig M. Gelderblom H.R. Siegert W. Nitsche A. Rapid quantification and differentiation of human polyomavirus DNA in undiluted urine from patients after bone marrow transplantation J. Clin. Microbiol 38 2000 3689 3695 11015385 Biggar R.J. Whitby D. Marshall V. Linhares A.C. Black F. Human herpesvirus 8 in Brazilian Amerindians: a hyperendemic population with a new subtype J. Infect. Dis 181 2000 1562 1568 10823754 Blair P.L. Witney A. Haynes J.D. Moch J.K. Carucci D.J. Adams J.H. Transcripts of developmentally regulated Plasmodium falciparum genes quantified by real-time RT-PCR Nucleic Acids Res 30 2002 2224 2231 12000842 Blaschke V. Reich K. Blaschke S. Zipprich S. Neumann C. Rapid quantitation of proinflammatory and chemoattractant cytokine expression in small tissue samples and monocyte-derived dendritic cells: validation of a new real-time RT-PCR technology J. Immunol. Meth 246 2000 79 90 Boivin G. Côte S. Déry P. De Serres G. Bergeron M.G. Multiplex real-time PCR assay for detection of influenza and human respiratory syncytial virus J. Clin. Microbiol 42 2004 45 51 14715730 Böhm J. Hahn A. Schubert R. Bahnweg G. Adler N. Nechwatal J. Oehlmann R. Oswald W. Real-time quantitative PCR: DNA determination in isolated spores of the mycorrhizal fungus Glomus mosseae and monitoring of Phytophthora infestans and Phytophthora citricola in their respective host plants J. Phytopathol 147 1999 409 416 Borson N.D. Strausbauch M.A. Wettstein P.J. Oda R.P. Johnston S.L. Landers J.P. Direct quantitation of RNA transcripts by competitive single-tube RT-PCR and capillary electrophoresis Biotechniques 25 1998 130 137 9668987 Brandt M.E. Padhye A.A. Mayer L.W. Holloway B.P. Utility of random amplified polymorphic DNA PCR and TaqMan automated detection in molecular identification of Aspergillus fumigatus J. Clin. Microbiol 36 1998 2057 2062 9650962 Brechtbuehl K. Whalley S.A. Dusheiko G.M. Saunders N.A. A rapid real-time quantitative polymerase chain reaction for hepatitis B virus J. Virol. Meth 93 2001 105 113 Bretagne S. Molecular diagnostics in clinical parasitology and mycology: limits of the current polymerase chain reaction (PCR) assays and interest of the real-time PCR assays Clin. Microbiol. Infect 9 2003 505 511 12848725 Brightwell G. Pearce M. Leslie D. Development of internal controls for PCR detection of Bacillus anthracis Mol. Cell. Probes 12 1998 367 377 9843654 Broberg E.K. Nygårdas M. Salmi A.A. Hukkanen V. Low copy number detection of herpes simplex virus type 1 mRNA and mouse Th1 type cytokine mRNAs by Light Cycler quantitative real-time PCR J. Virol. Meth 112 2003 53 65 Brorson K. Swann P.G. Lizzio E. Maudru T. Peden K. Stein K.E. Use of a quantitative product-enhanced reverse transcriptase assay to monitor retrovirus levels in mAb cell-culture and downstream processing Biotechnol. Prog 17 2001 188 196 11170498 Broussard L.A. Biological agents: weapons of warfare and bioterrorism Mol. Diagn 6 2001 323 333 11774197 Bruña-Romero O. Hafalla J.C.R. González-Aseguinolaza G. Sano G. Tsuji M. Zavala F. Detection of malaria liver-stages in mice infected through the bite of a single Anopheles mosquito using a highly sensitive real-time PCR Int. J. Parasitol 31 2001 1499 1502 11595237 Burgart L.J. Robinson R.A. Heller M.J. Wilke W.W. Iakoubova O.K. Cheville J.C. Multiplex polymerase chain reaction Mod. Pathol 5 1992 320 323 1323106 Burgos J.S. Ramírez C. Tenorio R. Sastre I. Bullido M.J. Influence of reagents formulation on real-time PCR parameters Mol. Cell. Probes 16 2002 257 260 12270266 Bustin S.A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays J. Mol. Endocrinol 25 2000 169 193 11013345 Bustin S.A. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems J. Mol. Endocrinol 29 2002 23 39 12200227 Callahan J.D. Wu S.-J.L. Dion-Schultz A. Mangold B.E. Peruski L.F. Watts D.M. Porter K.R. Murphy G.R. Suharyono W. King C.-C. Hayes C.G. Temenak J.J. Development ad evaluation of serotype- and group-specific fluorogenic reverse transcriptase PCR (TaqMan) assays for dengue virus J. Clin. Microbiol 39 2001 4119 4124 11682539 Cane P.A. Cook P. Ratcliffe D. Mutimer D. Pillay D. Use of real-time PCR and fluorimetry to detect lamivudine resistance-associated mutations in hepatitis B virus Antimicrob. Agent Chem 43 1999 1600 1608 Capone R.B. Pai S.I. Koch W.M. Gillison M.L. Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma Clin. Cancer Res 6 2001 4171 4175 Cardullo R.A. Agrawai S. Flores C. Zamecnik P.C. Wolf D.E. Detection of nucleic acid hybridization by nonradiative fluorescence resonance energy transfer Proc. Natl Acad. Sci. USA 85 1988 8790 8794 3194390 Carman B. Molecular techniques should now replace cell culture in diagnostic virology laboratories Rev. Med. Virol 11 2001 347 349 11746996 Carman W.F. Wallace L.A. Walker J. McIntyre S. Noone A. Christie P. Millar J. Douglas J.D. Rapid virological surveillance of community influenza infection in general practice Br. Med. J 321 2000 736 737 10999907 Casadevall A. Pirofski L. Host pathogen interactions: the attributes of virulence J. Infect. Dis 184 2001 337 344 11443560 Casadevall A. Pirofski L. What is a pathogen? Ann. Med 34 2002 2 4 12014430 Casadevall A. Pirofski L. Microbial virulence results from the interaction between host and microorganism Trends Microbiol 11 2003 157 158 12706990 Celi F.S. Mentuccia D. Proietti-Pannunzi L. di Gioia C.R.T. Andreoli M. Preparing poly-A-containing RNA internal standards for multiplex competitive RT-PCR Biotechniques 29 2000 454 458 10997257 Centers for Disease Control and Prevention Multistate outbreak of monkeypox – Illinois, Indiana and Wisconsin MMWR 52 2003 537 540 12803191 Chamberlain J.S. Gibbs R.A. Ranier J.E. Nguyen P.N. Caskey C.T. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification Nucleic Acids Res 16 1988 11141 11156 3205741 Chandelier A. Dubois N. Baelen F. De Leener F. Warnon S. Remacle J. Lepoivre P. RT-PCR-ELOSA tests on pooled sample units for the detection of virus Y in potato tubers J. Virol. Meth 91 2001 99 108 Chang L.-J. Urlacher V. Iwakuma T. Cui Y. Zucali J. Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system Gene Ther 6 1999 715 728 10505094 Chehab F.F. Doherty M. Cai S. Kan Y.W. Cooper S. Rubin E.M. Detection of sickle cell anaemia and thalassaemias Nature 329 1987 293 294 3627274 Chen S. Yee A. Griffiths M. Larkin C. Yamashiro C.T. Behari R. Paszko-Kolva C. Rahn K. De Grandis S.A. The evaluation of a fluorogenic polymerase chain reaction assay for the detection of Salmonella species in food commodities Int. J. Food Microbiol 35 1997 239 250 9105933 Chen R.W. Piiparinen H. Seppänen M. Koskela P. Sarna S. Lappalainen M. Real-time PCR for detection and quantitation of hepatitis B virus DNA J. Med. Virol 65 2001 250 256 11536230 Chen Y.P. Higgins J.A. Gundersen-Rindal D.E. Quantitation of a Glyptapanteles indiensis polydnavirus gene expressed in parasitized host, Lymantria dispar, by real-time quantitative RT-PCR J. Virol. Meth 114 2003 125 133 Chisholm S.A. Owen R.J. Teare E.L. Saverymuttu S. PCR-based diagnosis of Helicobacter pylori infection and real-time determination of clarithromycin resistance directly from human gastric biopsy samples J. Clin. Microbiol 39 2001 1217 1220 11283030 Choo C.K. Ling M.T. Suen C.K.M. Chan K.W. Kwong Y.L. Retrovirus-mediated delivery of HPV16 E7 antisense RNA inhibited tumorigenicity of CaSki cells Gynecol. Oncol 78 2000 293 301 10985883 Chou Q. Russell M. Birch D.E. Raymond J. Bloch W. Prevention of pre-PCR mis-priming and primer dimerization improves low-copy-number amplifications Nucleic Acids Res 20 1992 1717 1723 1579465 Clarke S.C. Reid J. Thom L. Denham B.C. Edwards G.F.S. Laboratory confirmation of meningococcal disease in Scotland, 1993–9 J. Clin. Pathol 55 2002 32 36 11825921 Clegg R.M. Fluorescence resonance energy transfer and nucleic acids Meth. Enzymol 211 1992 353 388 1406315 Clementi M. Quantitative molecular analysis of virus expression and replication J. Clin. Microbiol 38 2000 2030 2036 10834949 Clementi M. Menzo S. Manzin A. Bagnarelli P. Quantitative molecular methods in virology Arch. Virol 140 1995 1523 1539 7487485 Clewley J.P. A role for arrays in clinical virology: fact or fiction? J. Clin. Virol 29 2004 2 12 14675863 Cockerill F.R. III Smith T.F. Rapid-cycle real-time PCR: a revolution for clinical microbiology ASM News 68 2002 77 83 Compton J. Nucleic acid sequence-based amplification Nature 350 1991 91 92 1706072 Corbella M.E. Puyet A. Real-time reverse transcription-PCR analysis of expression of halobenzoate and salicylate catabolism-associated operons in two strains of Pseudomonas aeruginosa Appl. Environ. Microbiol 69 2003 2269 2275 12676709 Corless C.E. Guiver M. Borrow R. Edwards-Jones V. Fox A.J. Kaczmarski E.B. Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR J. Clin. Microbiol 39 2001 1553 1558 11283086 Corless C.E. Guiver M. Borrow R. Edwards-Jones V. Fox A.J. Kaczmarski E.B. Mutton K.J. Development and evaluation of a “real-time” RT-PCR for the detection of enterovirus and parechovirus RNA in CSF and throat swab samples J. Med. Virol 67 2002 555 562 12116004 Costa J.-M. Pautas C. Ernault P. Foulet F. Cordonnier C. Bretagne S. Real-time PCR for diagnosis and follow-up of toxoplasma reactivation after allogeneic stem cell transplantation using fluorescence resonance energy transfer hybridization probes J. Clin. Microbiol 38 2000 2929 2932 10921953 Costa J.-M. Ernault P. Gautier E. Bretagne S. Prenatal diagnosis of congenital toxoplasmosis by duplex real-time PCR using fluorescence resonance energy transfer hybridization probes Prenat. Diagn 21 2001 85 88 11241531 Costa C. Costa J.-M. Desterke C. Botterel F. Cordonnier C. Bretagne S. Real-time PCR coupled with automated DNA extraction and detection of galactomannan antigen in serum by enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis J. Clin. Microbiol 40 2002 2224 2227 12037092 Côte S. Abed Y. Boivin G. Comparative evaluation of real-time PCR assays for detection of the human metapneumovirus J. Clin. Microbiol 41 2003 3631 3635 12904367 Creelan J.L. McCullough S.J. Evaluation of strain-specific primer sequences from an abortifacient strain of ovine Chlamydophila abortus (Chlamydia psittaci) for the detection of EAE by PCR FEMS Microbiol. Lett 190 2000 103 108 10981698 Crockett A.O. Wittwer C.T. Fluorescein-labelled oligonucleotides for real-time PCR: using the inherent quenching of deoxyguanosine nucleotides Anal. Biochem 290 2001 89 97 11180941 Cruz-Perez P. Buttner M.P. Stetzenbach L.D. Specific detection of Stachybotrys chartarum in pure culture using quantitative polymerase chain reaction Mol. Cell. Probes 15 2001 129 138 11352593 Czerny C.P. Eis-Hubinger A.M. Mayr A. Schneweis K.E. Pfeiff B. Animal poxviruses transmitted from cat to man: current event with lethal end Zentralbl. Veterinarmed. B 38 1991 421 431 1659066 Daniels P. Ksiazek T. Eaton B.T. Laboratory diagnosis of Nipah and Hendra virus infections Microbes Infect 3 2001 289 295 11334746 de Viedma D.G. Diaz Infanntes M. Lasala F. Chaves F. Alcalá L. Bouza E. New real-time PCR able to detect in a single tube multiple rifamin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosis J. Clin. Microbiol 40 2002 988 995 11880428 de Wit C. Fautz C. Xu Y. Real-time quantitative PCR for retrovirus-like particle formation in CHO cell culture Biologicals 28 2000 137 148 10964440 DeGraves F.J. Gao D. Kaltenboeck B. High-sensitivity quantitative PCR platform Biotechniques 34 2003 106 115 12545547 Dekonenko A. Ibrahim M.S. Schmaljohn C.S. A colorimetric PCR–enzyme immunoassay to identify hantaviruses Clin. Diag. Virol 8 1997 113 121 Deng X. Li H. Tang Y.-W. Cytokine expression in respiratory syncytial virus-infected mice as measured by quantitative reverse-transcriptase PCR J. Virol. Meth 107 2003 141 146 Desjardin L.E. Chen Y. Perkins M.D. Teixeira L. Cave M.D. Eisenach K.D. Comparison of the ABI 7700 system (TaqMan) and competitive PCR for quantification of IS6110 DNA in sputum during treatment of tuberculosis J. Clin. Microbiol 36 1998 1964 1968 9650945 Devers M. Soulas G. Martin-Laurent F. Real-time reverse transcription PCR analysis of expression of atrazine catabolism genes in two bacterial strains isolated from soil J. Microbiol. Meth 56 2004 3 15 Didenko V.V. DNA probes using fluorescence resonance energy transfer (FRET): designs and applications Biotechniques 31 2001 1106 1121 11730017 Drago L. Lombardi A. De Vecchi E. Gismondo M.R. Real-time PCR assay for the rapid detection of Bacillus anthracis spores in clinical samples J. Clin. Microbiol 40 2002 4399 12409444 Drosten C. Gunther S. Preiser W. van der W.S. Brodt H.R. Becker S. Rabenau H. Panning M. Kolesnikova L. Fouchier R.A. Berger A. Burguiere A.M. Cinatl J. Eickmann M. Escriou N. Grywna K. Kramme S. Manuguerra J.C. Muller S. Rickerts V. Sturmer M. Vieth S. Klenk H.D. Osterhaus A.D. Schmitz H. Doerr H.W. Identification of a novel coronavirus in patients with severe acute respiratory syndrome N. Engl. J. Med 348 2003 1967 1976 12690091 Echevarria J.E. Erdman D.D. Swierkosz E.M. Holloway B.P. Anderson L.J. Simultaneous detection and identification of human parainfluenza viruses 1, 2, and 3 from clinical samples by multiplex PCR J. Clin. Microbiol 36 1998 1388 1391 9574711 Edelman D.C. Barletta J. Real-time PCR provides improved detection and titer determination of bacteriophage Biotechniques 35 2003 368 375 12951778 Egholm M. Buchardt O. Christensen L. Behrens C. Freier S.M. Driver D.A. Berg R.H. Kim S.K. Norden B. Nielsen P.E. PNA hybridizes to complementary oligonucleotides obeying the Watson–Crick hydrogen bonding rules Nature 365 1993 566 568 7692304 Eishi Y. Suga M. Ishige I. Kobayashi D. Yamada T. Takemura T. Takizawa T. Koike M. Kudoh S. Costabel U. Guzman J. Rizzato G. Gambacorta M. du Bois R. Nicholson A.G. Sharma O.P. Ando M. Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis J. Clin. Microbiol 40 2002 198 204 11773116 Elenitoba K.S.J. Bohling S.D. Wittwer C.T. King T.C. Multiplex PCR by multicolor fluorimetry and fluorescence melting curve analysis Nat. Med 7 2001 249 253 11175859 Ellerbrok H. Nattermann H. Özel M. Beutin L. Appel B. Pauli G. Rapid and sensitive identification of pathogenic and apathogenic Bacillus anthracis by real-time PCR FEMS Microbiol. Lett 214 2002 51 59 12204372 Ellis J.S. Zambon M.C. Molecular diagnosis of influenza Rev. Med. Virol 12 2002 375 389 12410529 Emery S.L. Erdman D.D. Bowen M.D. Newton B.R. Winchell J.M. Meyer R.F. Tong S. Cook B.T. Holloway B.P. McCaustland K.A. Rota P.A. Bankamp B. Lowe L.E. Ksiazek T.G. Bellini W.J. Anderson L.J. Real-time reverse transciption-polymerase chain reaction assay for SARS-associated Coronavirus Emerg. Infect. Dis 10 2004 311 316 15030703 Espy M.J. Ross T.K. Teo R. Svien K.A. Wold A.D. Uhl J.R. Smith T.F. Evaluation of LightCycler PCR for implementation of laboratory diagnosis of herpes simplex virus infections J. Clin. Microbiol 38 2000 3116 3118 10921993 Espy M.J. Uhl J.R. Mitchell P.S. Thorvilson J.N. Svien K.A. Wold A.D. Smith T.F. Diagnosis of herpes simplex virus infections in the clinical laboratory by LightCycler PCR J. Clin. Microbiol 38 2000 795 799 10655387 Espy M.J. Cockerill F.R. III Meyer R.F. Bowen M.D. Poland G.A. Hadfield T.L. Smith T.F. Detection of smallpox virus DNA by LightCycler PCR J. Clin. Microbiol 40 2002 1985 1988 12037052 Fan H. Gulley M.L. Epstein-Barr viral load measurement as a marker of EBV-related disease Mol. Diagn 6 2001 279 289 11774193 Fenollar F. Fournier P.-E. Raoult D. Gérolami R. Lepidi H. Poyart C. Quantitative detection of Tropheryma whipplei DNA by real-time PCR J. Clin. Microbiol 40 2002 1119 1120 11880458 Fernandez C. Boutolleau D. Manichanh C. Mangeney N. Agut H. Gautheret-Dejean A. Quantitation of HHV-7 genome by real-time polymerase chain reaction assay using MGB probe technology J. Virol. Meth 106 2002 11 16 Fiandaca M.J. Hyldig-Nielsen J.J. Gildea B.D. Coull J.M. Self-reporting PNA/DNA primers for PCR analysis Genome Res 11 2001 609 611 11282976 Förster T. Zwischenmolekulare energiewanderung und fluoreszenz Ann. Phys 6 1948 55 75 Fortin N.Y. Mulchandani A. Chen W. Use of real-time polymerase chain reaction and molecular beacons for the detection of Escherichia coli 0157:H7 Anal. Biochem 289 2001 281 288 11161323 Fraaije B.A. Lovell D.J. Coelho J.M. Baldwin S. Hollomon D.W. PCR-based assays to assess wheat varietal resistance to blotch (Septoria tritici and Stagonospora nodorum) and rust (Puccinia striiformis and Puccinia recondita) diseases Eur. J. Plant Pathol 107 2001 905 917 Fredricks D.N. Relman D.A. Application of polymerase chain reaction to the diagnosis of infectious disease Clin. Infect. Dis 29 1999 475 488 10530433 Freeman W.M. Walker S.J. Vrana K.E. Quantitative RT-PCR: pitfalls and potential Biotechniques 26 1999 112 125 9894600 French D.J. Archard C.L. Brown T. McDowell D.G. HyBeacon™ probes: a new tool for DNA sequence detection and allele discrimination Mol. Cell. Probes 15 2001 363 374 11851380 French D.J. Archard C.L. Andersen M.T. McDowell D.G. Ultra-rapid analysis using HyBeacon™ probes and direct PCR amplification from saliva Mol. Cell. Probes 16 2002 319 326 12477435 Freymuth F. Eugene G. Vabret A. Petitjean J. Gennetay E. Brouard J. Duhamel J.F. Guillois B. Detection of respiratory syncytial virus by reverse transcription-PCR and hybridization with a DNA enzyme immunoassay J. Clin. Microbiol 33 1995 3352 3355 8586738 Fujita H. Eishi Y. Ishige I. Saitoh K. Takizawa T. Quantitative analysis of bacterial DNA from Mycobacteria spp. Bacteroides vulgatus, and Escherichia coli in tissue samples from patients with inflammatory bowel diseases J. Gastroenterol 37 2002 509 516 12162408 Furuta Y. Ohtani F. Sawa H. Fukuda S. Inuyama Y. Quantitation of varicella-zoster virus DNA in patients with Ramsay Hunt syndrome and zoster sine herpete J. Clin. Microbiol 39 2001 2856 2859 11474003 Gallagher A. Armstrong A.A. MacKenzie J. Shield L. Khan G. Lake A. Proctor S. Taylor P. Clements G.B. Jarrett R.F. Detection of epstein-barr virus (EBV) genomes in the serum of patients with EBV-associated Hodgkin's disease Int. J. Can 84 1999 442 448 Gault E. Michel Y. Nicolas J.-C. Belabani C. Nicolas J.-C. Garbarg-Chenon A. Quantification of human cytomegalovirus DNA by real-time PCR J. Clin. Microbiol 39 2001 772 775 11158149 Gelmini S. Orlando C. Sestini R. Vona G. Pinzani P. Ruocco L. Pazzagli M. Quantitative polymerase chain reaction-based homogeneous assay with fluorogenic probes to measure c-cerB-2 oncogene amplification Clin. Chem 43 1997 752 758 9166227 Gerard C.J. Arboleda M.J. Solar G. Mule J.J. Kerr W.G. A rapid and quantitative assay to estimate gene transfer into retrovirally transduced hematopoietic stem/progenitor cells using a 96-well format PCR and fluorescent detection system universal for MMLV-based proviruses Hum. Gen. Ther 7 1996 343 354 Gibb T.R. Norwood D.A. Jr. Woollen N. Henchal E.A. Development and evaluation of a fluorogenic 5′-nuclease assay to identify Marburg virus Mol. Cell. Probes 15 2001 259 266 11735297 Gibb T.R. Norwood D.A. Jr. Woollen N. Henchal E.A. Development and evaluation of a fluorogenic 5′ nuclease assay to detect and differentiate between Ebola virus subtypes Zaire and Sudan J. Clin. Microbiol 39 2001 4125 4130 11682540 Gibson U.E.M. Heid C.A. Williams P.M. A novel method for real time quantitative RT-PCR Genome Res 6 1996 995 1001 8908519 Gibson J.R. Saunders N.A. Owen R.J. Novel method for rapid determination of clarithromycin sensitivity in Helicobacter pylori J. Clin. Microbiol 37 1999 3746 3748 10523591 Giglio S. Monis P.T. Saint C.P. Demonstration of preferential binding of SYBR Green I to specific DNA fragments in real-time multiplex PCR Nucleic Acids Res 31 2003 e136 14602929 Gilliland G. Perrin S. Bunn H.F. Competitive PCR for Quantitation of mRNA PCR Protocols: A Guide to Methods and Applications 1990 Academic Press New York pp. 60–69 Ginzinger D.G. Gene quantification using real-time quantitative PCR: an emerging technology hits mainstream Exp. Hematol 30 2002 503 512 12063017 Giulietti A. Overbergh L. Valckx D. Decallonne B. Bouillon R. Mathieu C. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression Methods 25 2001 386 401 11846608 Glasel J.A. Validity of nucleic acid purities monitored by 260 nm/280 nm absorbance ratios Biotechniques 18 1995 62 63 7702855 Goerke C. Bayer M.G. Wolz C. Quantification of bacterial transcripts during infection using competitive reverse transcription-PCR (RT-PCR) and LightCycler RT-PCR Clin. Diag. Lab. Immunol 8 2001 279 282 Gruber F. Falkner F.G. Dorner F. Hämmerle T. Quantitation of viral DNA by real-time PCR applying duplex amplification, internal standardization, and two-colour fluorescence detection Appl. Environ. Microbiol 67 2001 2837 2839 11375203 Guiver M. Oppenheim B.A. Rapid identification of Candida species by TaqMan PCR J. Clin. Pathol 54 2001 362 366 11328834 Gundry C.N. Bernard P.S. Herrmann M.G. Reed G.H. Wittwer C.T. Rapid F508del and F508C assay using fluorescent hybridization probes Genet. Test 3 1999 365 370 10627945 Gundry C.N. Vandersteen J.G. Reed G.H. Pryor R.J. Chen J. Wittwer C.T. Amplicon melting analysis with labeled primers: a closed-tube method for differentiating homozygotes and heterozygotes Clin. Chem 49 2003 396 406 12600951 Gyllensten U.B. Erlich H.A. Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus Proc. Natl Acad. Sci. USA 85 1988 7652 7656 3174659 Hackett N.R. El Sawy T. Lee L.Y. Silva I. O'Leary J. Rosengart T.K. Crystal R.G. Use of quantitative TaqMan real-time PCR to track the time-dependent distribution of gene transfer vectors in vivo Mol. Ther 2 2000 649 656 11124067 Halford W.P. The essential prerequisites for quantitative RT-PCR Nat. Biotechnol 17 1999 835 10471906 Halford W.P. Falco V.C. Gebhardt B.M. Carr D.J.J. The inherent quantitative capacity of the reverse transcription-polymerase chain reaction Anal. Biochem 266 1999 181 191 9888974 Hall L.L. Bicknell G.R. Primrose L. Pringle J.H. Shaw J.A. Furness P.N. Reproducibility in the quantification of mRNA levels by RT-PCR-ELISA and RT competitive-PCR-ELISA Biotechniques 24 1998 652 657 9564540 Halpin K. Young P.L. Field H.E. Mackenzie J.S. Isolation of Hendra virus from pteropid bats: a natural reservoir of Hendra virus J. Gen. Virol 81 2000 1927 1932 10900029 Hardick J. Yang S. Lin S. Duncan D. Gaydos C. Use of Roche LightCycler instrument in a real-time PCR for Trichomonas vaginalis in urine samples from females and males J. Clin. Microbiol 41 2003 5619 5622 14662951 Härtel C. Bein G. Kirchner H. Klüter H. A human whole-blood assay for analysis of T-cell function by quantification of cytokine mRNA Scand. J. Immunol 49 1999 649 654 10354377 Haugland R.A. Vesper S.J. Wymer L.J. Quantitative measurement of Stachybotrys chartarum conidia using real time detection of PCR products with the TaqMan (TM) fluorogenic probe system Mol. Cell. Probes 13 1999 329 340 10508554 Hawrami K. Breur J. Development of a fluorogenic polymerase chain reaction assay (TaqMan) for the detection and quantitation of varicella zoster virus J. Virol. Meth 79 1999 33 40 Hayden R.T. Uhl J.R. Qian X. Hopkins M.K. Aubry M.C. Limper A.H. Lloyd R.V. Cockerill F.R. Direct detection of Legionella species from bronchoalveolar lavage and open lung biopsy specimens: comparison of LightCycler PCR, in situ hybridization, direct fluorescence antigen detection, and culture J. Clin. Microbiol 37 2001 2618 2626 Heid C.A. Stevens J. Livak K.J. Williams P.M. Real time quantitative PCR Gen. Meth 6 1996 986 994 Hein I. Lehner A. Rieck P. Klein K. Brandl E. Wagner M. Comparison of different approaches to quantify Staphylococcus aureus by real-time quantitative PCR and application of this techniques for examination of cheese Appl. Environ. Microbiol 67 2001 3122 3126 11425731 Hein J. Schellenberg U. Bein G. Hackstein H. Quantification of murine IFN-γ mRNA and protein expression: impact of real-time kinetic RT-PCR using SYBR Green I dye Scand. J. Immunol 54 2001 285 291 11555392 Held T.K. Biel S.S. Nitsche A. Kurth A. Chen S. Gelderblom H.R. Siegert W. Treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir Bone Marrow Transpl 26 2000 347 350 Heller M.J. Morrison L.E. Chemiluminescent and fluorescent probes for DNA hybridization Kingsbury D.T. Falkow S. Rapid Detection and Identification of Infectious Agents 1985 Academic Press New York 245 256 Henderson D.A. Inglesby T.V. Bartlett J.G. Ascher M.S. Eitzen E. Jahrling P.B. Hauer J. Layton M. McDade J. Osterholm M.T. O'Toole T. Parker G. Perl T. Russell P.K. Tonat K. Smallpox as a biological weapon: medical and public health management. Working group on civilian biodefense JAMA 281 1999 2127 2137 10367824 Henegariu O. Heerema N.A. Dloughy S.R. Vance G.H. Vogt P.H. Multiplex PCR critical parameters and step-by-step protocol Biotechniques 23 1997 504 511 9298224 Hermsen C.C. Telgt D.S.C. Linders E.H.P. van de Locht L.A.T.F. Eling W.M.C. Mensink E.J.B.M. Sauerwein R.W. Detection of Plasmodium falciparum malaria parasites in vivo by real-time quantitative PCR Mol. Biochem. Parasitol 118 2001 247 251 11738714 Herrmann M.G. Dobrowolski S.F. Wittwer C.T. Rapid β-globin genotyping by multiplexing probe melting temperature and color Clin. Chem 46 2000 425 429 10702535 Higgins J.A. Ezzell J. Hinnebusch B.J. Shipley M. Henchal E.A. Ibrahim M.S. 5′ Nuclease PCR assay to detect Yersinia pestis J. Clin. Microbiol 36 1998 2284 2288 9666006 Higgins J.A. Hubalek Z. Halouzka J. Elkins K.L. Sjostedt A. Shipley M. Ibrahim M.S. Detection of Francisella tularensis in infected mammals and vectors using a probe-based polymerase chain reaction Am. J. Trop. Med. Hyg 62 2000 310 318 10813490 Higgins J.A. Cooper M. Schroeder-Tucker L. Black S. Miller D. Karns K.S. Manthey E. Breeze R. Perdue M.L. A field investigation of Bacillus anthracis contamination of U.S. department of agriculture and other Washington, DC, buildings during the anthrax attack of October 2001 Appl. Environ. Microbiol 69 2003 593 599 12514046 Higgins J.A. Nasarabadi S. Karns J.S. Shelton D.R. Cooper M. Gbakima A. Koopman R.P. A handheld real time thermal cycler for bacterial pathogen detection Biosens. Bioelectron 18 2003 1115 1123 12788554 Higuchi R. Dollinger G. Walsh P.S. Griffith R. Simultaneous amplification and detection of specific DNA sequences Biotechnology (NY) 10 1992 413 417 Higuchi R. Fockler C. Dollinger G. Watson R. Kinetic PCR analysis: real-time monitoring of DNA amplification reactions Biotechnology (NY) 11 1993 1026 1030 Holland P.M. Abramson R.D. Watson R. Gelfand D.H. Detection of specific polymerase chain reaction product by utilizing the 5′–3′ exonuclease activity of Thermus aquaticus Proc. Natl Acad. Sci. USA 88 1991 7276 7280 1871133 Holodniy M. Katzenstein D. Sengupta S. Wang A.M. Casipit C. Schwartz D.H. Konrad M. Groves E. Merigan T.C. Detection and quantification of human immunodeficiency virus RNA in patient serum by use of the polymerase chain reaction J. Infect. Dis 163 1991 862 866 2010639 Hoorfar J. Cook N. Malorny B. Wagner M. De Medici D. Abdulmawjood A. Fach P. Making an internal amplification control mandatory for diagnostic PCR J. Clin. Microbiol 41 2003 5835 14662997 Hoshino Y. Kimura H. Kuzushima K. Tsurumi T. Nemoto K. Kikuta A. Nishiyama Y. Kojima S. Matsuyama T. Morishima T. Early intervention in post-transplant lymphoproliferative disorders based on Epstein-Barr viral load Bone Marrow Transpl 26 2000 199 201 Howell W.M. Jobs M. Brookes A.J. iFRET: an improved fluorescence system for DNA-melting analysis Genome Res 12 2002 1401 1407 12213777 Hu A. Colella M. Tam J.S. Rappaport R. Cheng S.-M. Simultaneous detection, subgrouping, and quantitation of respiratory syncytial virus A and B by real-time PCR J. Clin. Microbiol 41 2003 149 154 12517840 Huang J. DeGraves F.J. Gao D. Feng P. Schlapp T. Kaltenboeck B. Quantitative detection of Chlamydia spp. by fluorescent PCR in the LightCycler Biotechniques 30 2001 150 157 11196306 Hughes G.J. Smith J.A. Hanlon C.A. Rupprecht C.E. Evaluation of a TaqMan PCR assay to detect rabies virus RNA: influence of sequence variation and application to quantification of viral loads J. Clin. Microbiol 41 2004 299 306 Hurtle W. Bode E. Kulesh D.A. Kaplan R.S. Garrison J. Bridge D. House M. Frye M.S. Loveless B. Norwood D. Detection of Bacillus anthracis gyrA gene by using a minor groove binder probe J. Clin. Microbiol 42 2004 179 185 14715750 Hyypiä T. Puhakka T. Ruuskanen O. Mäkelä M. Arola A. Arstila P. Molecular diagnosis of human rhinovirus infections: comparison with virus isolation J. Clin. Microbiol 36 1998 2081 2083 9650967 Ibekwe A.M. Watt P.M. Grieve C.M. Sharma V.K. Lyons S.R. Multiplex fluorogenic real-time PCR for detection and quantification of Escherichia coli O157:H7 in dairy wastewater wetlands Appl. Environ. Microbiol 68 2002 4853 4862 12324331 Ibrahim M.S. Esposito J.J. Jahrling P.B. Lofts R.S. The potential of 5′ nuclease PCR for detecting a single-base polymorphism in Orthopoxvirus Mol. Cell. Probes 11 1997 143 147 9160329 Ibrahim M.S. Lofts R.S. Jahrling P.B. Henchal E.A. Weedn V.W. Northrup M.A. Belgrader P. Real-time microchip PCR for detecting single-base differences in viral and human DNA Anal. Chem 70 1998 2013 2017 9599592 Ibrahim M.S. Kulesh D.A. Saleh S.S. Damon I.K. Esposito J.J. Schmaljohn A.L. Jahrling P.B. Real-time PCR assay to detect smallpox virus J. Clin. Microbiol 41 2003 3835 3839 12904397 Iriyama M. Kimura H. Nishikawa K. Yoshioka K. Wakita T. Nishimura N. Shibata M. Ozaki T. Morishima T. The prevalence of TT virus (TTV) infection and its relationship to hepatitis in children Med. Microbiol. Immunol. (Berl.) 188 1999 83 89 10753060 Isacsson J. Cao H. Ohlsson L. Nordgren S. Svanvik N. Westman G. Kubista M. Sjöback R. Sehlstedt U. Rapid and specific detection of PCR products using light-up probes Mol. Cell. Probes 14 2000 321 328 11040096 Ishiguro T. Saitoh J. Yawata H. Yamagishi H. Iwasaki S. Mitoma Y. Homogeneous quantitative assay of hepatitis C virus RNA by polymerase chain reaction in the presence of a fluorescent intercalater Anal. Biochem 229 1995 207 213 7485974 Jabs W.J. Hennig H. Kittel M. Pethig K. Smets F. Bucsky P. Kirchner H. Wagner H.J. Normalized quantification by real-time PCR of Epstein-Barr virus load in patients at risk for posttransplant lymphoproliferative disorders J. Clin. Microbiol 39 2001 564 569 11158107 Johnson J.R. Development of polymerase chain reaction-based assays for bacterial gene detection J. Microbiol. Meth 41 2000 201 209 Jordens J.Z. Lanham S. Pickett M.A. Amarasekara S. Aberywickrema I. Watt P.J. Amplification with molecular beacon primers and reverse line blotting for the detection and typing of human papillomaviruses J. Virol. Meth 89 2000 29 37 Josefsson A. Livak K. Gyllensten U. Detection and quantitation of human papillomavirus by using the fluorescent 5′ exonuclease assay J. Clin. Microbiol 37 1999 490 496 9986801 Josefsson A.M. Magnusson P.K.E. Ylitalo N. Sørensen P. Qwarforth-Tubbin P. Andersen P.K. Melbye M. Adami H.-O. Gyllensten U. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study Lancet 355 2000 2189 2193 10881891 Jung R. Soondrum K. Neumaier M. Quantitative PCR Clin. Chem. Lab. Med 38 2000 833 836 11097336 Kaneko S. Murakami S. Unoura M. Kobayashi K. Quantitation of hepatitis C virus RNA by competitive polymerase chain reaction J. Med. Virol 37 1992 278 282 1328502 Kares S. Lönnrot M. Vuorinen P. Oikarinen S. Taurianen S. Hyöty H. Real-time PCR for rapid diagnosis of entero- and rhinovirus infections using LightCycler J. Clin. Virol 29 2004 99 104 14747028 Kato T. Mizokami M. Mukaide M. Orito E. Ohno T. Nakano T. Tanaka Y. Kato H. Sugauchi F. Ueda R. Hirashima N. Shimamatsu K. Kage M. Kojiro M. Development of a TT virus DNA quantification system using real-time detection PCR J. Clin. Microbiol 38 2000 94 98 10618070 Kawai S. Yokosuka O. Kanda T. Imazeki F. Maru Y. Saisho H. Quantification of hepatitis C virus by TaqMan PCR: comparison with HCV amplicor monitor assay J. Med. Virol 58 1999 121 126 10335858 Ke D. Ménard C. Picard F.J. Boissinot M. Ouellette M. Roy P.H. Bergeron M.G. Development of conventional and real-time PCR assays for the rapid detection of group B streptococci Clin. Chem 46 2000 324 331 10702518 Kearns A.M. Draper B. Wipat W. Turner A.J.L. Wheeler J. Freeman R. Harwood J. Gould F.K. Dark J.H. LightCycler-based quantitative PCR for detection of cytomegalovirus in blood, urine and respiratory samples J. Clin. Microbiol 39 2001 2364 2365 11414242 Kearns A.M. Guiver M. James V. King J. Development and evaluation of a real-time quantitative PCR for the detection of human cytomegalovirus J. Virol. Meth 95 2001 121 131 Kearns A.M. Turner A.J.L. Taylor C.E. George P.W. Freeman R. Gennery A.R. LightCycler-based quantitative PCR for rapid detection of human herpesvirus 6 DNA in clinical material J. Clin. Microbiol 39 2001 3020 3021 11499395 Kehl S.C. Henrickson K.J. Hua W. Fan J. Evaluation of the hexaplex assay for detection of respiratory viruses in children J. Clin. Microbiol 39 2001 1696 1701 11325976 Keller G.H. Huang D.-P. Shih J.W.-K. Manak M.M. Detection of hepatitis B virus DNA in serum by polymerase chain reaction amplification and microtiter sandwich hybridization J. Clin. Microbiol 28 1990 1411 1416 2199501 Kemp D.J. Churchill M.J. Smith D.B. Biggs B.A. Foote S.J. Peterson M.G. Samaras N. Deacon N.J. Doherty R. Simplified colorimetric analysis of polymerase chain reactions: detection of HIV sequences in AIDS patients Gene 94 1990 223 228 2258054 Kennedy M.M. Lucas S.B. Jones R.R. Howells D.D. Picton S.J. Hanks E.E. McGee J.O. O'Leary J. HHV8 and Kaposi's sarcoma: a time cohort study J. Clin. Pathol 50 1997 96 100 Kennedy M.M. Lucas S.B. Russell-Jones R. Howells D.D. Picton S.J. Bardon A. Comley I.L. McGee J.O. O'Leary J.J. HHV8 and female Kaposi's sarcoma J. Pathol 183 1997 447 452 9496262 Kennedy M.M. Cooper K. Howells D.D. Picton S. Biddolph S. Lucas S.B. McGee J.O. O'Leary J.J. Identification of HHV8 in early Kaposi's sarcoma: implications for Kaposi's sarcoma pathogenesis J. Clin. Pathol 51 1998 14 20 Kennedy M.M. O'Leary J.J. Oates J.L. Lucas S.B. Howells D.D. Picton S. McGee J.O. Human herpes virus 8 (HHV-8) in Kaposi's sarcoma: lack of association with Bcl-2 and p53 protein expression J. Clin. Pathol 51 1998 155 159 Kennedy M.M. Biddolph S. Lucas S.B. Howells D.D. Picton S. McGee J.O. O'Leary J.J. CD40 upregulation is independent of HHV-8 in the pathogenesis of Kaposi's sarcoma J. Clin. Pathol 52 1999 32 36 Kennedy M.M. Biddolph S. Lucas S.B. Howells D.D. Picton S. McGee J.O. Silva I. Uhlmann V. Luttich K. O'Leary J. Cyclin D1 expression and HHV-8 in Kaposi sarcoma J. Clin. Pathol 52 1999 569 573 10645225 Kidd I.M. Clark D.A. Emery V.C. A non-radioisotopic quantitative competitive polymerase chain reaction method: application in measurement of human herpesvirus 7 load J. Virol. Meth 87 2000 177 181 Kievits T. van Gemen B. van Strijp D. Schukkink R. Dircks M. Adriaanse H. Malek L. Sooknanan R. Lens P. NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection J. Virol. Meth 35 1991 273 286 Kikuchi T. Iwasaki K. Nishihara H. Takamura Y. Yagi O. Quantitative and rapid detection of the trichloroethylene-degrading bacterium Methylocystis sp. in groundwater by real-time PCR Appl. Microbiol. Biotechnol 59 2002 731 736 12226733 Kilpatrick D.R. Nottay B. Yang C.F. Yang S.J. Mulders M.N. Holloway B.P. Pallansch M.A. Kew O.M. Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residue at positions of codon degeneracy J. Clin. Microbiol 34 1996 2990 2996 8940436 Kimura H. Morita M. Yabuta Y. Kuzushima K. Kato K. Kojima S. Matsuyama T. Morishima T. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay J. Clin. Microbiol 37 1999 132 136 9854077 Klaschik S. Lehmann L.E. Raadts A. Book M. Hoeft A. Stuber F. Real-time PCR for the detection and differentiation of Gram-positive and Gram-negative bacteria J. Clin. Microbiol 40 2002 4304 4307 12409416 Klein D. Quantification using real-time PCR technology: applications and limitations Trends Mol. Med 8 2002 257 260 12067606 Klein D. Janda P. Steinborn R. Salmons B. Günzburg W.H. Proviral load determination of different feline immunodeficiency virus isolates using real-time polymerase chain reaction: Influence of mismatches on quantification Electrophoresis 20 1999 291 299 10197436 Komurian-Pradel F. Paranhos-Baccalà G. Sodoyer M. Chevallier P. Mandrand B. Lotteau V. André P. Quantitation of HCV RNA using real-time PCR and fluorimetry J. Virol. Meth 95 2001 111 119 Koshkin A.A. Singh S.K. Nielsen P. Rajwanshi V.K. Kumar R. Meldgaard M. Olsen C.E. Wengel J. LNA (locked nuciec acids): synthesis of the adenine, cytosine, guanine, 5-methylcytosine, thymine and uracil bicyclonucleoside monomers, oligomerisation, and unprecedented nucleic acid recognition Tetrahedron 54 1998 3607 3630 Kox L.F.F. Noordhoek G.T. Kunakorn M. Mulder S. Sterrenburg M. Kolk A.H.J. Microwell hybridization assay for detection of PCR products from Mycobacterium tuberculosis complex and the recombinant Mycobacterium smegmatis strain 1008 used as an internal control J. Clin. Microbiol 34 1996 2117 2120 8862568 Kraus G. Cleary T. Miller N. Seivright R. Young A.K. Spruill G. Hnatyszyn H.J. Rapid and specific detection of the Mycobacterium tuberculosis complex using fluorogenic probes and real-time PCR Mol. Cell. Probes 15 2001 375 383 11851381 Kreuzer K.-A. Bohn A. Lass U. Peters U.R. Schmidt C.A. Influence of DNA polymerases on quantitative PCR results using TaqMan probe format in the LightCycler instrument Mol. Cell. Probes 14 2000 57 60 10799265 Kruse N. Pette M. Toyka K. Rieckmann P. Quantification of cytokine mRNA expression by RT PCR in samples of previously frozen blood J. Immunol. Meth 210 1997 195 203 Kumar R. Singh S.K. Koshkin A.A. Rajwanshi V.K. Meldgaard M. Wengel J. The first analogues of LNA (locked nucleic acids): phosphorothioate-LNA and 2′-thio-LNA Bioorg. Med. Chem. Lett 8 1998 2219 2222 9873516 Kupferschmidt O. Krüger D. Held T.K. Ellerbrok H. Siegert W. Janitschke K. Quantitative detection of Toxoplasma gondii DNA in human body fluids by TaqMan polymerase chain reaction Clin. Microbiol. Infect 7 2001 120 124 11318809 Kurata S. Kanagawa T. Yamada K. Torimura M. Yokomaku T. Kamagata Y. Kurane R. Fluorescent quenching-based quantitative detection of specific DNA/RNA using a BODIPY® FL-labeled probe or primer Nucleic Acids Res 29 2001 e34 11239011 Kutyavin I.V. Afonina I.A. Mills A. Gorn V.V. Lukhtanov E.A. Belousov E.S. Singer M.J. Walburger D.K. Lokhov S.G. Gall A.A. Dempcy R. Reed M.W. Meyer R.B. Hedgpeth J. 3′-Minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures Nucleic Acids Res 28 2000 655 661 10606668 Lai K.K.-Y. Cook L. Wendt S. Corey L. Jerome K.R. Evaluation of real-time PCR versus PCR with liquid-phase hybridization for detection of enterovirus RNA in cerebrospinal fluid J. Clin. Microbiol 41 2003 3133 3141 12843053 Lallemand F. Desire N. Rozenbaum W. Nicolas J.-C. Marechal V. Quantitative analysis of human herpesvirus 8 viral load using a real-time PCR assay J. Clin. Microbiol 38 2000 1404 1408 10747115 Lanciotti R.S. Kerst A.J. Nucleic acid sequence-based amplification assays for rapid detection of West Nile and St. Louis Encephalitis J. Clin. Microbiol 39 2001 4506 4513 11724870 Lanciotti R.S. Kerst A.J. Nasci R.S. Godsey M.S. Mitchell C.J. Savage H.M. Komar N. Panella N.A. Allen B.C. Volpe K.E. Davis B.S. Roehrig J.T. Rapid detection of West Nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay J. Clin. Microbiol 38 2000 4066 4071 11060069 Landt O. Selection of hybridisation probes for real-time quantification and genetic analysis Meuer S. Wittwer C. Nakagawara K. Rapid Cycle Real-Time PCR: Methods and Applications 2001 Springer Germany 35 41 Lanham S. Herbert A. Watt P. HPV detection and measurement of HPV-16, telomerase, and survivin transcripts in colposcopy clinic patients J. Clin. Pathol 54 2001 304 308 11304848 Laue T. Emmerich P. Schmitz H. Detection of dengue virus RNA inpatients after primary or secondary dengue infection by using the TaqMan automated amplification system J. Clin. Microbiol 37 1999 2543 2547 10405398 Lay M.J. Wittwer C.T. Real-time fluorescence genotyping of factor V Leiden during rapid-cycle PCR Clin. Chem 43 1997 2262 2267 9439442 Lee L.G. Connell C.R. Bloch W. Allelic discrimination by nick-translation PCR with fluorogenic probes Nucleic Acids Res 21 1993 3761 3766 8367293 Lee L.G. Livak K.J. Mullah B. Graham R.J. Vinayak R.S. Woudenberg T.M. Seven-color, homogeneous detection of six PCR products Biotechniques 27 1999 342 349 10457842 Lee M.A. Brightwell G. Leslie D. Bird H. Hamilton A. Fluorescent detection techniques for real-time multiplex strand specific detection of Bacillus anthracis using rapid PCR J. Appl. Microbiol 87 1999 218 223 10475953 Lee M.-A. Tan C.-H. Aw L.-T. Tang C.-S. Singh M. Lee S.-H. Chia H.-P. Yap E.P.H. Real-time fluorescence-based PCR for detection of malaria parasites J. Clin. Microbiol 40 2002 4343 4345 12409427 Lee M.A. Siddle A.L. Page R.H. ResonSense®: simple linear fluorescent probes for quantitative homogeneous rapid polymerase chain reaction Anal. Chim. Acta 457 2002 61 70 Lefevre J. Hankins C. Pourreaux K. Voyer H. Coutlée F. Real-time PCR assays using internal controls for quantitation of HPV-16 and β-globin DNA in cervicovaginal lavages J. Virol. Meth 114 2003 135 144 Leutenegger C.M. Klein D. Hofmann-Lehmann R. Mislin C. Hummel U. Boni J. Boretti F. Guenzburg W.H. Lutz H. Rapid feline immunodeficiency virus provirus quantitation by polymerase chain reaction using the TaqMan fluorogenic real-time detection system J. Virol. Meth 78 1999 105 116 Lew A.E. Bock R.E. Miles J. Cuttell L.B. Steer P. Nadin-Davis S.A. Sensitive and specific detection of bovine immunodeficiency virus and bovine syncytial virus by 5′ Taq nuclease assays with fluorescent 3′ minor groove binder-DNA probes J. Virol. Meth 116 2004 1 9 Lew A.E. Bock R.E. Molloy J.B. Minchin C.M. Robinson S.J. Steer P. Sensitive and specific detection of proviral bovine leukemia virus by 5′ Taq nuclease PCR using a 3′ minor groove binder fluorogenic probe J. Virol. Meth 115 2004 167 175 Lewin S.R. Vesanen M. Kostrikis L. Hurley A. Duran M. Zhang L. Ho D.D. Markowitz M. Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type 1-infected individuals on prolonged effective antiretroviral therapy J. Virol 73 1999 6099 6103 10364365 Lewis-Jones S. The zoonotic poxviruses Dermatol. Nurs 14 2002 79 82 12017086 Li Q.-G. Liang J.-X. Luan G.-Y. Zhang Y. Wang K. Molecular beacon-based homogeneous fluorescence PCR assay for the diagnosis of infectious diseases Anal. Sci 16 2000 245 249 Li Q. Luan G. Guo Q. Liang J. A new class of homogeneous nucleic acid probes based on specific displacement hybridization Nucleic Acids Res 30 2002 e5 11788731 Limaye A.P. Jerome K.R. Kuhr C.S. Ferrenberg J. Huang M.-L. Davis C.L. Corey L. Marsh C.L. Quantitation of BK virus load in serum for the diagnosis of BK virus-associated nephropathy in renal transplant recipients J. Infect. Dis 183 2000 1669 1672 Limaye A.P. Huang M.-L. Leisenring W. Stensland L. Corey L. Boeckh M. Cytomegalovirus (CMV) DNA load in plasma for the diagnosis of CMV disease before engraftment in hematopoietic stem-cell transplant recipients J. Infect. Dis 183 2001 377 382 11133368 Lindler L.E. Fan W. Development of a 5′ nuclease assay to detect ciprofloxacin resistant isolates of the biowarfare agent Yersinia pestis Mol. Cell. Probes 17 2003 41 47 12628593 Lindler L.E. Fan W. Jahan N. Detection of ciprofloxacin-resistant Yersinia pestis by fluorogenic PCR using the LightCycler J. Clin. Microbiol 39 2001 3649 3655 11574586 Lipson S.M. Rapid laboratory diagnostics during the winter respiratory virus season J. Clin. Microbiol 40 2002 733 734 11826012 Liss B. Improved quantitative real-time RT-PCR for expression profiling of individual cells Nucleic Acids Res 30 2002 e89 12202777 Liu Yin J.A. Minimal residual disease in acute myeloid leukaemia Best Pract. Res. Clin. Haematol 15 2002 119 135 11987920 Liu W. Saint D.A. A new quantitative method of real time reverse transcription polymerase chain reaction assay based on simulation of polymerase chain reaction kinetics Anal. Biochem 302 2002 52 59 11846375 Livak K.J. Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2t−ΔΔC method Methods 25 2001 402 408 11846609 Livak K.J. Flood S.J.A. Marmaro J. Giusti W. Deetz K. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization PCR Meth. Appl 4 1995 357 362 Lo Y.M.D. Chan L.Y.S. Lo K.-W. Leung S.-F. Zhang J. Chan A.T.C. Lee J.C.K. Hjelm N.M. Johnson P.J. Huang D.P. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma Cancer Res 59 1999 1188 1191 10096545 Locatelli G. Santoro F. Veglia F. Gobbi A. Lusso P. Malnati M.S. Real-time quantitative PCR for human herpesvirus 6 DNA J. Clin. Microbiol 38 2000 4042 4048 11060066 Lockhart D.J. Winzeler E.A. Genomics, gene expression and DNA arrays Nature 405 2000 827 836 10866209 Lomeli H. Tyagi S. Pritchard C.G. Lizardi P.M. Kramer F.R. Quantitative assays based on the use of replicatable hybridization probes Clin. Chem 35 1989 1826 1831 2673578 Loparev V.N. McCaustland K. Holloway B.P. Krause P.R. Takayama M. Schmid D.S. Rapid genotyping of varicella-zoster virus vaccine and wild-type strains with fluorophore-labeled hybridization probes J. Clin. Microbiol 38 2000 4315 4319 11101557 Löseke S. Grage-Griebenow E. Wagner A. Gehlhar K. Bufe A. Differential expression of IFN-α subtypes in human PBMC: evaluation of novel real-time PCR assays J. Immunol. Meth 276 2003 207 222 Lucchini S. Thompson A. Hinton J.C.D. Microarrays for microbiologists Microbiology 147 2001 1403 1414 11390672 Lunge V.R. Miller B.J. Livak K.J. Batt C.A. Factors affecting the performance of 5′ nuclease PCR assays for Listeria monocytogenes detection J. Microbiol. Meth 51 2002 361 368 Luria S.E. Darnell J.E. Titration of viruses Luria S.E. Darnell J.E. General Virology 2nd edn. 1967 New York Wiley 35 49 Lyamichev V. Brow M.A.D. Dahlberg J.E. Structure-specific endonucleolytic cleavage of nucleic acids by eubacterial DNA polymerases Science 260 1993 778 783 7683443 Machida U. Kami M. Fukui T. Kazuyama Y. Kinoshita M. Tanaka Y. Kanda Y. Ogawa S. Honda H. Chiba S. Mitani K. Muto Y. Osumi K. Kimura S. Hirai H. Real-time automated PCR for early diagnosis and monitoring of cytomegalovirus infection after bone marrow transplantation J. Clin. Microbiol 38 2000 1536 1542 10747139 Mackay I.M. Metharom P. Sloots T.P. Wei M.Q. Quantitative PCR-ELAHA for the determination of retroviral vector transduction efficiency Mol. Ther 3 2001 801 807 11356085 Mackay I.M. Arden K.E. Nitsche A. Real-time PCR in virology Nucleic Acids Res 30 2002 1292 1305 11884626 Mackay I.M. Gardam T. Arden K.E. McHardy S. Whiley D.M. Crisante E. Sloots T.P. Co-detection and discrimination of six human herpesviruses by multiplex PCR-ELAHA J. Clin. Virol 28 2003 291 302 14522068 Mackay I.M. Jacob K.C. Woolhouse D. Waller K. Syrmis M.W. Whiley D.M. Siebert D.J. Nissen M.N. Sloots T.P. Molecular assays for the detection of human metapneumovirus J. Clin. Microbiol 41 2003 100 105 12517833 MacKenzie J. Gallagher A. Clayton R.A. Perry J. Eden O.B. Ford A.M. Greaves M.F. Jarrett R.F. Screening for herpesvirus genomes in common acute lymphoblastic leukemia Leukemia 15 2001 415 421 11237065 Makino S.-I. Cheun H.I. Watarai M. Uchida I. Takeshi K. Detection of anthrax spores from the air by real-time PCR Lett. Appl. Microbiol 33 2001 237 240 11555211 Martell M. Gómez J. Esteban J.I. Sauleda S. Quer J. Cabot B. Esteban R. Guardia J. High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA J. Clin. Microbiol 37 1999 327 332 9889212 Martineau F. Picard F.J. Lansac N. Ménard C. Roy P.H. Ouellette M. Bergeron M.G. Correlation between resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis Antimicrob. Agent Chem 44 2000 231 238 Matsumura M. Hikiba Y. Ogura K. Togo G. Tsukuda I. Ushikawa K. Shiratori Y. Omata M. Rapid detection of mutations in the 23S rRNA gene of Helicobacter pylori that confers resistance to clarithromycin treatment to the bacterium J. Clin. Microbiol 39 2001 691 695 11158129 Matthews J.A. Kricka L.J. Analytical strategies for the use of DNA probes Anal. Biochem 169 1988 1 25 3285726 McCartney H.A. Foster S.J. Fraaije B.A. Ward E. Molecular diagnostics for fungal plant pathogens Pest Manag. Sci 59 2003 129 142 12587866 McCreedy B.J. Callaway T.H. Laboratory design and work flow Persing D.H. Smith T.F. Tenover F.C. White T.J. Diagnostic Molecular Microbiology: Principles and Applications 1993 ASM Washington, DC 149 159 Menzo S. Bagnarelli P. Giacca M. Manzin A. Varaldo P.E. Clementi M. Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction J. Clin. Microbiol 30 1992 1752 1757 1629331 Mhlanga M.M. Malmberg L. Using molecular beacons to detect single-nucleotide polymorphisms with real-time PCR Methods 25 2001 463 471 11846616 Miller N. Cleary T. Kraus G. Young A.K. Spruill G. Hnatyszyn H.J. Rapid and specific detection of Mycobacterium tuberculosis from acid-fast bacillus smear-positive respiratory specimens and BacT/ALERT MP culture bottles by using fluorogenic probes and real time-PCR J. Clin. Microbiol 40 2002 4143 4147 12409388 Mitchell T.J. Molecular basis of virulence Arch. Dis. Child 78 1998 197 209 9613345 Monopoeho S. Mignotte B. Schwartzbrod L. Marechal V. Nicolas J.-C. Billaudel S. Férré V. Quantification of enterovirus RNA in sludge samples using single tube real-time RT-PCR Biotechniques 29 2000 88 93 10907082 Monpoeho S. Coste-Burel M. Costa-Mattioli M. Besse B. Chomel J.J. Billaudel S. Ferré V. Application of a real-time polymerase chain reaction with internal positive control for detection and quantification of enterovirus in cerebrospinal fluid Eur. J. Clin. Microbiol. Infect. Dis 21 2002 532 536 12172744 Moody A. Sellers S. Bumstead N. Measuring infectious bursal disease virus RNA in blood by multiplex real-time quantitative RT-PCR J. Virol. Meth 85 2000 55 64 Möller A. Jansson J.K. Quantification of genetically tagged cyanobacteria in Baltic sea sediment by competitive PCR Biotechniques 22 1997 512 518 9067031 Morrison L.E. Halder T.C. Stols L.M. Solution-phase detection of polynucleotides using interacting fluorescent labels and competitive hybridization Anal. Biochem 183 1989 231 244 2624314 Morrison T.B. Weis J.J. Wittwer C.T. Quantification of low-copy transcripts by continuous SYBR® green I monitoring during amplification Biotechniques 24 1998 954 962 9631186 Morrison T.M. Weis J.J. Wittwer C.T. Quantification of low-copy transcripts by continuous SYBR green I monitoring during amplification Biotechniques 24 1998 954 962 9631186 Mothershed E.A. Sacchi C.T. Whitney A.M. Barnett G.A. Ajello G.W. Schmink S. Mayer L.W. Phelan M. Taylor T.H. Bernhardt S.A. Rosenstein N.E. Popovic T. Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis J. Clin. Microbiol 42 2004 320 328 14715772 Mullis K.B. Faloona F. Specific synthesis of DNA in vitro via a polymerase-catalysed chain reaction Meth. Enzymol 155 1987 335 350 3431465 Muti G. Klersy C. Baldanti F. Granata S. Oreste P. Pezzetti L. Gatti M. Gargantini L. Caramella M. Mancini V. Gerna G. Morra E. Epstein-Barr virus (EBV) load and interleukin-10 in EBV-positive and EBV-negative post-transplant lymphoproliferative disorders Br. J. Haem 122 2003 927 933 Najioullah F. Thouvenot D. Lina B. Development of a real-time PCR procedure including an internal control for the measurement of HCMV viral load J. Virol. Meth 92 2001 55 64 Nakayama H. Yokoi H. Fujita J. Quantification of mRNA by non-radioactive RT-PCR and CCD imaging system Nucleic Acids Res 20 1992 4939 1383932 Natarajan V. Plishka R.J. Scott E.W. Lane H.C. Salzman N.P. An internally controlled virion PCR for the measurement of HIV-1 RNA in plasma PCR Meth. Appl 3 1994 346 350 Nazarenko I.A. Bhatnager S.K. Hohman R.J. A closed tube format for amplification and detection of DNA based on energy transfer Nucleic Acids Res 25 1997 2516 2521 9171107 Nazarenko I. Lowe B. Darfler M. Ikonomi P. Schuster D. Raschtchian A. Multiplex quantitative PCR using self-quenched primers labeled with a single fluorophore Nucleic Acids Res 30 2002 e37 11972352 Ng L.F.P. Wong M. Koh S. Ooi E.-E. Tang K.-F. Leong H.-N. Ling A.-E. Agathe L.V. Tan J. Liu E.T. Ren E.-C. Ng L.-C. Hibberd M.L. Detection of severe acute respiratory syndrome coronavirus in blood of infected patients J. Clin. Microbiol 42 2004 347 350 14715775 Nicoll S. Brass A. Cubie H.A. Detection of herpes viruses in clinical samples using real-time PCR J. Virol. Meth 96 2001 25 31 Niesters H.G.M. Quantitation of viral load using real-time amplification techniques Methods 25 2001 419 429 11846611 Niesters H.G.M. Clinical virology in real time J. Clin. Virol 25 2002 S3 S12 12467772 Niesters H.G. van Esser J. Fries E. Wolthers K.C. Cornelissen J. Osterhaus A.D. Development of a real-time quantitative assay for detection of Epstein-Barr virus J. Clin. Microbiol 38 2000 712 715 10655372 Nijhuis M. van Maarseveen N. Schuurman R. Verkuijlen S. de Vos M. Hendricksen K. van Loon A.M. Rapid and sensitive routine detection of all members of the genus Enterovirus in different clinical specimens by real-time PCR J. Clin. Microbiol 40 2002 3666 3670 12354863 Nitsche A. Steuer N. Schmidt C.A. Landt O. Siegert W. Different real-time PCR formats compared for the quantitative detection of human cytomegalovirus DNA Clin. Chem 45 1999 1932 1937 10545062 Nitsche A. Steuer N. Schmidt C.A. Landt O. Ellerbrok H. Pauli G. Siegert W. Detection of human cytomegalovirus DNA by real-time quantitative PCR J. Clin. Microbiol 38 2000 2734 2737 10878073 Nitsche A. Ellerbrok H. Pauli G. Detection of orthopoxvirus DNA by real-time PCR and identification of variola virus DNA by melting analysis J. Clin. Microbiol 42 2004 1207 1213 15004077 Nogva H.K. Rudi K. Naterstad K. Holck A. Lillehaug D. Application of 5′-nuclease PCR for quantitative detection of Listeria monocytogenes in pure cultures, water, skim milk and unpasteurized whole milk Appl. Environ. Microbiol 66 2000 4266 4271 11010869 Northrup M.A. A miniature analytical instrument for nucleic acids based on micromachined silicon reaction chambers Anal. Chem 70 1998 918 922 9511467 Nulens E. Voss A. Laboratory diagnosis and biosafety issues of biological warfare agents Clin. Microbiol. Infect 8 2002 455 466 12197868 Nutiu R. Li Y. Tripartite molecular beacons Nucleic Acids Res 30 2002 e94 12235396 Obika S. Nanbu D. Hari Y. Andoh J.-I. Morio K.-I. Doi T. Imanishi T. Stability and structural features of the duplexes containing nucleoside analogues with a fixed N-type conformation, 2′-O,4′-C-methyleneribonucleosides Tetrahedron Lett 39 1998 5401 5404 Oggioni M.R. Meacci F. Carattoli A. Ciervo A. Orru G. Cassone A. Pozzi G. Protocol for real-time PCR inhibition of anthrax spores from nasal swabs after broth enrichment J. Clin. Microbiol 40 2002 3956 3963 12409358 Ogilvie M. Molecular techniques should not now replace cell culture in diagnostic virology laboratories Rev. Med. Virol 11 2001 351 354 11746997 Ohyashiki J.K. Suzuki A. Aritaki K. Nagate A. Shoji N. Ohyashiki K. Ojima T. Abe K. Yamamoto K. Use of real-time PCR to monitor human herpesvirus 6 reactivation after allogeneic bone marrow transplantation Int. J. Mol. Med 6 2000 427 432 10998432 O'Leary J. Kennedy M. Howells D. Silva I. Uhlmann V. Luttich K. Biddolph S. Lucas S. Russell J. Bermingham N. O'Donovan M. Ring M. Kenny C. Sweeney M. Sheils O. Martin C. Picton S. Gatter K. Cellular localisation of HHV-8 in Castleman's disease: is there a link with lymph node vascularity? J. Clin. Pathol 53 2000 69 76 O'Leary J.J. Kennedy M. Luttich K. Uhlmann V. Silva I. Russell J. Sheils O. Ring M. Sweeney M. Kenny C. Bermingham N. Martin C. O'Donovan M. Howells D. Picton S. Lucas S.B. Localisation of HHV-8 in AIDS related lymphadenopathy J. Clin. Pathol 53 2000 43 47 O'Mahony J. Hill C. A real time PCR assay for the detection and quantitation of Mycobacterium avium subsp. paratuberculosis using SYBR green and the Light Cycler J. Microbiol. Meth 51 2002 283 293 Orlando C. Pinzani P. Pazzagli M. Developments in quantitative PCR Clin. Chem. Lab. Med 36 1998 255 269 9676381 O'Sullivan C.E. Kasai M. Francesconi A. Petraitis V. Petraitiene R. Kelaher A.M. Sarafandi A.A. Walsh T.J. Development and validation of a quantitative real-time PCR assay using fluorescence resonance energy transfer technology for detection of Aspergillus fumigatus in experimental invasive pulmonary aspergillosis J. Clin. Microbiol 41 2003 5676 5682 14662960 Overbergh L. Valckx D. Waer M. Mathieu C. Quantification of murine cytokine mRNAs using real-time quantitative reverse transcriptase PCR Cytokine 11 1999 305 312 10328870 Overbergh L. Giulietti A. Valckx D. Decallonne B. Bouillon R. Mathieu C. The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression J. Biomol. Tech 14 2003 33 43 12901609 Pahl A. Kühlbrandt U. Brune K. Röllinghoff M. Gessner A. Quantitative detection of Borrelia burgdorferi by real-time PCR J. Clin. Microbiol 37 1999 1958 1963 10325354 Pang X.L. Increased detection of rotavirus using a real time reverse transcription-polymerase chain reaction (RT-PCR) assay in stool specimens from children with diarrhea J. Med. Virol 72 2004 496 501 14748075 Peiris J.S. Lai S.T. Poon L.L. Guan Y. Yam L.Y. Lim W. Nicholls J. Yee W.K. Yan W.W. Cheung M.T. Cheng V.C. Chan K.H. Tsang D.N. Yung R.W. Ng T.K. Yuen K.Y. SARS study group Coronavirus as a possible cause of severe acute respiratory syndrome Lancet 361 2003 1319 1325 12711465 Persing D.H. In vitro nucleic acid amplification techniques Persing D.H. Smith T.F. Tenover F.C. White T.J. Diagnostic Molecular Microbiology: Principles and Applications 1993 ASM Washington, DC 51 87 Peter J.B. Sevall J.S. Review of 3200 serially received CSF samples submitted for type-specific HSV detection by PCR in the reference laboratory setting Mol. Cell. Probes 15 2001 177 182 11352599 Petersen M. Wengel J. LNA: a versatile tool for therapeutics and genomics Trends Biotechnol 21 2003 74 81 12573856 Petrik J. Pearson G.J.M. Allain J.-P. High throughput PCR detection of HCV based on semiautomated multisample RNA capture J. Virol. Meth 64 1997 147 159 Pfaffl M.W. Horgan G.W. Dempfle L. Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR Nucleic Acids Res 30 2002 e36 11972351 Pfaller M.A. Molecular epidemiology in the care of patients Arch. Pathol. Lab. Med 123 1999 1007 1010 10539897 PhorTech. Rapid rise in platforms for realtime PCR transforms DNA amplification instrumentation market. http://www.phortech.com/02ampi.htm, 2003. Pietilä J. He Q. Oksi J. Viljanen M.K. Rapid differentiation of Borrelia garinii from Borrelia afzelii and Borrelia burgdorferi sensu stricto by LightCycler fluorescence melting curve analysis of a PCR product of the recA gene J. Clin. Microbiol 38 2000 2756 2759 10878080 Pinzani P. Bonciani L. Pazzagli M. Orlando C. Guerrini S. Granchi L. Rapid detection of Oenococcus oeni in wine by real-time quantitative PCR Lett. Appl. Microbiol 38 2004 118 124 14746542 Poutanen S.M. Low D.E. Henry B. Finkelstein S. Rose D. Green K. Tellier R. Draker R. Adachi D. Ayers M. Chan A.K. Skowronski D.M. Salit I. Simor A.E. Slutsky A.S. Doyle P.W. Krajden M. Petric M. Brunham R.C. McGeer A.J. Identification of severe acute respiratory syndrome in Canada N. Engl. J. Med 348 2003 1995 2005 12671061 Probert W.S. Bystrom S.L. Khashe S. Schrader K.N. Wong J.D. 5′ Exonuclease assay for detection of serogroup Y Neisseria meningitidis J. Clin. Microbiol 40 2002 4325 4328 12409421 Qi Y. Patra G. Liang X. Williams L.E. Rose S. Redkar R.J. del Vecchio V.G. Utilization of the rpoB gene as a specific chromosomal marker for real-time PCR detection of Bacillus anthracis Appl. Environ. Microbiol 67 2001 3720 3727 11472954 Quereda C. Corral I. Laguna F. Valencia M.E. Tenorio A. Echevarria J.E. Navas E. Martín-Davilla P. Moreno A. Moreno V. Gonzalez-Lahoz J.M. Arribas J.R. Guerrero A. Diagnostic utility of a multiplex herpesvirus PCR assay performed with cerebrospinal fluid from human immunodeficiency virus-infected patients with neurological disorders J. Clin. Microbiol 38 2000 3061 3067 10921978 Radonic A. Thulke S. Mackay I.M. Landt O. Siegert W. Nitsche A. Guideline to reference gene selection for quantitative real-time PCR Biochem. Biophys. Res. Commun 313 2004 856 862 14706621 Randegger C.C. Hachler H. Real-time PCR and melting curve analysis for reliable and rapid detection of SHV extended-spectrum β-lactamases Antimicrob. Agent Chem 45 2001 1730 1736 Ratge D. Scheiblhuber B. Landt O. Berg J. Knabbe C. Two-round rapid-cycle RT-PCR in single closed capillaries increases the sensitivity of HCV RNA detection and avoids amplicon carry-over J. Clin. Virol 24 2002 161 172 11856617 Rauter C. Oehme R. Diterich I. Engele M. Hartung T. Distribution of clinically relevant Borrelia genospecies in ticks assessed by a novel, single-run, real-time PCR J. Clin. Microbiol 40 2002 36 43 11773090 Read S.J. Recovery efficiencies of nucleic acid extraction kits as measured by quantitative LightCycler™ PCR J. Clin. Pathol 54 2001 86 90 Read S.J. Mitchell J.L. Fink C.G. LightCycler multiplex PCR for the laboratory diagnosis of common viral infections of the central nervous system J. Clin. Microbiol 39 2001 3056 3059 11526128 Reid S.M. Gerris N.P. Hutchings G.H. King D.P. Alexandersen S. Evaluation of real-time reverse transcription polymerase chain reaction assays for the detection of swine vesicular disease virus J. Virol. Meth 116 2004 169 176 Reischl U. Linde H.-J. Metz M. Leppmeier B. Lehn N. Rapid identification of methicillin-resistant Staphylococcus aureus and simultaneous species confirmation using real-time fluorescence PCR J. Clin. Microbiol 38 2000 2429 2433 10835024 Reischl U. Linde H.-J. Lehn N. Landt O. Barratt K. Wellinghausen N. Direct detection and differentiation of Legionella spp. and Legionella pneumophila in clinical specimens by dual-colour real-time PCR and melting curve analysis J. Clin. Microbiol 40 2002 3814 3817 12354888 Reiss R.A. Rutz B. Quality control PCR: a method for detecting inhibitors of Taq DNA polymerase Biotechniques 27 1999 920 926 10572637 Ririe K.M. Rasmussen R.P. Wittwer C.T. Product differentiation by analysis of DNA melting curves during the polymerase chain reaction Anal. Biochem 245 1997 154 160 9056205 Roberts T.C. Brennan D.C. Buller R.S. Gaudreault-Keener M. Schnitzler M.A. Sternhell K.E. Garlock K.A. Singer G.G. Storch G.A. Quantitative polymerase chain reaction to predict occurrence of symptomatic cytomegalovirus infection and assess response to ganciclovir therapy in renal transplant recipients J. Infect. Dis 178 1998 626 636 9728529 Rodrigo A.G. Goracke P.C. Rowhanian K. Mullins J.I. Quantitation of target molecules from polymerase chain reaction-based limiting dilution assays AIDS Res. Hum. Retro 13 1997 737 742 Roe J.D. Haugland R.A. Vesper S.J. Wymer L.J. Quantification of Stachybotrys chartarum conidia in indoor dust using real time, fluorescent probe-based detection of PCR products J. Exposure Anal. Environ. Epidemiol 11 2001 12 20 Rohr U.-P. Wulf M.-A. Stahn S. Steidl U. Haas R. Kronenwett R. Fast and reliable titration of recombinant adeno-associated virus type-2 using quantitative real-time PCR J. Virol. Meth 106 2002 81 88 Rollag H. Sagedal S. Holter E. Degre M. Ariansen S. Nordal K.P. Diagnosis of cytomegalovirus infection in kidney transplant recipients by a quantitative RNA-DNA hybrid capture assay for cytomegalovirus DNA in leukocytes Eur. J. Clin. Microbiol. Infect. Dis 17 1998 124 127 9629980 Rosenstraus M. Wang Z. Chang S.-Y. DeBonville D. Spadoro J.P. An internal control for routine diagnostic PCR: design, properties, and effect on clinical performance J. Clin. Microbiol 36 1998 191 197 9431945 Ruan Y.J. Wei C.L. Ee A.L. Vega V.B. Thoreau H. Su S.T. Chia J.M. Ng P. Chiu K.P. Lim L. Zhang T. Peng C.K. Lin E.O. Lee N.M. Yee S.L. Ng L.F. Chee R.E. Stanton L.W. Long P.M. Liu E.T. Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection Lancet 361 2003 1779 1785 12781537 Rudi K. Nogva H.K. Moen B. Nissen H. Bredholt S. Møretrø T. Naterstad K. Holck A. Development and application of new nucleic acid-based technologies for microbial community analyses in food Int. J. Food Microbiol 78 2002 171 180 12222632 Rutledge R.J. Côte C. Mathematics of quantitative kinetic PCR and the application of standard curves Nucleic Acids Res 31 2003 e93 12907745 Ryncarz A.J. Goddard J. Wald A. Huang M.-L. Roizman B. Corey L. Development of a high-throughput quantitative assay for detecting herpes simplex virus DNA in clinical samples J. Clin. Microbiol 37 1999 1941 1947 10325351 Sanburn N. Cornetta K. Rapid titer determination using quantitative real-time PCR Gene Ther 6 1999 1340 1345 10455446 Schaade L. Kockelkorn P. Ritter K. Kleines M. Detection of cytomegalovirus DNA in human specimens by LightCycler PCR J. Clin. Microbiol 38 2000 4006 4009 11060060 Schalasta G. Arents A. Schmid M. Braun R.W. Enders G. Fast and type-specific analysis of herpes simplex virus types 1 and 2 by rapid PCR and fluorescence melting-curve-analysis Infection 28 2000 85 91 10782393 Schalasta G. Eggers M. Schmid M. Enders G. Analysis of human cytomegalovirus DNA in urines of newborns and infants by means of a new ultrarapid real-time PCR-system J. Clin. Virol 19 2000 175 185 11090754 Scherr M. Battmer K. Blömer U. Ganser A. Grez M. Quantitative determination of lentiviral vector particle numbers by real-time PCR Biotechniques 31 2001 520 526 11570495 Schoder D. Schmalwieser A. Schauberger G. Kuhn M. Hoorfar J. Wagner M. Physical characteristics of six new thermocyclers Clin. Chem 49 2003 960 963 12765996 Schutten M. van den Hoogen B. van der Ende M.E. Gruters R.A. Osterhaus A.D.M.E. Niesters H.G.M. Development of a real-time quantitative RT-PCR for the detection of HIV-2 RNA in plasma J. Virol. Meth 88 2000 81 87 Schütz E. von Ashen N. Oellerich M. Genotyping of eight thiopurine methyltransferase mutations: three-color multiplexing, two-color/shared anchor, and fluorescence-quenching hybridization probe assays based on thermodynamic nearest-neighbour probe design Clin. Chem 46 2000 1728 1737 11067806 Selvey S. Thompson E.W. Matthaei K. Lea R.A. Irving M.G. Griffiths L.R. β-actin – an unsuitable internal control for RT-PCR Mol. Cell. Probes 15 2001 307 311 11735303 Selvin P. Fluorescence resonance energy transfer Meth. Enzymol 246 1995 300 334 7752929 Semighini C.P. Marins M. Goldman M.H.S. Goldman G.H. Quantitative analysis of the relative transcript levels of ABC transporter Atr genes in Aspergillus nidulans by real-time reverse transcription-PCR assay Appl. Environ. Microbiol 68 2002 1351 1357 11872487 Sharp J.G. Chan W.C. Detection and relevance of minimal disease in lymphomas Cancer Metastasis Rev 18 1999 127 142 10505551 Shaw R.D. Hempson S.J. Mackow E.R. Rotavirus diarrhea is caused by nonreplicating viral particles J. Virol 69 1995 5946 5950 Erratum: J. Virol. 1996. 70 (8), 5740 7666499 Shrestha N.K. Tuohy M.J. Hall G.S. Isada C.M. Procop G.W. Rapid identification of Staphylococcus aureus and the mecA gene from BacT/ALERT blood culture bottles by using the LightCycler system J. Clin. Microbiol 40 2002 2659 2661 12089301 Siebert P.D. Larrick J.W. Competitive PCR Nature 359 1992 557 558 1383831 Simeonov A. Nikiforov T.T. Single nucleotide polymorphism genotyping using short, fluorescently labeled locked nucleic acid (LNA) probes and fluorescence polarization detection Nucleic Acids Res 30 2002 e91 12202779 Singh S.K. Nielsen P. Koshkin A.A. Wengel J. LNA (locked nucleic acids): synthesis and high-affinity nucleic acid recognition Chem. Commun 1998 455 456 Sintchenko V. Iredell J.R. Gilbert G.L. Is it time to replace the petri dish with PCR? Application of culture-independent nucleic acid amplification in diagnostic bacteriology: expectations and reality Pathology 31 1999 436 439 10643023 Smith I.L. Halpin K. Warrilow D. Smith G.A. Development of a fluorogenic RT-PCR assay (TaqMan) for the detection of Hendra virus J. Virol. Meth 98 2001 33 40 Smith I.L. Northill J.A. Harrower B.J. Smith G.A. Detection of Australian bat lyssavirus using a fluorogenic probe J. Clin. Virol 25 2002 285 291 12423692 Solinas A. Brown L.J. McKeen C. Mellor J.M. Nicol J.T.G. Thelwell N. Brown T. Duplex scorpion primers in SNP analysis and FRET applications Nucleic Acids Res 29 2001 e96 11600715 Song E.S. Lee V. Surh C.D. Lynn A. Brumm D. Jolly D.J. Warner J.F. Chada S. Antigen presentation in retroviral vector-mediated gene transfer in vivo Proc. Natl Acad. Sci. USA 94 1997 1943 1948 9050884 Song J. Ohkura T. Sugimoto M. Mori Y. Inagi R. Yamanishi K. Yoshizaki K. Nishimoto N. Human interleukin-6 induces human herpesvirus-8 replication in a body cavity-based lymphoma cell line J. Med. Virol 68 2002 404 411 12226829 Stender H. Fiandaca M. Hyldig-Nielsen J.J. Coull J. PNA for rapid microbiology J. Microbiol. Meth 48 2002 1 17 Stephenson J. Monkeypox outbreak a reminder of emerging infections vulnerabilities JAMA 290 2003 23 24 12837700 Stevens S.J.C. Verkuijlen S.A.W.M. van den Brule A.J.C. Middeldorp J.M. Comparison of quantitative competitive PCR with LightCycler-based PCR for measuring Epstein-Barr virus DNA load in clinical specimens J. Clin. Microbiol 40 2002 3986 3992 12409363 Stöcher M. Leb V. Hölzl G. Berg J. A simple approach to the generation of heterologous competitive internal controls for real-time PCR assays on the LightCycler J. Clin. Virol 25 2002 S47 S53 12467777 Stocher M. Leb V. Bozic M. Kessler H.H. Halwachs-Baumann G. Landt O. Stekel H. Berg J. Parallel detection of five human herpes virus DNAs by a set of real-time polymerase chain reactions in a single run J. Clin. Virol 26 2003 85 93 12589838 Stockton J. Ellis J.S. Saville M. Clewley J.P. Zambon M.C. Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses J. Clin. Microbiol 36 1998 2990 2995 9738055 Stordeur P. Poulin L.F. Craciun L. Zhou L. Schandené L. de Lavareille A. Goriely S. Goldman M. Cytokine mRNA quantification by real-time PCR J. Immunol. Meth 259 2002 55 64 Stram Y. Kuznetzova L. Guini M. Rogel A. Meirom R. Chai D. Yadin H. Brenner J. Detection and quantitation of Akabane and Aino viruses by multiplex real-time reverse-transcriptase PCR J. Virol. Meth 116 2004 147 154 Strieter R.M. Belperio J.A. Keane M.P. Host innate defenses in the lung: the role of cytokines Curr. Opin. Infect. Dis 16 2003 193 198 12821807 Stryer L. Haugland R.P. Energy transfer: a spectroscopic ruler Proc. Natl Acad. Sci. USA 58 1967 719 726 5233469 Suzuki K. Aoki K. Ohnami S. Yoshida K. Kazui T. Kato N. Inoue K. Kohara M. Yoshida T. Adenovirus-mediated gene transfer of interferon α inhibits hepatitis C virus replication in hepatocytes Biochem. Biophys. Res. Commun 307 2003 814 819 12878183 Svanvik N. Sehlstedt U. Sjöback R. Kubista M. Detection of PCR products in real time using light-up probes Anal. Biochem 287 2000 179 182 11078598 Svanvik N. Westman G. Wang D. Kubista M. Light-up probes: thiazole orange-conjugated peptide nucleic acid for the detection of target nucleic acid in homogeneous solution Anal. Biochem 281 2001 26 35 Swan D.C. Tucker R.A. Holloway B.P. Icenogle J.P. A sensitive, type-specific, fluorogenic probe assay for detection of human papillomavirus DNA J. Clin. Microbiol 35 1997 886 891 9157148 Sykes P.J. Brisco M.J. Snell L.E. Dolman G. Neoh S.-H. Peng L.-M. Toogood I. Minimal residual disease in childhood acute lymphoblastic leukaemia quantified by aspirate and trephine: is the disease multifocal? Br. J. Haematol 103 1998 60 65 9792290 Takaya K. Ogawa Y. Hiraoka J. Hosoda K. Yamori Y. Nakao K. Nonesense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat Nat. Gen 14 1996 130 131 Tan T.Y. Corden S. Barnes R. Cookson B. Rapid identification of methicillin-resistant Staphylococcus aureus from positive blood cultures by real-time fluorescence PCR J. Clin. Microbiol 39 2001 4529 4531 11724876 Tanaka N. Kimura H. Hoshino Y. Kato K. Yoshikawa T. Asano Y. Horibe K. Kojima S. Morishima T. Monitoring four herpesviruses in unrelated cord blood transplantation Bone Marrow Transpl 26 2000 1193 1197 Tanaka N. Kimura H. Iida K. Saito Y. Tsuge I. Yoshimi A. Matsuyama T. Morishima T. Quantitative analysis of cytomegalovirus load using a real-time PCR assay J. Med. Virol 60 2000 455 462 10686030 Tanriverdi S. Tanyeli A. Baslamisli F. Köksal F. Kilinç Y. Feng X. Batzer G. Tzipori S. Widmer G. Detection and genotyping of oocysts of Cryptosporidium parvum by real-time PCR and melting curve analysis J. Clin. Microbiol 40 2002 3237 3244 12202559 Tarnuzzer R.W. Macauley S.P. Farmerie W.G. Caballero S. Ghassemifar M.R. Anderson J.T. Robinson C.P. Grant M.B. Humphreys-Beher M.G. Franzen L. Peck A.B. Schultz G.S. Competitive RNA templates for detection and quantitation of growth factors, cytokines, extracellular matrix components and matrix metalloproteinases by RT-PCR Biotechniques 20 1996 670 674 8800688 Tasker S. Helps C.R. Day M.J. Gruffydd-Jones T.J. Harbour D.A. Use of real-time PCR to detect and quantify Mycoplasma haemofelis and Candidatus Mycoplasma haemominutum DNA J. Clin. Microbiol 41 2003 439 441 12517888 Tasker S. Helps C.R. Day M.J. Harbour D.A. Gruffydd-Jones T. Lappin M.R. Use of Taqman PCR to determine the response of Mycoplasma haemofelis infection to antibiotic treatment J. Microbiol. Meth 56 2004 63 71 Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies J. Immunol 126 1981 1614 1619 7009746 Taylor M.J. Hughes M.S. Skuce R.A. Neill S.D. Detection of Mycobacterium bovis in bovine clinical specimens using real-time fluorescence and fluorescence resonance energy transfer probe rapid-cycle PCR J. Clin. Microbiol 39 2001 1272 1278 11283040 Thellin O. Zorzi W. Lakaye B. De Borman B. Coumans B. Hennen G. Grisar T. Igout A. Heinen E. Housekeeping genes as internal standards: use and limits J. Biotech 75 1999 291 295 Thelwell N. Millington S. Solinas A. Booth J. Brown T. Mode of action and applictation of Scorpion primers to mutation detection Nucleic Acids Res 28 2000 3752 3761 11000267 Todd A.V. Fuery C.J. Impey H.L. Applegate T.L. Haughton M.A. DzyNA-PCR: use of DNAzymes to detect and quantify nucleic acid sequences in a real-time fluorescent format Clin. Chem 46 2000 625 630 10794743 Torres M.J. Criado A. Palomares J.C. Aznar J. Use of real-time PCR and fluorimetry for rapid detection of rifampin and isoniazid resistance-associated mutations in Mycobacterium tuberculosis J. Clin. Microbiol 38 2000 3194 3199 10970356 Tsang K.W. Ho P.L. Ooi G.C. Yee W.K. Wang T. Chan-Yeung M. Lam W.K. Seto W.H. Yam L.Y. Cheung T.M. Wong P.C. Lam B. Ip M.S. Chan J. Yuen K.Y. Lai K.N. A cluster of cases of severe acute respiratory syndrome in Hong Kong N. Engl. J. Med 348 2003 1977 1985 12671062 Tseng S.Y. Macool D. Elliott V. Tice G. Jackson R. Barbour M. Amorese D. An homogeneous fluorescence polymerase chain reaction assay to identify Salmonella Anal. Biochem 245 1997 207 212 9056213 Tuma R.S. Beaudet M.P. Jin X. Jones L.J. Cheung C.-Y. Yue S. Singer V.L. Characterization of SYBR gold nucleic acid gel stain: a dye optimised for use with 300-nm ultraviolet transilluminators Anal. Biochem 268 1999 278 288 10075818 Tyagi S. Kramer F.R. Molecular beacons: probes that fluoresce upon hybridization Nat. Biotechnol 14 1996 303 308 9630890 Tyagi S. Bratu D.P. Kramer F.R. Multicolor molecular beacons for allele discrimination Nat. Biotechnol 16 1998 49 53 9447593 Tyagi S. Marras S.A.E. Kramer F.R. Wavelength-shifting molecular beacons Nat. Biotechnol 18 2000 1191 1196 11062440 Uhl J.R. Bell C.A. Sloan L.M. Espy M.J. Smith T.F. Rosenblatt J.E. Cockerill F.R. III Application of rapid-cycle real-time polymerase chain reaction for the detection of microbial pathogens: the Mayo-Roche rapid anthrax test Mayo Clin. Proc 77 2002 673 680 12108605 Vaisse C. Halaas J.L. Horvath C.M. Darnell J.E. Stoffel M. Friedman J.M. Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice Nat. Gen 14 1996 95 97 Valentine-Thon E. Quality control in nucleic acid testing-where do we stand? J. Clin. Virol 25 2002 S13 S21 van der Vliet G.M.E. Hermans C.J. Klatser P.R. Simple colorimetric microtiter plate hybridization assay for detection of amplified Mycobacterium leprae DNA J. Clin. Microbiol 31 1993 665 670 8458960 van Elden L.J.R. Nijhuis M. Schipper P. Schuurman R. van Loon A.M. Simultaneous detection of influenza viruses A and B using real-time quantitative PCR J. Clin. Microbiol 39 2001 196 200 11136770 van Santen V.L. Kaltenboeck B. Joiner K.S. Macklin K.S. Norton R.A. Real-time quantitative PCR-based serum neutralization test for detection and titration of neutralizing antibodies to chicken anemia virus J. Virol. Meth 115 2004 123 135 Versalovic J. Lupski J.R. Molecular detection and genotyping of pathogens: more accurate and rapid answers Trends Microbiol 10 2002 S15 S21 12377563 Verstrepen W.A. Kuhn S. Kockx M.M. van de Vyvere M.E. Rapid detection of enterovirus RNA in cerebrospinal fluid specimens with a novel single-tube real-time reverse transcription-PCR assay J. Clin. Microbiol 39 2001 4093 4096 11682535 Verstrepen W.A. Bruynseels P. Mertens A.H. Evaluation of a rapid real-time RT-PCR assay for the detection of enterovirus RNA in cerebrospinal fluid specimens J. Clin. Virol 25 2002 S39 S43 12091080 Vet J.A.M. Majithia A.R. Marras S.A.E. Tyagi S. Dube S. Poiesz B.J. Kramer F.R. Multiplex detection of four pathogenic retroviruses using molecular beacons Proc. Natl Acad. Sci. USA 96 1999 6394 6399 10339598 Vilcek Š. Paton D.J. A RT-PCR assay for the rapid recognition of border disease virus Vet. Res 31 2000 437 445 10958243 Walker G.T. Little M.C. Nadeau J.G. Shank D.D. Isothermal in vitro amplification of DNA by a restriction enzyme/DNA polymerase system Proc. Natl Acad. Sci. USA 89 1992 392 396 1309614 Walker R.A. Saunders N. Lawson A.J. Lindsay E.A. Dassama M. Ward L.R. Woodward M.J. Davies R.H. Liebana E. Threlfall E.J. Use of a LightCycler gyrA mutation assay for rapid identification of mutations conferring decreased susceptibility to ciprofloxacin in multiresistant Salmonella enterica serotype typhimurium DT104 isolates J. Clin. Microbiol 39 2001 1443 1448 11283069 Wall S.J. Edwards D.R. Quantitative reverse transcription-polymerase chain reaction (RT-PCR): a comparison of primer-dropping, competitive, and real-time RT-PCRs Anal. Biochem 300 2002 269 273 11779121 Wang T. Brown M.J. mRNA quantitation by real-time TaqMan polymerase chain reaction: validation and comparison with RNase protection Anal. Biochem 269 1999 198 201 10094795 Wang Z. Spadoro J. Determination of target copy number of quantitative standards used in PCR based diagnostic assays Ferré F. Gene Quantification Determination of target copy number of quantitative standards used in PCR based diagnostic assays 1998 Birkhauser Boston Watkins-Reidel T. Woegerbauer M. Hollemann D. Hufnagl P. Rapid diagnosis of enterovirus infections by real-time PCR on the LightCycler using the TaqMan format Diagn. Microbiol. Infect. Dis 42 2002 99 105 11858904 Watzinger F. Hörth E. Lion T. Quantitation of mRNA expression by competitive PCR using non-homologous competitors containing a shifted restriction site Nucleic Acids Res 29 2001 e52 11376164 Weigl J.A.I. Puppe W. Gröndahl B. Schmitt H.-J. Epidemiological investigation of nine respiratory pathogens in hospitalized children in Germany using multiplex reverse-transcriptase polymerase chain reaction Eur. J. Clin. Microbiol. Infect. Dis 19 2000 336 343 10898133 Weinberger K.M. Wiedenmann E. Böhm S. Jilg W. Sensitive and accurate detection of hepatitis B virus DNA using a kinetic fluorescence detection system (TaqMan PCR) J. Virol. Meth 85 2000 75 82 Weis J.H. Tan S.S. Martin B.K. Wittwer C.T. Detection of rare mRNAs via quantitative RT-PCR TIG 8 1992 263 264 1509514 Wellinghausen N. Frost C. Marre E. Detection of Legionellae in hospital water samples by quantitative real-time LightCycler PCR Appl. Environ. Microbiol 67 2001 3985 3993 11525995 Wetmur J.G. DNA probes: applications of the principles of nucleic acid hybridization Crit. Rev. Biochem. Mol. Biol 26 1991 227 259 1718662 Whelan A.C. Persing D.H. The role of nucleic acid amplification and detection in the clinical microbiology laboratory Annu. Rev. Gen 50 1996 349 373 Whiley D.M. Mackay I.M. Sloots T.P. Detection and differentiation of human polyomaviruses JC and BK by LightCycler PCR J. Clin. Microbiol 39 2001 4357 4361 11724845 Whiley D.M. LeCornec G.M. Mackay I.M. Siebert D.J. Sloots T.P. A real-time PCR assay for the detection of Neisseria gonorrhoeae by LightCycler Diagn. Microbiol. Infect. Dis 42 2002 85 89 11858902 Whiley D.M. Syrmis M.W. Mackay I.M. Sloots T.P. Detection of human respiratory syncytial virus in respiratory samples by LightCycler reverse transcriptase PCR J. Clin. Microbiol 40 2002 4418 4422 12454129 Whiley D.M. Crisante M.E. Syrmis M.W. Mackay I.M. Sloots T.P. Detection of Neisseria meningitidis by LightCycler PCR Pathology 35 2003 347 349 12959772 Whiley D.M. Syrmis M.W. Mackay I.M. Sloots T.P. Preliminary Comparison of Three LightCycler PCR assays for the detection of herpes simplex virus in swab specimens Eur. J. Clin. Microbiol. Infect. Dis 22 2003 764 767 14605937 Whitcombe D. Theaker J. Guy S.P. Brown T. Little S. Detection of PCR products using self-probing amplicons and fluorescence Nat. Biotechnol 17 1999 804 807 10429248 White I. Campbell T.C. Quantitation of cell-free and cell-associated Kaposi's sarcoma associated herpesvirus DNA by real-time PCR J. Clin. Microbiol 38 2000 1992 1995 10790138 White P.A. Pan Y. Freeman A.J. Marinos G. Ffrench R.A. Lloyd A.R. Rawlinson W.D. Quantification of hepatitis C virus in human liver and serum samples by using LightCycler reverse transcriptase PCR J. Clin. Microbiol 40 2002 4346 4348 12409428 Whitley R.J. Smallpox: a potential agent of bioterrorism Antiviral Res 57 2003 7 12 12615298 WHO Declaration of global eradication of smallpox Wkly Epidemiol. Rec 55 1980 145 152 WHO Acute respiratory syndrome. China, Hong Kong Special Administrative Region of China, and Vietnam Wkly Epidemiol. Rec 78 2003 73 74 12674023 Wilhelm J. Hahn M. Pingoud A. Influence of DNA target melting behavior on real-time PCR quantification Clin. Chem 46 2001 1738 1743 Wilhelm J. Pingoud A. Hahn M. Comparison between Taq DNA polymerase and its Stoffel fragment for quantitative real-time PCR with hybridization probes Biotechniques 30 2001 1052 1062 11355341 Witney A.A. Doolan D.L. Anthony R.M. Weiss W.R. Hoffman S.L. Carucci D.J. Determining liver stage parasite burden by real time quantitative PCR as a method for evaluating pre-erythrocytic malaria vaccine efficacy Mol. Biochem. Parasitol 118 2001 233 245 11738713 Wittwer C.T. Fillmore G.C. Garling D.J. Minimizing the time required for DNA amplification by efficient heat transfer to small samples Anal. Biochem 186 1990 328 331 2363506 Wittwer C.T. Herrmann M.G. Moss A.A. Rasmussen R.P. Continuous fluorescence monitoring of rapid cycle DNA amplification Biotechniques 22 1997 130 138 8994660 Wittwer C.T. Ririe K.M. Andrew R.V. David D.A. Gundry R.A. Balis U.J. The LightCycler™: a microvolume multisample fluorimeter with rapid temperature control Biotechniques 22 1997 176 181 8994665 Wolffs P. Grage H. Hagberg O. Rådstrom P. Impact of DNA polymerases and their buffer systems on quantitative real-time PCR J. Clin. Microbiol 42 2004 408 411 14715792 Wolk D.M. Schneider S.K. Wengenack N.L. Sloan L.M. Rosenblatt J.E. Real-time PCR method for detection of Encephalitozoon intestinalis from stool specimens J. Clin. Microbiol 40 2002 3922 3928 12409353 Woo T.H.S. Patel B.K.C. Smythe L.D. Symonds M.L. Norris M.A. Dohnt M.F. Identification of pathogenic Leptospira genospecies by continuous monitoring of fluorogenic hybridization probes during rapid-cycle PCR J. Clin. Microbiol 35 1997 3140 3146 9399509 Wood L. Questions about comparative genomics of SARS coronavirus isolates Lancet 362 2003 578 579 12932399 Woodford N. Tysall L. Auckland C. Stockdale M.W. Lawson A.J. Walker R.A. Livermore D.M. Detection of oxazolidinone-resistant Enterococcus faecalis and Enterococcus faecium strains by real-time PCR and PCR-restriction fragment length polymorphism analysis J. Clin. Microbiol 40 2002 4298 4300 12409414 Yin J.L. Shackel N.A. Zekry A. McGuinness P.H. Richards C. van der Putten K. McCaughan G.W. Eris J.M. Bishop G.A. Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR green I Immunol. Cell. Biol 79 2001 213 221 11380673 Zerr D.M. Huang M.-L. Corey L. Erickson M. Parker H.L. Frenkel L.M. Sensitive method for detection of human herpesvirus 6 and 7 in saliva collected in field studies J. Clin. Microbiol 38 2000 1981 1983 10790134 Zhai J. Briese T. Dai E. Wang X. Pang X. Du Z. Liu H. Wang J. Wang H. Guo Z. Chen Z. Jiang L. Zhou D. Han Y. Jabado O. Palacios G. Lipkin W.I. Yang R. Real-time polymerase chain reaction for detecting SARS coronavirus, Beijing, 2003 Emerg. Infect. Dis 10 2004 300 303 15030701 Zhang J. Yankaskas J.R. Engelhardt J.F. In vivo analysis of fluid transport in cystic fibrosis airway epithelia of bronchial xenografts Am. J. Physiol 270 1996 C1326 C1335 8967432 Zhang Y. Zhang D. Li W. Chen J. Peng Y. Cao W. A novel real-time quantitative PCR method using attached universal template probe Nucleic Acids Res 31 2003 e123 14530456 Zimmermann K. Manhalter J.W. Technical aspects of quantitative competitive PCR Biotechniques 21 1996 268 279 8862812